<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005584.pub3" GROUP_ID="UPPERGI" ID="550104121917382118" MERGED_FROM="" MODIFIED="2014-10-09 16:30:33 +0100" MODIFIED_BY="Karin Dearness" NOTES="&lt;p&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2&lt;/p&gt;" NOTES_MODIFIED="2014-10-07 14:58:14 -0400" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="15" REVMAN_SUB_VERSION="5.3.4 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2014-10-09 16:30:33 +0100" MODIFIED_BY="Karin Dearness">
<TITLE MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers</TITLE>
<CONTACT MODIFIED="2014-10-09 16:30:33 +0100" MODIFIED_BY="Karin Dearness"><PERSON ID="95D6629F82E26AA201C330AAFDB34C21" ROLE="AUTHOR"><FIRST_NAME>Mercedes</FIRST_NAME><LAST_NAME>Vergara</LAST_NAME><EMAIL_1>mvergara@tauli.cat</EMAIL_1><ADDRESS><DEPARTMENT>Servei de Malalties Digestives</DEPARTMENT><ORGANISATION>Hospital de Sabadell &amp; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd)</ORGANISATION><ADDRESS_1>Parc Tauli s/n</ADDRESS_1><CITY>Sabadell</CITY><REGION>Barcelona</REGION><COUNTRY CODE="ES">Spain</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2014-10-09 16:30:33 +0100" MODIFIED_BY="Karin Dearness"><PERSON ID="95D6629F82E26AA201C330AAFDB34C21" ROLE="AUTHOR"><FIRST_NAME>Mercedes</FIRST_NAME><LAST_NAME>Vergara</LAST_NAME><EMAIL_1>mvergara@tauli.cat</EMAIL_1><ADDRESS><DEPARTMENT>Servei de Malalties Digestives</DEPARTMENT><ORGANISATION>Hospital de Sabadell &amp; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd)</ORGANISATION><ADDRESS_1>Parc Tauli s/n</ADDRESS_1><CITY>Sabadell</CITY><REGION>Barcelona</REGION><COUNTRY CODE="ES">Spain</COUNTRY></ADDRESS></PERSON><PERSON ID="828110F882E26AA200E51E67E25FC1CF" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Cathy</FIRST_NAME><LAST_NAME>Bennett</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>info@systematicresearch.co.uk</EMAIL_1><EMAIL_2>info@systematicresearch.co.uk</EMAIL_2><ADDRESS><ORGANISATION>Systematic Research Ltd.</ORGANISATION><CITY>Leicester</CITY><REGION>Leicestershire</REGION><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS><FOOTNOTE>Joint first author</FOOTNOTE></PERSON><PERSON ID="16635" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Xavier</FIRST_NAME><LAST_NAME>Calvet</LAST_NAME><EMAIL_1>xcalvet@cspt.es</EMAIL_1><MOBILE_PHONE>+34 615890929</MOBILE_PHONE><ADDRESS><DEPARTMENT>Servei de Malalties Digestives</DEPARTMENT><ORGANISATION>Hospital de Sabadell &amp; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd)</ORGANISATION><ADDRESS_1>Parc Taulí, s/n</ADDRESS_1><CITY>Sabadell</CITY><ZIP>08208</ZIP><COUNTRY CODE="ES">Spain</COUNTRY><PHONE_1>+34 937231010</PHONE_1><FAX_1>+34 937160646</FAX_1></ADDRESS></PERSON><PERSON ID="16655" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Javier</FIRST_NAME><MIDDLE_INITIALS>P</MIDDLE_INITIALS><LAST_NAME>Gisbert</LAST_NAME><EMAIL_1>javier.p.gisbert@gmail.com</EMAIL_1><ADDRESS><ORGANISATION>Gastroenterology Unit, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa (IP), and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd)</ORGANISATION><CITY>Madrid</CITY><COUNTRY CODE="ES">Spain</COUNTRY><PHONE_1>+34 913093911</PHONE_1><FAX_1>+34 914022299</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-10-01 10:54:24 -0400" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="4" MONTH="7" YEAR="2014"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="22" MONTH="5" YEAR="2014"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="4" MONTH="7" YEAR="2016"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="10" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="30" MONTH="5" YEAR="2014"/>
<DESCRIPTION>
<P>Updated with new search results, 1 new trial added</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="30" MONTH="5" YEAR="2014"/>
<DESCRIPTION>
<P>New author (CB); new, updated results</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2011-09-22 09:27:32 -0400" MODIFIED_BY="Cathy Bennett">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-09-22 09:27:32 -0400" MODIFIED_BY="Karin Dearness">
<DATE DAY="5" MONTH="11" YEAR="2009"/>
<DESCRIPTION>
<P>Updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-11-05 06:04:02 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="16" MONTH="6" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="17" MONTH="1" YEAR="2007"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-12-02 05:38:57 -0500" MODIFIED_BY="Cathy Bennett">
<DATE DAY="6" MONTH="1" YEAR="2007"/>
<DESCRIPTION>
<P>Minor update.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-12-02 05:38:57 -0500" MODIFIED_BY="Cathy Bennett">
<DATE DAY="14" MONTH="2" YEAR="2006"/>
<DESCRIPTION>
<P>New studies found and included or excluded.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2009-11-04 02:00:58 -0500" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2009-11-04 02:00:58 -0500" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2009-11-04 02:00:58 -0500" MODIFIED_BY="[Empty name]">
<NAME>Mercedes Vergara, Xavier Calvet and Javier P Gisbert are investigators of the Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas (CIBERhed). CIBERhed is funded by the Instituto de Salud Carlos III.</NAME>
<COUNTRY CODE="ES">Spain</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-10-07 14:58:14 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2014-10-07 14:58:14 -0400" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers</TITLE>
<SUMMARY_BODY MODIFIED="2014-10-07 14:58:14 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>Background</B>
</P>
<P>Peptic ulcers develop when the usual protective mechanism of the body breaks down and digestive juices produced in the stomach, intestines and digestive glands damage the lining of the stomach or duodenum. Non-steroidal anti-inflammatory drugs and a bacterium called <I>Helicobacter pylori</I> are common causes of ulcers.</P>
<P>When ulcers in the stomach and small intestine (duodenum) start to bleed extensively (haemorrhage), the bleeding can be life threatening and requires emergency treatment.</P>
<P>Patients undergo an endoscopy so clinicians can locate the source of bleeding. Active bleeding or non-bleeding visible blood vessels at endoscopy are deemed 'high risk,' in that further bleeding may occur even if the initial haemorrhage can be stopped. Once the source of bleeding has been identified, endoscopic therapy reduces rebleeding rate, need for surgery and deaths. Endoscopic therapy consists of an agent to stop the bleeding, which is injected into the bleeding area; epinephrine (adrenaline) is the most popular agent. Experts disagree on the need for a second procedure such as bipolar electrocoagulation, heater probe, sclerosant or clips immediately after epinephrine; although it seems to reduce further bleeding, the effects of a second procedure on continuing illness (morbidity), surgery rates and death remain unclear.</P>
<P>
<B>Review question</B>
</P>
<P>In bleeding peptic ulcers, does a second endoscopic method reduce further bleeding, the need for emergency surgery and death rates?</P>
<P>
<B>Study characteristics</B>
</P>
<P>We performed an extensive search for randomised trials comparing epinephrine alone versus epinephrine plus a second method. We found 19 clinical trials involving 2033 randomly assigned participants</P>
<P>
<B>Key results</B>
</P>
<P>We found that adding a second procedure reduced the further bleeding rate and the need for emergency surgery, but the effect of this approach on death rates has not been proven. In conclusion, additional endoscopic treatment after epinephrine injection reduces further bleeding and the need for surgery in patients with high-risk bleeding peptic ulcer.</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>Our risk of bias estimates show that the overall quality of the included studies was moderate or high. Although some studies had limitations in their design or implementation, most were clear about important quality criteria including randomisation and allocation concealment, sequence generation and blinding. We rated the quality of evidence as moderate for most outcomes. Further research is likely to have an impact on our confidence in the estimate of effect and may change the conclusions of this review.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-10-01 13:26:14 -0400" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Endoscopic therapy reduces the rebleeding rate and the need for surgery in patients with bleeding peptic ulcers.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>To determine whether a second procedure improves haemostatic efficacy or patient outcomes or both after epinephrine injection in adults with high-risk bleeding ulcers.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>For our update in 2014, we searched the following versions of these databases, limited from June 2009 to May 2014: Ovid MEDLINE(R) 1946 to May Week 2 2014; Ovid MEDLINE(R) Daily Update May 22, 2014; Ovid MEDLINE(R) In-Process &amp; Other Non-Indexed Citations May 22, 2014 (<A HREF="01">Appendix 1</A>); Evidence-Based Medicine (EBM) Reviews&#8212;the Cochrane Central Register of Controlled Trials (CENTRAL) April 2014 (<A HREF="02">Appendix 2</A>); and EMBASE 1980 to Week 20 2014 (<A HREF="03">Appendix 3</A>).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>We included randomised controlled trials (RCTs) comparing epinephrine alone versus epinephrine plus a second method. Populations consisted of patients with high-risk bleeding peptic ulcers, that is, patients with haemorrhage from peptic ulcer disease (gastric or duodenal) with major stigmata of bleeding as defined by Forrest classification Ia (spurting haemorrhage), Ib (oozing haemorrhage), IIa (non-bleeding visible vessel) and IIb (adherent clot) (Forrest Ia-Ib-IIa-IIb).</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>We used standard methodological procedures as expected by The Cochrane Collaboration. Meta-analysis was undertaken using a random-effects model; risk ratios (RRs) with 95% confidence intervals (CIs) are presented for dichotomous data.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Nineteen studies of 2033 initially randomly assigned participants were included, of which 11 used a second injected agent, five used a mechanical method (haemoclips) and three employed thermal methods.</P>
<P>The risk of further bleeding after initial haemostasis was lower in the combination therapy groups than in the epinephrine alone group, regardless of which second procedure was applied (RR 0.53, 95% CI 0.35 to 0.81). Adding any second procedure significantly reduced the overall bleeding rate (persistent and recurrent bleeding) (RR 0.57, 95% CI 0.43 to 0.76) and the need for emergency surgery (RR 0.68, 95% CI 0.50 to 0.93). Mortality rates were not significantly different when either method was applied.</P>
<P>Rebleeding in the 10 studies that scheduled a reendoscopy showed no difference between epinephrine and combined therapy; without second-look endoscopy, a statistically significant difference was observed between epinephrine and epinephrine and any second endoscopic method, with fewer participants rebleeding in the combined therapy group (nine studies) (RR 0.32, 95% CI 0.21 to 0.48).</P>
<P>For ulcers of the Forrest Ia or Ib type (oozing or spurting), the addition of a second therapy significantly reduced the rebleeding rate (RR 0.66, 95% CI 0.49 to 0.88); this difference was not seen for type IIa (visible vessel) or type IIb (adherent clot) ulcers. Few procedure-related adverse effects were reported, and this finding was not statistically significantly different between groups. Few adverse events occurred, and no statistically significant difference was noted between groups.</P>
<P>The addition of a second injected method reduced recurrent and persistent rebleeding rates and surgery rates in the combination therapy group, but these findings were not statistically significantly different. Significantly fewer participants died in the combined therapy group (RR 0.50, 95% CI 0.25 to 1.00).</P>
<P>Epinephrine and a second mechanical method decreased recurrent and persistent bleeding (RR 0.31, 95% CI 0.18 to 0.54) and the need for emergency surgery (RR 0.20, 95% CI 0.06 to 0.62) but did not affect mortality rates.</P>
<P>Epinephrine plus thermal methods decreased the rebleeding rate (RR 0.49, 95% CI 0.30 to 0.78) and the surgery rate (RR 0.20, 95% CI 0.06 to 0.62) but did not affect the mortality rate.</P>
<P>Our risk of bias estimates show that risk of bias was low, as, although the type of study did not allow a double-blind trial, rebleeding, surgery and mortality were not dependent on subjective observation. Although some studies had limitations in their design or implementation, most were clear about important quality criteria, including randomisation and allocation concealment, sequence generation and blinding.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-10-01 13:26:14 -0400" MODIFIED_BY="[Empty name]">
<P>Additional endoscopic treatment after epinephrine injection reduces further bleeding and the need for surgery in patients with high-risk bleeding peptic ulcer. The main adverse events include risk of perforation and gastric wall necrosis, the rates of which were low in our included studies and favoured neither epinephrine therapy nor combination therapy. The main conclusion is that combined therapy seems to work better than epinephrine alone. However, we cannot conclude that a particular form of treatment is equal or superior to another.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-10-01 14:10:12 -0400" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2014-10-01 13:26:53 -0400" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Peptic ulcers develop when the usual protective mechanism of the body breaks down and digestive juices produced in the stomach, intestines and digestive glands damage the lining of the stomach or duodenum. Non-steroidal anti-inflammatory drugs and <I>Helicobacter pylori</I> are the most common causes of peptic ulcer.</P>
<P>Bleeding peptic ulcer is a serious condition in which ulcers in the upper digestive system (stomach) and the small intestine (duodenum) start to bleed extensively (haemorrhage). The bleeding can be life threatening and requires emergency treatment.</P>
<P>Patients usually require an endoscopy during the first 24 hours after admission so clinicians can locate the source of bleeding (<LINK REF="REF-Cooper-1999" TYPE="REFERENCE">Cooper 1999</LINK>). Patients with active bleeding or non-bleeding visible vessels at endoscopy are deemed 'high risk,' as this finding predicts risk of further bleeding and guides management decisions. Once the source of bleeding has been identified, endoscopic therapy reduces rebleeding rate, need for surgery and morbidity and mortality among patients bleeding from a peptic ulcer (<LINK REF="REF-Cook-1992" TYPE="REFERENCE">Cook 1992</LINK>).</P>
<P>Endoscopic therapy should be provided to patients with stigmata of high risk (<LINK REF="REF-Laine-2012" TYPE="REFERENCE">Laine 2012</LINK>). Such high-risk patients receive endoscopic therapy consisting of an agent to stop the bleeding, which is injected into the bleeding area. Injection of epinephrine is the most popular method used to stop bleeding. Second endoscopic methods may include bipolar electrocoagulation, heater probe, sclerosant or clips. At the time of publication of the first version of this review, some experts disagreed on the need for a second procedure immediately after epinephrine; although it seems to reduce further bleeding, the effects of a second procedure on continuing illness (morbidity), surgery rates and death (mortality) remain unclear.</P>
</CONDITION>
<INTERVENTION MODIFIED="2014-10-01 13:26:53 -0400" MODIFIED_BY="[Empty name]">
<P>Many different endoscopic haemostatic techniques have been developed and studied over the past 25 years. Methods are based on injection of vasoconstrictor substances (epinephrine), sclerosant substances (polidocanol, absolute alcohol), clotting factors (thrombin, fibrin glue) or adhesives (cyanoacrylate). Thermal therapies include laser, monopolar electrocoagulation, argon plasma coagulation, bipolar probes and heater probe. More recently, use of mechanical devices to clip the bleeding vessel (haemoclip) has been incorporated. Epinephrine injection&#8212;alone or in combination with another technique&#8212;has become the most popular endoscopic method for emergency endoscopic haemostasis because of its safety, low cost and easy application (<LINK REF="REF-Savides-2000" TYPE="REFERENCE">Savides 2000</LINK>).</P>
<P>Previous guidelines suggested that no clear evidence shows that any technique is superior to injection of epinephrine alone for the endoscopic treatment of high-risk bleeding peptic ulcers (<LINK REF="REF-British-Society-2002" TYPE="REFERENCE">British Society 2002</LINK>; <LINK REF="REF-Feu-2003" TYPE="REFERENCE">Feu 2003</LINK>; <LINK REF="REF-Laine-2009" TYPE="REFERENCE">Laine 2009</LINK>). However, some individual studies have reported a significant reduction in further bleeding rates with the addition of a second endoscopic treatment (<LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>). Although absolute improvements in haemostatic efficacy were relatively small (from 10% to 20%), they represent a 30% to 60% reduction in the relative risk of recurrent haemorrhage.</P>
<P>At the time of publication of the first version of this review, although some randomised studies had established that epinephrine in combination with a second haemostatic technique is better than epinephrine alone, guidelines available at the time did not provide clear recommendations on this point (<LINK REF="REF-British-Society-2002" TYPE="REFERENCE">British Society 2002</LINK>; <LINK REF="REF-Feu-2003" TYPE="REFERENCE">Feu 2003</LINK>). The American Society for Gastrointestinal Endoscopy (ASGE) suggests that combination therapy is better than epinephrine alone for the treatment of peptic ulcer bleeding (<LINK REF="REF-ASGE-2004" TYPE="REFERENCE">ASGE 2004</LINK>). After publication of the first version of our review in <I>The Cochrane Library</I> (<LINK REF="REF-Vergara-2007" TYPE="REFERENCE">Vergara 2007</LINK>), further reviews recommended combined treatment for high-risk peptic ulcer (<LINK REF="REF-Kovacs-2008" TYPE="REFERENCE">Kovacs 2008</LINK>; <LINK REF="REF-Peter-2008" TYPE="REFERENCE">Peter 2008</LINK>). Since then, updated guidelines for acute non-variceal bleeding have been produced. The ASGE has recommended that if "epinephrine is used to treat peptic ulcer bleeding with high-risk stigmata, a second endoscopic treatment modality (co-aptive thermal device, sclerosants, thrombin/fibrin glue or clips) should also be used" (<LINK REF="REF-Hwang-2012" TYPE="REFERENCE">Hwang 2012</LINK>). This is also stated in UK National Institute for Health and Care Excellence (NICE) guideline, which indicates that epinephrine should not be used alone for the treatment of bleeding, but it should be used in combination with a mechanical method, thermal coagulation or fibrin or thrombin (<LINK REF="REF-NICE-2012" TYPE="REFERENCE">NICE 2012</LINK>). Repeat endoscopy, with treatment as appropriate, should be considered for all patients at high risk of rebleeding, particularly if doubt exists about adequate haemostasis at the first endoscopy. The American College of Gastroenterology (AGA) Guideline of 2012 (<LINK REF="REF-Laine-2012" TYPE="REFERENCE">Laine 2012</LINK>) suggested that patients with acute upper gastrointestinal bleeding should undergo endoscopy within 24 hours of admission, with stigmata of recent haemorrhage recorded, as they predict risk of further bleeding (using the Forrest classification). Endoscopic therapy should be provided to patients with active spurting or oozing bleeding and to those with a non-bleeding visible vessel. A strong recommendation with high-quality evidence suggests that epinephrine therapy should be used in combination, as epinephrine monotherapy is less effective than other monotherapies in preventing further bleeding. The second treatments recommended include thermal therapy and injection of a sclerosant. Clips were recommended, as they appear to decrease further bleeding and the need for surgery, although the guidance does state that "comparisons of clips versus other therapies yield variable results and currently used clips have not been well studied." The guidance goes further and states that "for the subset of patients with actively bleeding ulcers, thermal therapy or epinephrine plus a second modality may be preferred over clips or sclerosant alone to achieve initial haemostasis." Routine second-look endoscopy was not recommended in this guideline.</P>
</INTERVENTION>
<IMPORTANCE MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Although use of a second endoscopic procedure for the treatment of high-risk bleeding peptic ulcers is now accepted, the addition of a second endoscopic technique can increase cost and risk of complications of the procedure; therefore we investigated whether a reduction in further bleeding actually offsets these drawbacks.</P>
<P>In this updated review, we wanted to ensure that we included all recently published studies of epinephrine injection versus epinephrine and a second endoscopic method for treatment of high-risk bleeding ulcers.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>To determine whether a second procedure improves haemostatic efficacy or patient outcomes or both after epinephrine injection in adults with high-risk bleeding ulcers.</P>
</OBJECTIVES>
<METHODS MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2014-05-30 07:02:42 -0400" MODIFIED_BY="Cathy Bennett">
<P>Randomised trials. </P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Patients with high-risk bleeding peptic ulcers, that is, patients with haemorrhage from peptic ulcer disease (gastric or duodenal) with major stigmata of bleeding as defined by Forrest classification: Ia (spurting haemorrhage), Ib (oozing haemorrhage), IIa (non-bleeding visible vessel) and IIb (adherent clot) (Forrest Ia-Ib-IIa-IIb) (<LINK REF="REF-Forrest-1974" TYPE="REFERENCE">Forrest 1974</LINK>).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2014-05-30 07:03:41 -0400" MODIFIED_BY="Cathy Bennett">
<P>Epinephrine injection versus epinephrine injection and a second endoscopic method.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Rebleeding rates (persistent bleeding and recurrent bleeding) as confirmed by endoscopy and further clinically significant bleeding as defined according to the criteria established in each study.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<UL>
<LI>Surgery rate.</LI>
<LI>Mortality rate.</LI>
<LI>Adverse effects.</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>For the first published version of this review, we searched the following databases.</P>
<UL>
<LI>Cochrane Central Register of Controlled Trials (CENTRAL) (which includes the Cochrane Upper Gastrointestinal and Pancreatic Diseases Group (UGPD) Trials Register) (2006, Issue 1).</LI>
<LI>MEDLINE (1966 to February 2006).</LI>
<LI>EMBASE (1980 to February 2006).</LI>
</UL>
<P>We also searched the reference lists of articles.</P>
<P>We contacted experts in the field.</P>
<P>We searched the following databases in 2009.</P>
<UL>
<LI>Cochrane Central Register of Controlled Trials (CENTRAL) (which includes the Cochrane UGPD Group Trials Register) (2009, Issue 1).</LI>
<LI>MEDLINE (2006 to September 2009).</LI>
<LI>EMBASE (2006 to September 2009).</LI>
</UL>
<P>For our update in 2014, we searched the following versions of the databases, limited from June 2009 to May 2014.</P>
<UL>
<LI>Ovid MEDLINE(R) 1946 to May Week 2 2014 (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>).</LI>
<LI>Ovid MEDLINE(R) Daily Update May 22, 2014.</LI>
<LI>Ovid MEDLINE(R) In-Process &amp; Other Non-Indexed Citations May 22, 2014.</LI>
<LI>EBM Reviews&#8212;Cochrane Central Register of Controlled Trials April 2014 (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>).</LI>
<LI>EMBASE 1980 to Week 20 2014 (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>).</LI>
</UL>
<P>The search strategy for this review was constructed by using a combination of medical subject headings (MeSH) and text words related to the use of epinephrine injection alone and epinephrine injection with a secondary endoscopic therapy for the treatment of bleeding peptic ulcers. Articles published in any language were included.</P>
<P>To identify RCTs, the search strategy in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> (MEDLINE) was combined with recommendations provided in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>We handsearched reference lists from trials selected by electronic searching to identify further relevant trials and published abstracts from conference proceedings from United European Gastroenterology Week (published in <I>Gut</I>) and Digestive Disease Week (published in <I>Gastroenterology</I>).</P>
<P>We also contacted members of the Cochrane UGPD Group and experts in the field to provide details of outstanding clinical trials and relevant unpublished materials.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Two review authors separately evaluated potentially included studies, that is, studies designed to compare the efficacy of different endoscopic methods to achieve definitive haemostasis in patients with peptic ulcer.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Two review authors (XC and MV) extracted data, which were reviewed by a third review author (JPG). When results were discordant, papers were jointly reviewed until differences were resolved. For this update, CB and MV reviewed updated search results, selected new trials for inclusion, extracted data separately and conferred over discrepancies until consensus was achieved. CB and MV updated the text of the review.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>In this updated version of the review, we introduced the risk of bias table to assess study quality. Consistent with the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>), this version of the review incorporates additional elements into 'Risk of bias' tables that were not included in the previous published review. Two review authors (MV with XC, MV with CB) independently assessed study quality. Discrepancies in interpretation were resolved by consensus.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Risk ratios (RRs) and 95% confidence intervals (CIs) were used in comparisons. We used a random-effects model for analyses. We performed subanalysis for further bleeding to examine the efficacy of different techniques (sclerosant agents, mechanical haemostasis and thermal devices) associated with epinephrine injection versus epinephrine alone.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Randomisation of clusters can result in overestimation of the precision of results (with higher risk of a Type I error) when their use has not been compensated for in the analysis. None of the included studies employed cluster randomisation. For studies that included more than one active intervention group and only one control group, we selected the interventions that most closely matched our inclusion criteria and excluded the others (Chapter 16.5.4, <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>When data were not available in published trial reports, or when clarification was needed, we contacted trial investigators to request missing information.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>The extent to which variations were noted in methods, populations, interventions or outcomes was assessed. Consistency of results was assessed by visual inspection of the forest plot and by examination of I<SUP>2</SUP> (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>), a quantity that describes the approximate proportion of variation in point estimates that is due to heterogeneity rather than to sampling error.</P>
<P>Some clinical heterogeneity was noted across the included studies (see <LINK TAG="STUDY_DESCRIPTION" TYPE="SECTION">Description of studies</LINK>), as was some statistical heterogeneity for outcomes for which it was possible to combine study data. Quantitative syntheses of the data therefore were undertaken using a random-effects model.</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Main comparisons contrasted epinephrine injection versus epinephrine injection plus another haemostatic method. The primary outcome variable was further bleeding, defined as persistence or recurrence of bleeding during follow-up. We analysed emergency surgery during hospitalisation and morbidity and mortality rates. All results were obtained using Review Manager 5 (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). The statistical tests and formulae implemented in RevMan are described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Subanalysis was also performed according to the type of peptic ulcer haemorrhage observed: active spurting or oozing (Forrest Ia or Ib), non-bleeding visible vessel (Forrest IIa) or adherent clot (Forrest IIb). We split further bleeding rates into failure to achieve initial haemostasis and recurrence during follow-up and analysed the data separately. Finally, to ascertain the influence of second-look endoscopy on the results, we analysed separately studies that performed this procedure. We also conducted separate analyses depending on the second type of endoscopic technique associated with epinephrine (thermal, sclerosant or mechanical).</P>
</SUBGROUP_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-10-01 14:10:12 -0400" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2014-10-01 13:55:58 -0400" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Previous searches in 2006 and 2009 identified 18 included studies and 13 excluded studies.The updated search in May 2014 identified 116 new citations (MEDLINE 45, EMBASE 83, CENTRAL 19); eight potentially relevant records were obtained and scrutinised; seven of these reports did not meet the inclusion criteria (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>) and had to be excluded. One new trial met the inclusion criteria and was included (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). Review authors identified a total of 19 included studies and 20 excluded studies.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2014-10-01 13:55:58 -0400" MODIFIED_BY="[Empty name]">
<P>For this update, we included one new study (<LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>). Nineteen articles compared epinephrine injection versus epinephrine plus any other endoscopic method for the endoscopic treatment of bleeding peptic ulcers (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>). A total of 2033 initially randomly assigned participants were included. <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK> was published in Serbo-Croatian, and <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK> in Spanish. Two studies were published as abstracts only (<LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Design</HEADING>
<P>All included studies were RCTs, as specified in our inclusion criteria. Two studies were published as abstracts (not as papers). Sixteen studies used a two-arm trial design (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>); only three studies (<LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>) used a three-arm trial design.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>Characteristics of the participants in each study were recorded, including numbers of participants, age and gender of participants, percentage of duodenal and gastric ulcers and Forrest type.</P>
<P>The number randomly assigned varied from 276 participants in <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK> to 42 participants in <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK> (the smallest trial). Eleven studies initially randomly assigned fewer than 100 participants (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>).</P>
<P>Study participants were adults with a mean age greater than 54 years. Age was not reported in <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>, <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK> or <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>. A predominance of male participants was noted in all included studies. <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>, <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK> and <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK> did not report the male-to-female ratio. More duodenal than gastric ulcers were included in the trials that reported this characteristic; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK> and <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK> did not report this characteristic.</P>
<P>The Forrest classification of type of bleeding group was reported in all studies, but only 13 studies (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>) reported ulcers categorised by type of bleeding.</P>
<P>Further details of each study can be found in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>We recorded any dosage of epinephrine and second endoscopic treatment applied. Medical treatments given as adjuncts were different in each study or were not specified. However, the best treatment for haemorrhage from peptic ulcer is the endoscopic treatment that we analysed in the meta-analysis.</P>
<P>Twelve studies compared epinephrine versus epinephrine plus a second injected agent. The second injected agents were thrombin in <LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK> and <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; fibrin glue in <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; ethanolamine in <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; sodium tetradecyl sulphate in <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; ethanol in <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>, <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK> and <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; polidocanol in <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>, <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK> and <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>; and ethoxy sclerol in <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>.</P>
<P>Three studies compared epinephrine versus epinephrine plus heat: <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK> used a heat probe, <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK> used bipolar electrocoagulation and <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK> employed neodymium-doped yttrium aluminium garnet (Nd:YAG) laser photocoagulation. The remaining four studies used a mechanical method such as haemoclips (<LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>) or band ligation (<LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>). The dosage of epinephrine and the method of injection used were stated in the study reports. Two studies used the same dosage of epinephrine in both groups&#8212;epinephrine alone or combined treatment&#8212;independently of whether the haemorrhage stopped (7.5 mL <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; 10 mL <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>). Another study (<LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>) injected epinephrine until haemostasis or to a maximum dose of 20 mL of epinephrine in both groups, independently of achieving haemostasis. The remaining included studies investigated the use of injected epinephrine until haemostasis was achieved. Seven included studies did not specify the dosage (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>). In the remaining studies (<LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>), the volume of epinephrine used was reported (<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>).</P>
<P>Ten studies performed one or more scheduled second-look endoscopies 24 to 72 hours after the initial technique was applied (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>) (n = 1203). When active bleeding or persistent high-risk stigmata (Forrest Ia-Ib-IIa-IIb) were observed, a second therapeutic procedure was performed. Nine studies did not schedule second-look endoscopy (<LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Persistent and recurrent bleeding</HEADING>
<P>We used the following terms: Persistent bleeding occurs when no initial haemostasis was achieved, and recurrent bleeding is a new bleed after initial haemostasis; in trials in which all participants had successful initial haemostasis, the number relates only to the number with recurrent bleeding (as persistent bleeding cannot occur if initial haemostasis is successful).</P>
<P>In most studies, the primary endpoint was defined as endoscopic therapy failure, that is, a combination of persistent haemorrhage and recurrence during follow-up (further bleeding). Clinical criteria used for presuming further bleeding differed between studies (<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). Recurrent bleeding in the outcome 'with second-look endoscopy' was confirmed endoscopically, and 10 studies reported this outcome (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>); otherwise rebleeding rates included both endoscopic and clinically evident rebleeding. Analyses were also performed on included studies that reported data for persistent haemorrhage and recurrence separately during follow-up.</P>
<P>Fourteen studies reported initial failure of haemostasis and recurrent bleeding separately (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>). The remaining five studies did not distinguish between persistent and recurrent bleeding (<LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>).</P>
<P>Fourteen studies randomly assigned participants who reported bleeding rates when peptic ulcers were actively bleeding (spurting Forrest Ia or oozing Forrest Ib) (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>).</P>
<P>Nine studies with a total of 448 participants provided data on peptic ulcers with a non-bleeding visible vessel (Forrest IIa) (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>). Only four studies (<LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>) included participants with adherent clot (Forrest IIb), although <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK> and <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK> did not report results according to Forrest category, and therefore results from only 30 participants appear in our analyses.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Surgery and mortality</HEADING>
<P>Criteria for emergency surgery were not specified in most studies. Thirty-day mortality and in-hospital mortality were the criteria used most often for defined mortality (<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>).</P>
<P>The need for emergency surgery was evaluated in 18 studies (1841 participants) (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>). <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK> did not specify surgery rates in each group, only total rate.</P>
<P>The criteria for mortality rate were also different between studies. Some studies used hospital mortality; others used 30-day mortality or did not specify the criteria for mortality. The mortality rate was evaluated in 18 studies (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>); only <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK> did not report mortality.</P>
<P>In addition, 12 studies reported complications that occurred in the study population (<LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2014-10-01 13:45:18 -0400" MODIFIED_BY="[Empty name]">
<P>A total of 20 studies were excluded from the review; 13 were excluded before this update was performed (<LINK REF="STD-Buffoli-2001" TYPE="STUDY">Buffoli 2001</LINK>; <LINK REF="STD-Chua-2001" TYPE="STUDY">Chua 2001</LINK>; <LINK REF="STD-Chung-1990" TYPE="STUDY">Chung 1990</LINK>; <LINK REF="STD-Chung-1992" TYPE="STUDY">Chung 1992</LINK>; <LINK REF="STD-Chung-1997a" TYPE="STUDY">Chung 1997a</LINK>; <LINK REF="STD-De-Goede-1998" TYPE="STUDY">De Goede 1998</LINK>; <LINK REF="STD-Dedeu-2003" TYPE="STUDY">Dedeu 2003</LINK>; <LINK REF="STD-Ell-2002" TYPE="STUDY">Ell 2002</LINK>; <LINK REF="STD-Gevers-2002" TYPE="STUDY">Gevers 2002</LINK>; <LINK REF="STD-Male-1999" TYPE="STUDY">Male 1999</LINK>; <LINK REF="STD-Pescatore-1999" TYPE="STUDY">Pescatore 1999</LINK>; <LINK REF="STD-Sabat-1998" TYPE="STUDY">Sabat 1998</LINK>; <LINK REF="STD-Wehrmann-1994" TYPE="STUDY">Wehrmann 1994</LINK>), and we excluded a further seven studies in 2014 (<LINK REF="STD-Chittmittrapap-2010" TYPE="STUDY">Chittmittrapap 2010</LINK>; <LINK REF="STD-Grgov-2013" TYPE="STUDY">Grgov 2013</LINK>; <LINK REF="STD-Karaman-2011" TYPE="STUDY">Karaman 2011</LINK>; <LINK REF="STD-Lecleire-2009" TYPE="STUDY">Lecleire 2009</LINK>; <LINK REF="STD-Ljubicic-2012" TYPE="STUDY">Ljubicic 2012</LINK>; <LINK REF="STD-Taghavi-2009" TYPE="STUDY">Taghavi 2009</LINK>; <LINK REF="STD-Tsoi-2009" TYPE="STUDY">Tsoi 2009</LINK>). The main reasons for exclusion of studies were as follows: non-randomised studies (<LINK REF="STD-Buffoli-2001" TYPE="STUDY">Buffoli 2001</LINK>; <LINK REF="STD-Chittmittrapap-2010" TYPE="STUDY">Chittmittrapap 2010</LINK>; <LINK REF="STD-Chua-2001" TYPE="STUDY">Chua 2001</LINK>; <LINK REF="STD-Tsoi-2009" TYPE="STUDY">Tsoi 2009</LINK>); preliminary results published later in another article (<LINK REF="STD-Chung-1990" TYPE="STUDY">Chung 1990</LINK>; <LINK REF="STD-Chung-1992" TYPE="STUDY">Chung 1992</LINK>; <LINK REF="STD-Chung-1997a" TYPE="STUDY">Chung 1997a</LINK>; <LINK REF="STD-De-Goede-1998" TYPE="STUDY">De Goede 1998</LINK>; <LINK REF="STD-Male-1999" TYPE="STUDY">Male 1999</LINK>; <LINK REF="STD-Pescatore-1999" TYPE="STUDY">Pescatore 1999</LINK>); impossible to extract data (<LINK REF="STD-Dedeu-2003" TYPE="STUDY">Dedeu 2003</LINK>; <LINK REF="STD-Ell-2002" TYPE="STUDY">Ell 2002</LINK>); did not fit our criteria for intervention, that is, did not compare epinephrine alone versus epinephrine plus a second agent (<LINK REF="STD-Gevers-2002" TYPE="STUDY">Gevers 2002</LINK>; <LINK REF="STD-Grgov-2013" TYPE="STUDY">Grgov 2013</LINK>; <LINK REF="STD-Karaman-2011" TYPE="STUDY">Karaman 2011</LINK>; <LINK REF="STD-Ljubicic-2012" TYPE="STUDY">Ljubicic 2012</LINK>; <LINK REF="STD-Taghavi-2009" TYPE="STUDY">Taghavi 2009</LINK>); participants did not fit our inclusion criteria (<LINK REF="STD-Lecleire-2009" TYPE="STUDY">Lecleire 2009</LINK>); or important methodological problems were noted within the study (<LINK REF="STD-Sabat-1998" TYPE="STUDY">Sabat 1998</LINK>; <LINK REF="STD-Wehrmann-1994" TYPE="STUDY">Wehrmann 1994</LINK>) (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>A summary of the risk of bias across studies is given in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.<BR/>
</P>
<ALLOCATION MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomisation was adequately described in only 10 of the included studies (<LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>) and was judged as unclear in the remaining studies. Allocation concealment was adequate in 13 studies and was judged as unclear in six studies (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2010-01-06 13:17:08 -0500" MODIFIED_BY="[Empty name]">
<P>The studies were not double blind because the endoscopist must know the technique to be applied. </P>
</BLINDING>
<EXCLUSIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Only six studies were judged as unclear for incomplete outcome data (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>); all remaining studies were judged as having low risk of bias.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>A total of 11 studies were rated as having low risk of bias for selected outcome reporting (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>). The remaining studies were rated as having unclear risk of bias. However in the absence of initial study protocols, it is not clear whether all studies reported outcomes as prespecified in the trial protocol.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Other potential sources of bias were noted in the design of studies in terms of interventions used and outcomes assessed. The different treatment strategies used could bias results, as some may appear more favourable in terms of achieving haemostasis, such as the technique used by <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>, in which epinephrine was injected until haemostasis was achieved or until a maximum dose of 20 mL of epinephrine was given in both groups, independently of achieving haemostasis. It is difficult, however, to establish whether this method could decrease the frequency of recurrence.</P>
<P>Some studies used different definitions of haemorrhage. However, all studies included in the meta-analysis that reported rebleeding criteria were very similar, suggesting that the definition of rebleeding was not a source of bias. As explained, outcome criteria in all studies were very similar, so we believe that these data did not bias study results.</P>
<P>The mortality rate was also different between studies using different criteria. Some studies used hospital mortality, while others used 30-day mortality or did not specify the criteria for mortality. This made comparison of mortality rates difficult and hindered conclusions about the rate of mortality resulting from haemorrhage in people with ulcers. Moreover, data on previous morbidity among study participants often were not provided in study reports.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-10-01 14:10:12 -0400" MODIFIED_BY="[Empty name]">
<P>We use the following terms: Persistent bleeding occurs when no initial haemostasis is achieved, and recurrent bleeding is a new bleed after initial haemostasis. In trials in which all had successful haemostasis, the number relates only to the number with recurrent bleeding (as bleeding cannot be persistent if the initial haemostasis is successful).</P>
<P>In the text below, an I² statistical value for heterogeneity is reported as follows: 30% to 60%: may represent moderate heterogeneity; 50% to 90%: may represent substantial heterogeneity; 75% to 100%: shows considerable heterogeneity.</P>
<P>Numbers given show the total numbers of participants in the analysis. When it was possible to calculate an effect size, these values were reported with 95% confidence intervals. When the calculated effect size was statistically significant (P value &lt; 0.05), we stated whether the result favours the intervention or the control condition.</P>
<P>We have summarised results below under headings corresponding to the primary and secondary outcomes outlined in the section entitled <LINK TAG="CRIT_OUTCOMES" TYPE="SECTION">Types of outcome measures</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 1. Epinephrine versus epinephrine and any second endoscopic method</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Initial failure of haemostasis (persistent bleeding)</HEADING>
<P>For this outcome, we found 14 relevant trials that provided separate data on participants who did not achieve initial haemostasis (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>) (n = 1380). No significant difference was noted between epinephrine and epinephrine and any second endoscopic method (RR random 0.77, 95% CI 0.42 to 1.4; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Recurrent bleeding only (bleeding after initial haemostasis)</HEADING>
<P>For this outcome, we found 14 relevant trials (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>) (n = 1333). A statistically significant difference was reported between epinephrine and epinephrine and any second endoscopic method favouring combined therapy (RR random0.53, 95% CI 0.35 to 0.81, P value 0.03; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). This outcome had moderate levels of heterogeneity (Chi<SUP>2</SUP> = 21.92, df = 13, P value 0.06, I<SUP>2</SUP> = 41%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Recurrrent and persistent bleeding overall rates with or without second-look endoscopy</HEADING>
<P>All articles that compared substances administered by endoscopic injection (sclerosants such as ethanol, polidocanol, ethanolamine or tetradecyl sulphate; adhesive agents such as cyanoacrylate; and thrombotic substances such as fibrin glue or thrombin), epinephrine plus thermal agents and epinephrine plus a mechanical method such as clips were analysed together. All studies reported this outcome, that is, clinically diagnosed and/or endoscopically confirmed rebleeding (19 relevant trials; <LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>) (n = 1926). A statistically significant difference between epinephrine and epinephrine and any second endoscopic method favoured combined therapy (RR random 0.57, 95% CI 0.43 to 0.76, P value 0.0001; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). This outcome had moderate levels of heterogeneity (Chi<SUP>2</SUP> = 29.11, df = 18, P value 0.05, I<SUP>2</SUP> = 38%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Recurrent and persistent bleeding and second-look endoscopy</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">With second-look endoscopy (endoscopically confirmed persistent or recurrent bleeding)</HEADING>
<P>Ten studies performed one or more scheduled second-look endoscopies 24 to 72 hours after the initial technique was applied (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>) (n = 1203). When active bleeding or persistent high-risk stigmata (Forrest Ia-Ib-IIa-IIb) were observed endoscopically, a second therapeutic procedure was performed. No significant difference was noted between the numbers with endoscopically confirmed rebleeding in the epinephrine group and in the epinephrine and second endoscopic method groups (RR 0.82, 95% CI 0.64 to 1.06; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Without second-look endoscopy</HEADING>
<P>Nine studies did not schedule second-look endoscopy (<LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>) (n = 720). A statistically significant difference in the numbers of participants with rebleeding (clinically diagnosed and endoscopically confirmed) between epinephrine and epinephrine and any second endoscopic method favoured combined therapy (RR random 0.32, 95% CI 0.21 to 0.48, P value &lt; 0.00001; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Surgery rate</HEADING>
<P>For this outcome, we found 18 relevant trials that reported the numbers of participants who needed surgical intervention on an emergency basis because initial haemostasis could not be obtained, or because rebleeding occurred (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>) (n = 1841). A statistically significant difference between epinephrine and epinephrine and any second endoscopic method favoured combined therapy (RR random 0.68 95% CI 0.50 to 0.93, P value 0.02; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Mortality rate</HEADING>
<P>For this outcome, we found 18 relevant trials reporting mortality as death in hospital or as a result of bleeding peptic ulcer (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>) (n = 1841). No significant difference was noted between epinephrine and epinephrine and any second endoscopic method (RR random 0.64, 95% CI 0.39 to 1.06; <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Adverse effects of endoscopic therapy</HEADING>
<P>For this outcome, we found 12 relevant trials that reported whether complications had occurred and the types of complications reported (<LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>, <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>) (n = 1281). No significant difference was noted between epinephrine and epinephrine and any second endoscopic method (RR random 1.25, 95% CI 0.4 to 3.96; <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). Details of adverse effects encountered (found in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>) included perforations, mucosal injury and necrosis. Induction of massive bleeding requiring surgery was more frequent in the epinephrine only group (n = 5); necrosis appeared in three participants (two in the combined therapy group and one in the epinephrine alone group), and perforation (three participants) was observed in the combined therapy group. Thus, adverse events were slightly more frequent in the combined therapy group (6/610 participants) than in the epinephrine alone group (5/648 participants), although this difference did not reach statistical significance.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Recurrent and persistent bleeding according to type of haemorrhage</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Forrest Ia-Ib (spurting or oozing haemorrhage)</HEADING>
<P>Thirteen studies with a total of 1019 participants reported bleeding rates when peptic ulcers were actively bleeding (spurting Forrest Ia; oozing Forrest Ib) We included participants who had confirmed bleeding by endoscopy and those who clinically rebled in <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>) (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK> (n = 1019). A statistically significant difference favoured the combined therapy group (RR 0.66, 95% CI 0.49 to 0.88, P value 0.005, I<SUP>2</SUP> = 15%)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Forrest IIa (visible vessel)</HEADING>
<P>Nine studies with a total of 440 participants provided data on peptic ulcers with a non-bleeding visible vessel (Forrest IIa) (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>). No significant difference was reported between epinephrine and epinephrine and any second endoscopic method (RR 0.97, 95% CI 0.47 to 1.99, I<SUP>2</SUP> = 29%; <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Forrrest IIb (adherent clot)</HEADING>
<P>Only four studies (<LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>) included participants with adherent clot (Forrest IIb). <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>and <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK> did not provide results on different Forrest groups included in the study and so were not included in this analysis. In the epinephrine alone group, 4/15 (26.7%) presented further bleeding versus 3/15 (20%) in the combined therapy group. In this subgroup, we found two relevant trials (n = 30). No significant difference between epinephrine and epinephrine and any second endoscopic method was noted (RR random 0.75, 95% CI 0.22 to 2.6; <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 2. Epinephrine plus epinephrine and a second injected agent</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Recurrent and persistent bleeding</HEADING>
<P>For this outcome, we found 11 RCTs (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>) (n = 1135); no statistically significant difference favoured combination therapy (RR 0.74, 95% CI 0.53 to 1.04, P value 0.08; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). This outcome had moderate levels of heterogeneity (Chi<SUP>2</SUP> = 15.66, df = 10, P value 0.11, I<SUP>2</SUP> = 36%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Surgery rate</HEADING>
<P>For this outcome, we found 10 RCTs (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>) (n = 1050) (RR 0.85, 95% CI 0.59 to 1.21; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). No significant differences were noted between epinephrine and epinephrine and any second injected agent.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Mortality rate</HEADING>
<P>For this outcome, we found 10 RCTs (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>; <LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>; <LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>; <LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>) (n = 1050) (RR 0.5, 95% CI 0.25 to 1.0; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>). A statistically significant difference was reported between epinephrine and epinephrine and any second injected agent.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 3. Epinephrine versus epinephrine and mechanical endoscopic methods</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Recurrrent and persistent bleeding</HEADING>
<P>For this outcome, we found five relevant trials that reported the efficacy of adding a mechanical haemoclip to epinephrine injection (<LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>) (n = 415). A statistically significant difference between epinephrine and epinephrine and mechanical endoscopic methods favoured epinephrine plus a mechanical method (RR random 0.31, 95% CI 0.18 to 0.55, P value &lt; 0.0001; <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Surgery rate</HEADING>
<P>Five RCTs provided data on surgery rate (<LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>) (n = 415). A statistically significant difference between epinephrine and epinephrine and mechanical endoscopic methods favoured epinephrine plus a mechanical method (RR random 0.2, 95% CI 0.06 to 0.62, P value 0.005; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Mortality rate</HEADING>
<P>Mortality rate was provided in five RCTs (<LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>; <LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>) (n = 415). No significant difference was noted between epinephrine and epinephrine and mechanical endoscopic methods (RR random 0.73, 95% CI 0.19 to 2.71; <LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 4. Epinephrine plus epinephrine and thermal methods</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Recurrent and persistent bleeding</HEADING>
<P>Three studies compared epinephrine alone versus epinephrine combined with thermal haemostatic methods (contact heat probe, Nd:YAG laser or bipolar electrocoagulation) (<LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>) (n = 376) (RR random 0.49, 95% CI 0.30 to 0.78, P value 0.003; <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>). A statistically significant difference was observed between epinephrine and epinephrine and thermal endoscopic methods.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Surgery rate</HEADING>
<P>Surgery rate was given in three trials (<LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>) (n = 376), A statistically significant difference between epinephrine and epinephrine and thermal endoscopic methods favoured the combination therapy group (RR random 0.45, 95% CI 0.21 to 0.95, P value 0.04; <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Mortality rate</HEADING>
<P>For this outcome, we found three relevant trials (<LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>) (n = 376) (RR random 0.92, 95% CI 0.37 to 2.26; <LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>). No significant difference was observed between epinephrine and epinephrine and thermal endoscopic methods.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-10-01 13:54:09 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Nineteen studies including a total of 2033 initially randomly assigned participants were included, of which 11 used a second injected agent, five used a mechanical method (haemoclips) and three employed thermal methods.</P>
<P>For the comparison of epinephrine versus any second agent, we produced meta-analyses for eight outcomes. Few participants failed initial haemostasis, and analyses of epinephrine versus epinephrine plus any second method failed to show differences in achieving initial haemostasis between epinephrine alone and epinephrine with a second endoscopic method.</P>
<P>Adding any second procedure significantly reduced rebleeding rates in three analyses, that is, fewer participants in the combined therapies groups experienced recurrent bleeding after initial haemostasis (RR 0.53, 95% CI 0.35 to 0.81); fewer participants had persistent and recurrent bleeding (with or without second-look endoscopy) (RR 0.57, 95% CI 0.43 to 0.76) and fewer had persistent or recurrent bleeding (without scheduled second-look endoscopy) (RR 0.32, 95% CI 0.21 to 0.48). No difference in rebleeding rates was seen between groups in studies that did schedule second-look endoscopy.</P>
<P>The numbers needing emergency surgery were significantly lower in the combined group (RR 0.68, 95% CI 0.50 to 0.93), but mortality rates were not significantly different with either method. Adverse events included perforations, mucosal injury and necrosis; these events were few, and no statistically significant difference between groups was noted.</P>
<P>For ulcers of the Forrest Ia or Ib type (oozing or spurting), the addition of a second therapy significantly reduced the rebleeding rate (RR 0.66, 95% CI 0.49 to 0.88); this difference was not seen for type IIa (visible vessel) or type IIb (adherent clot) ulcers.</P>
<P>Our analyses therefore showed that the risk of further bleeding was lower in the combination therapy groups than in the epinephrine alone groups, regardless of which second procedure was applied. Failure of endoscopic therapy is the main predictor of the need for surgery and of morbidity and mortality in patients with bleeding peptic ulcer (<LINK REF="REF-Brullet-1996" TYPE="REFERENCE">Brullet 1996</LINK>). Therefore, it seems highly likely that reduction of further bleeding rates decreased the need for surgery and improved survival.</P>
<P>We also compared epinephrine versus epinephrine plus injected agents, versus epinephrine plus a mechanical method and versus epinephrine plus thermal methods separately.</P>
<P>For the comparison of epinephrine versus epinephrine plus any injected method, we produced meta-analyses for three outcomes. Fewer participants in the combination group experienced recurrent and persistent bleeding, but this finding was not statistically significant. Fewer participants in the combination therapy group died and this was statistically significant (RR 0.50, 95% CI 0.25 to 1.00), but no difference between groups was noted for the number needing emergency surgery.</P>
<P>For the comparison of epinephrine versus epinephrine plus a mechanical method such as haemoclips, results favoured the combination therapy group for recurrent or persistent bleeding (RR 0.31, 95% CI 0.18 to 0.55); fewer participants in the combination group needed surgery (RR 0.20, 95% CI 0.06 to 0.62), but no statistically significant difference was reported for mortality.</P>
<P>For the comparison of epinephrine versus epinephrine plus a thermal method, results favoured combined therapy for recurrent and persistent bleeding (RR 0.49, 95% CI 0.30 to 0.78) and for surgery (RR 0.92, 95% CI 0.37 to 2.26), but no statistically significant difference was reported for mortality.</P>
<P>Our updated review with new data confirms the results published in our previous review (<LINK REF="REF-Vergara-2007" TYPE="REFERENCE">Vergara 2007</LINK>).</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2014-10-01 13:27:31 -0400" MODIFIED_BY="[Empty name]">
<P>One limitation of this review is that definitions for haemorrhage, surgery and death were not the same in the different studies (<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). Marked heterogeneity observed in defining further bleeding among studies precluded the definition of a homogeneous, predetermined criterion for the primary endpoint. We therefore accepted the definition established for each study. Further bleeding definitions are shown in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. As the analysis includes only randomised, comparative studies, the criteria were similar for the two groups (epinephrine alone and combined therapy) in each study, thus allowing further comparison. Furthermore, endoscopic confirmation of bleeding was required for studies that reported second-look endoscopy, thus reducing heterogeneity. Criteria for mortality rate were different between studies. Some studies used hospital mortality as a key, and others used 30-day mortality or did not specify the mortality criteria applied. This makes it difficult to extract definitive conclusions about mortality rates in haemorrhage from those in ulcer disease. Moreover, characteristics of the co-morbidities of participants were not included in the results of most of the studies.</P>
<P>Medical treatments were also different between studies or were not specified. However, the best treatment for bleeding from a peptic ulcer is the endoscopic treatment that we analysed in the present meta-analysis.</P>
<P>One important point to state involves the dosage of epinephrine and the methodological process used in each study. The dosage of epinephrine used was detailed in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. Seven included studies did not specify the dosage (<LINK REF="STD-Balanzo-1990" TYPE="STUDY">Balanzo 1990</LINK>; <LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>; <LINK REF="STD-Chung-1996" TYPE="STUDY">Chung 1996</LINK>; <LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="STD-Garrido-2002" TYPE="STUDY">Garrido 2002</LINK>; <LINK REF="STD-Park-2004" TYPE="STUDY">Park 2004</LINK>; <LINK REF="STD-Villanueva-1996" TYPE="STUDY">Villanueva 1996</LINK>). Two studies used the same dosage of epinephrine for both groups independently of whether haemorrhage stopped (<LINK REF="STD-Choudari-1994" TYPE="STUDY">Choudari 1994</LINK>; <LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>). Another study (<LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>) injected epinephrine until haemostasis or to a maximum dose of 20 mL of epinephrine in both groups, independently of achieving haemostasis.</P>
<P>Comparisons of epinephrine versus epinephrine plus a specific second method also raise some unanswered questions. First, although one might consider that the efficacy of injecting a second agent is similar to that achieved with thermal and mechanical methods, this interpretation should be treated with extreme caution. The only conclusion that can be drawn from our meta-analysis is that, whichever second treatment is used, combined therapy seems to work better than epinephrine alone. However, we cannot conclude that a particular form of treatment is equal or superior to another. Indeed, an earlier meta-analysis evaluating endoscopic therapy for bleeding peptic ulcers demonstrated that all methods of controlling bleeding in peptic ulcers (thermal devices, injectable agents such as sclerosants and thrombin/fibrin glue and haemoclips) were effective, with no single modality determined to be superior (<LINK REF="REF-Laine-2009" TYPE="REFERENCE">Laine 2009</LINK>). There are two main reasons for this. First, the subgroups (further injection, thermal methods or mechanical methods) include different procedures that may present heterogeneous activity. In fact, each endoscopic treatment presents different characteristics: Epinephrine produces vasoconstriction, vessel compression and platelet aggregation, but it does not seem to induce permanent thrombosis in blood vessels (<LINK REF="REF-Lin-2002" TYPE="REFERENCE">Lin 2002</LINK>). Sclerosant agents such as polidocanol or ethanol can produce thrombosis of vessels favouring haemostasis, although they may also induce significant tissue injury (<LINK REF="REF-Randall-1989" TYPE="REFERENCE">Randall 1989</LINK>; <LINK REF="REF-Ritgeers-1989" TYPE="REFERENCE">Ritgeers 1989</LINK>). Whether human thrombin injection could reduce the risk of tissue damage remains unclear, and thrombin is more expensive than other additional treatments (<LINK REF="REF-Laine-2003" TYPE="REFERENCE">Laine 2003</LINK>). Thermal agents produce thrombosis of vessels and risk damaging tissue. Among them, laser photocoagulation seems to be associated with higher risks of perforation, optical hazard, high cost and imperfect haemostatic effect. Multi-polar electrocoagulation and heater probe thermocoagulation have been reported to produce excellent results; they are also less expensive and are more easily portable than laser methods (<LINK REF="REF-Llach-1996" TYPE="REFERENCE">Llach 1996</LINK>). Mechanical methods close the vessel. They were also associated with few complications, but technical difficulty was associated with applying the haemoclip to the posterior wall of the proximal body and cardia of the stomach (<LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>), and to the posterior wall of the duodenum, because of the requirement that the haemoclip meet the lesion at a right angle (<LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="REF-Simoens-2001" TYPE="REFERENCE">Simoens 2001</LINK>). A meta-analysis compared haemoclip versus other methods to investigate the possible benefits of haemoclips versus other endoscopic methods. The evidence showed no differences between them (<LINK REF="REF-Yuan-2008" TYPE="REFERENCE">Yuan 2008</LINK>).</P>
<P>Even more important, the statistical treatments used in our meta-analyses are not designed to compare additional treatments head to head. In fact, we lack randomised trials comparing different additional treatments after epinephrine injection, although some recent studies are available (e.g. <LINK REF="STD-Grgov-2013" TYPE="STUDY">Grgov 2013</LINK>; <LINK REF="STD-Karaman-2011" TYPE="STUDY">Karaman 2011</LINK>; <LINK REF="STD-Taghavi-2009" TYPE="STUDY">Taghavi 2009</LINK>), and we must await analysis of comparative studies to establish which is the best therapy when combined with epinephrine.</P>
<P>Our review did not determine whether combined therapy is better than sclerosants, thermal methods or mechanical methods alone. Little evidence in the literature suggests that this is the case. In a small study, <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK> found that combined therapy seems better than bipolar electrocoagulation alone. Also, a recent meta-analysis concluded that combined injection is superior to a sclerosant alone (<LINK REF="REF-Rollhauser-2000" TYPE="REFERENCE">Rollhauser 2000</LINK>). In any event, the clinical relevance of this question may be minor.</P>
<P>One of the major fears associated with using combined therapy involves the possible risk of gastric wall necrosis or perforation or both. The present meta-analysis shows that the risk of significant complications is very low. This review failed to find evidence of a difference in complication rates between groups. When the complications are examined in detail, it can be seen that induction of massive bleeding requiring surgery was more frequent in the epinephrine group, whereas gastric wall necrosis or perforation was more common in the combined therapy group. This possible small increase in the risk of perforation or necrosis is clearly compensated for by the benefits derived from reducing further bleeding, which result in a significant decrease in the need for surgery and in mortality; therefore this risk is not a reason for avoiding combined therapy.</P>
<P>Epinephrine injection is cheap, easy to perform and safe. In addition, according to our analysis, epinephrine seems as good as combined therapy for achieving initial haemostasis. By controlling active bleeding, it could allow a better endoscopic view and more accurate targeting of additional therapy. Therefore, medical or economic arguments against epinephrine injection are few.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2014-10-01 13:54:09 -0400" MODIFIED_BY="[Empty name]">
<P>Of the 19 trials included in this review, some had limitations in design or implementation, but most were clear about important quality criteria including randomisation and allocation concealment, sequence generation and blinding. Our risk of bias estimates show that overall most studies were not at high risk of bias in any of the domains that we assessed. It should be noted that we did not rate performance bias because it is not possible to blind participants and personnel in studies of this nature. Although the type of study did not allow a double-blind trial (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>), rebleeding, surgery and mortality were not dependent on subjective observation.</P>
<P>The meta-analysis involved a large number of well-designed studies, but for most outcomes, the quality of the evidence was rated as moderate, and further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. We summarised the quality of the studies in Summary of findings table 1. When we downgraded the evidence to moderate quality, we did so because few events were reported; this was the case for the outcomes of surgery, mortality and adverse effects. The included studies involved relatively few participants, but larger populations are difficult to achieve in this type of trial. Some imprecision was noted (wide confidence intervals), and the results of some meta-analyses showed low to moderate levels of statistical heterogeneity (inconsistency). One explanation for this may be the differences noted between trials (populations, definitions of outcomes such as in-hospital or 30-day mortality and definitions of rebleeding), as discussed above.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>One limitation of our review is that despite exhaustive searching, it is difficult to be certain that every published and unpublished study was identified. We acknowledge that there is always a risk that some studies were not identified. However for the studies that we identified, the quality was rated as moderate for most outcomes, and because of the serious nature of this condition, incidences of adverse effects were reported in many trials.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>The findings of our updated review are in agreement with the recommendations provided in three major clinical guidelines produced since the first published version of this review. Combined therapy of epinephrine plus a second endoscopic agent (e.g. bipolar electrocoagulation, heater probe, sclerosant, clips) for the treatment of patients with high-risk bleeding peptic ulcers (<LINK REF="REF-Laine-2012" TYPE="REFERENCE">Laine 2012</LINK>; <LINK REF="REF-NICE-2012" TYPE="REFERENCE">NICE 2012</LINK>; <LINK REF="REF-Hwang-2012" TYPE="REFERENCE">Hwang 2012</LINK>) is the main recommendation for active bleeding or non-bleeding visible vessels.</P>
<P>As far as second-look endoscopy is concerned, one meta-analysis showed that although scheduled second-look endoscopies reduced the rebleeding rate, they did not decrease the need for surgery nor mortality (<LINK REF="REF-Marmo-2003" TYPE="REFERENCE">Marmo 2003</LINK>). It was also suggested that selective second-look endoscopy for selected high-risk patients could be a cost-effective approach (<LINK REF="REF-Spiegel-2003" TYPE="REFERENCE">Spiegel 2003</LINK>). However, this strategy exposes patients to uncomfortable and somewhat risky procedures and increases the workload of the endoscopy unit. Results of the present study did not confirm that second-look endoscopy diminished the risk of rebleeding. For all of these reasons, it remains unclear whether second-look endoscopy offers any added benefit to combined therapy associated with proton pump inhibitor infusion. This finding is in agreement with current guidelines on the management of acute non-variceal upper gastrointestinal bleeding. In the <LINK REF="REF-NICE-2012" TYPE="REFERENCE">NICE 2012</LINK> guideline, the recommendation is to "consider a repeat endoscopy, with treatment as appropriate" (further endoscopic treatment or emergency surgery),"for all patients at high risk of re-bleeding, particularly if there is doubt about initial haemostasis at the first endoscopy." The AGA guideline (<LINK REF="REF-Laine-2012" TYPE="REFERENCE">Laine 2012</LINK>) does not recommend routine second-look endoscopy 24 hours after initial endoscopic haemostatic therapy but says that this should be offered for patients with clinical evidence of recurrent bleeding, and in these cases, haemostatic therapy should be applied for those with greater risk of stigmata of haemorrhage. Routine second-look endoscopy, defined as a planned endoscopy performed within 24 hours of the initial endoscopy, in patients who have received adequate endoscopy is not recommended by the ASGE in its 2012 guideline (<LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>; <LINK REF="REF-Hwang-2012" TYPE="REFERENCE">Hwang 2012</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>The present study shows that adding a second endoscopic procedure after epinephrine injection reduces the rate of recurrence in patients with high-risk bleeding peptic ulcer. This study also shows that adding any second endoscopic method reduces the need for surgery. In view of the evidence, and while we await the results of further studies, combined therapy should be considered the standard procedure in high-risk peptic ulcer haemorrhage (Forrest Ia, Ib, IIa).</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>The current evidence shows that addition of a second endoscopic method to epinephrine injection is better than epinephrine injection alone in high-risk bleeding peptic ulcers, in terms of preventing both rebleeding and the need for emergency surgery. Future research should investigate the best endoscopic method that, when associated with epinephrine, achieves low rebleeding rates, reduced need for surgery and prevention of mortality and procedure-related adverse effects when standardised outcome criteria such as use of a scheduled second endoscopy and criteria for rebleeding are used, and whether this was confirmed endoscopically. Further systematic reviews and meta-analyses should assess such head-to-head comparisons to compare the efficacy of additional treatments.</P>
<P>Other therapeutic approaches, such as use of a high-dose proton pump inhibitor or second-look endoscopy, could influence the efficacy of combined therapy. Use of high-dose proton pump inhibitors for patients with bleeding peptic ulcers is gaining acceptance. Evidence clearly suggests that these drugs reduce the risk of rebleeding (<LINK REF="REF-Gisbert-2001" TYPE="REFERENCE">Gisbert 2001</LINK>). However, many points remain unclear, such as the cost-effectiveness of this approach, the ideal drug dosage to be used and whether this strategy should be reserved for patients at high risk of rebleeding. Both combined endoscopic therapy and proton pump inhibitor infusion are safe and comfortable for the patient. Therefore, although the extent of the benefit of combining the two approaches remains uncertain, this strategy seems reasonable until additional evidence becomes available.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Discussions by the group that developed the Catalan Guidelines for non-variceal upper gastrointestinal bleeding were invaluable in helping to determine gaps in knowledge on bleeding peptic ulcer treatment. We are indebted to all participants, especially to Dr Faust Feu as the co-ordinator of this group.</P>
<P>We thank Dr Nadja Smailagic, who provided translations of <LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK> and <LINK REF="STD-Grgov-2013" TYPE="STUDY">Grgov 2013</LINK>.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Dr Cathy Bennett is the proprietor of Systematic Research Ltd, a company that provides research services and is an employee of that company; Dr Bennett received a consultancy fee, as well as travel expenses for travel to work-related meetings and conferences. Dr Bennett has received consultancy fees for other Cochrane reviews and for her work in evidence-based medicine. Dr Bennett is a member of the data monitoring committee for the BOSS clinical trial; this work is not related to writing of systematic reviews.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Mercedes Vergara and Xavier Calvet developed the protocol, performed the main search strategy, assessed eligibility, extracted data, performed statistical analyses (meta-analysis) and wrote the manuscript.</P>
<P>Javier P. Gisbert was involved in reviewing the final manuscript and providing relevant methodological support.</P>
<P>Cathy Bennett updated the review in May 2014, along with Mercedes Vergara.</P>
<P>Mercedes Vergara is responsible for data accuracy and is the guarantor of this review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>We edited the background text of this review protocol after initial publication by providing updated information.</P>
<P>For studies with more than one active intervention and only one control group, we selected the intervention that most closely matched our inclusion criteria and excluded the others (see <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>, Chapter 16.5.4).</P>
<P>We completely updated and revised the methods section for clarity, although our methods remain unchanged from the previous version of the review.</P>
<P>We checked all data extracted and amended minor errors.</P>
<P>We updated the tables, content and presentation of the review to be consistent with MECIR reporting standards for systematic reviews. This included the addition of domains to the risk of bias tables and a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow chart of studies.</P>
<P>We clarified that persistent bleeding is failure of initial haemostasis, and recurrent bleeding is bleeding that recurs after initial haemostasis. Rebleeding rates included both endoscopic and clinical rebleeding.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2010-01-06 11:39:34 -0500" MODIFIED_BY="[Empty name]">
<P>None.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-10-01 11:06:53 -0400" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2014-10-01 11:06:53 -0400" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2014-10-01 11:06:53 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Balanzo-1990" MODIFIED="2014-10-01 10:57:09 -0400" MODIFIED_BY="[Empty name]" NAME="Balanzo 1990" YEAR="1990">
<REFERENCE MODIFIED="2014-10-01 10:57:09 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Balanzo J, Villanueva C, Sainz S, Espinos JC, Mendez C, Guarner C et al</AU>
<TI>Injection therapy of bleeding peptic ulcer. A prospective randomized trial using epinephrine and thrombin</TI>
<SO>Endoscopy</SO>
<YR>1990</YR>
<VL>22</VL>
<PG>157-9</PG>
<IDENTIFIERS MODIFIED="2014-10-01 10:57:09 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 10:57:09 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="2209496"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Choudari-1994" MODIFIED="2014-10-01 10:57:47 -0400" MODIFIED_BY="[Empty name]" NAME="Choudari 1994" YEAR="1994">
<REFERENCE MODIFIED="2014-10-01 10:57:47 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Choudari CP, Palmer KR</AU>
<TI>Endoscopic injection therapy for bleeding peptic ulcer: a comparison of adrenaline alone with adrenaline plus ethanolamine oleate</TI>
<SO>Gut</SO>
<YR>1994</YR>
<VL>35</VL>
<PG>608-10</PG>
<IDENTIFIERS MODIFIED="2014-10-01 10:57:47 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 10:57:47 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8200551"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chung-1993" MODIFIED="2014-10-01 10:58:28 -0400" MODIFIED_BY="[Empty name]" NAME="Chung 1993" YEAR="1993">
<REFERENCE MODIFIED="2014-10-01 10:58:28 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chung SC, Leung JW, Leong HT, Lo KK, Li AK</AU>
<TI>Adding a sclerosant to endoscopic epinephrine injection in actively bleeding peptic ulcers: a randomized trial</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1993</YR>
<VL>39</VL>
<PG>611-5</PG>
<IDENTIFIERS MODIFIED="2014-10-01 10:58:28 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 10:58:28 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8224679"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chung-1996" MODIFIED="2014-10-01 10:59:03 -0400" MODIFIED_BY="[Empty name]" NAME="Chung 1996" YEAR="1996">
<REFERENCE MODIFIED="2014-10-01 10:59:03 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chung SC, Leong HT, Chab AC, Lau JY, Yung MY, Leung JW, Li AK</AU>
<TI>Epinephrine or epinephrine plus alcohol for injection of bleeding ulcers: a prospective randomized trial</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1996</YR>
<VL>43</VL>
<PG>591-5</PG>
<IDENTIFIERS MODIFIED="2014-10-01 10:59:03 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 10:59:03 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8781939"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chung-1997" MODIFIED="2014-10-01 10:59:31 -0400" MODIFIED_BY="[Empty name]" NAME="Chung 1997" YEAR="1997">
<REFERENCE MODIFIED="2014-10-01 10:59:31 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chung SS, Lau JY, Sung JJ, Chan AC, Lai CW, Ng EK et al</AU>
<TI>Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>314</VL>
<PG>1307-11</PG>
<IDENTIFIERS MODIFIED="2014-10-01 10:59:31 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 10:59:31 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9158465"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chung-1999" MODIFIED="2014-10-01 11:00:06 -0400" MODIFIED_BY="[Empty name]" NAME="Chung 1999" YEAR="1999">
<REFERENCE MODIFIED="2014-10-01 11:00:06 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chung IK, Ham JS, Kim HS, Park SH</AU>
<TI>Comparison of the hemostatic efficacy of the endoscopic hemoclip method with hypertonic saline epinephrine injection and a combination of the two for the management of bleeding peptic ulcers</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1999</YR>
<VL>49</VL>
<PG>13-8</PG>
<IDENTIFIERS MODIFIED="2014-10-01 11:00:06 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 11:00:06 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9869717"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garrido-2002" MODIFIED="2014-10-01 11:00:43 -0400" MODIFIED_BY="[Empty name]" NAME="Garrido 2002" YEAR="2002">
<REFERENCE MODIFIED="2014-10-01 11:00:43 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Garrido A, Guerrero FJ, Perianes C, Arenas FJ, Palomo S</AU>
<TI>Local therapeutic injection in bleeding peptic ulcer: a comparison of adrenaline to adrenaline plus a sclerosing agent</TI>
<TO>Inyección local terapeutica en la ulcera gastroduodenal sangrante: estudio comparativo de adrenalina frente adrenalina más agente esclerosante</TO>
<SO>Revista Española de Enfermedades Digestivas</SO>
<YR>2002</YR>
<VL>94</VL>
<NO>7</NO>
<PG>395-400</PG>
<IDENTIFIERS MODIFIED="2014-10-01 11:00:43 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 11:00:43 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12432836"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grgov-2012" MODIFIED="2014-10-01 11:01:28 -0400" MODIFIED_BY="[Empty name]" NAME="Grgov 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-10-01 11:01:28 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Grgov S, Stamenkovi&#263; P, Janji&#263; D</AU>
<TI>Comparison of haemostatic efficacy for endoscopic injection therapy of epinephrine and combination therapy of epinephrine and hemoclips for bleeding peptic ulcers</TI>
<SO>Srpski Arhiv za Celokupno Lekarstvo</SO>
<YR>2012</YR>
<VL>140</VL>
<NO>5-6</NO>
<PG>299-304</PG>
<IDENTIFIERS MODIFIED="2014-10-01 11:01:28 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 11:01:28 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="22826982"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kubba-1996" MODIFIED="2014-10-01 11:01:57 -0400" MODIFIED_BY="[Empty name]" NAME="Kubba 1996" YEAR="1996">
<REFERENCE MODIFIED="2014-10-01 11:01:57 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kubba AK, Murphy W, Palmer KR</AU>
<TI>Endoscopic injection for bleeding peptic ulcer: a comparison of adrenaline alone with adrenaline plus human thrombin</TI>
<SO>Gastroenterology</SO>
<YR>1996</YR>
<VL>111</VL>
<NO>3</NO>
<PG>623-8</PG>
<IDENTIFIERS MODIFIED="2014-10-01 11:01:57 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 11:01:57 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8780566"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-1997" NAME="Lee 1997" YEAR="1997">
<REFERENCE PRIMARY="YES" TYPE="OTHER">
<AU>Lee MH, Jung HY, Yang SK, Kim HR, Homg WS, Min YI</AU>
<TI>Epinephrine alone versus epinephrine plus ethanol for injection therapy of bleeding peptic ulcers</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1997</YR>
<VL>45</VL>
<PG>A283</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lin-1993" MODIFIED="2014-10-01 11:02:48 -0400" MODIFIED_BY="[Empty name]" NAME="Lin 1993" YEAR="1993">
<REFERENCE MODIFIED="2014-10-01 11:02:48 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lin MJ, Peung CL, Lee SD</AU>
<TI>Is sclerosant injection mandatory after an epinephrine injection for arrest of peptic ulcer hemorrhage? A prospective, randomised, comparative study</TI>
<SO>Gut</SO>
<YR>1993</YR>
<VL>34</VL>
<PG>1182-5</PG>
<IDENTIFIERS MODIFIED="2014-10-01 11:02:48 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 11:02:48 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8406150"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lin-1999" MODIFIED="2014-10-01 11:03:14 -0400" MODIFIED_BY="[Empty name]" NAME="Lin 1999" YEAR="1999">
<REFERENCE MODIFIED="2014-10-01 11:03:14 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lin HJ, Tseng GY, Perng CL, Lee FY, Chang FY, Lee SD</AU>
<TI>Comparison of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleeding</TI>
<SO>Gut</SO>
<YR>1999</YR>
<VL>44</VL>
<PG>715-9</PG>
<IDENTIFIERS MODIFIED="2014-10-01 11:03:14 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 11:03:14 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10205211"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lo-2006" MODIFIED="2014-10-01 11:03:54 -0400" MODIFIED_BY="[Empty name]" NAME="Lo 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-10-01 11:03:54 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lo C-C, Hsu P-J, Lo G-H, Lin C-K, Chan H-L, Tsai W-L et al</AU>
<TI>Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcers</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2006</YR>
<VL>63</VL>
<NO>6</NO>
<PG>767-73</PG>
<IDENTIFIERS MODIFIED="2014-10-01 11:03:52 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 11:03:52 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16650535"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Loizou-1991" MODIFIED="2014-10-01 11:04:26 -0400" MODIFIED_BY="[Empty name]" NAME="Loizou 1991" YEAR="1991">
<REFERENCE MODIFIED="2014-10-01 11:04:26 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Loizou LA, Bown SG</AU>
<TI>Endoscopic treatment for bleeding peptic ulcers: randomized comparison of adrenaline injection and adrenaline injection + Nd YAG laser photocoagulation</TI>
<SO>Gut</SO>
<YR>1991</YR>
<VL>32</VL>
<NO>10</NO>
<PG>1100-3</PG>
<IDENTIFIERS MODIFIED="2014-10-01 11:04:22 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 11:04:22 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="1955161"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Park-2004" MODIFIED="2014-10-01 11:05:03 -0400" MODIFIED_BY="[Empty name]" NAME="Park 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-10-01 11:05:03 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Park CH, Joo YE, Kim HS, Choi SK, Rew JS, Kim SJ</AU>
<TI>A prospective, randomized trial comparing mechanical methods of hemostasis plus epinephrine injection to epinephrine injection alone for bleeding peptic ulcer</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2004</YR>
<VL>60</VL>
<NO>2</NO>
<PG>173-9</PG>
<IDENTIFIERS MODIFIED="2014-10-01 11:05:03 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 11:04:59 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15278040"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pescatore-2002" MODIFIED="2014-10-01 11:05:35 -0400" MODIFIED_BY="[Empty name]" NAME="Pescatore 2002" YEAR="2002">
<REFERENCE MODIFIED="2014-10-01 11:05:35 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Pescatore P, Jormod P, Borovicka J, Pantoflickova D, Suter W, Meyenberger C et al</AU>
<TI>Epinephrine versus epinephrine plus fibrin glue injection in peptic ulcer bleeding: a prospective randomized trial</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2002</YR>
<VL>55</VL>
<NO>3</NO>
<PG>348-53</PG>
<IDENTIFIERS MODIFIED="2014-10-01 11:05:35 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 11:05:35 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11868007"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sollano-1991" MODIFIED="2014-10-01 11:06:15 -0400" MODIFIED_BY="[Empty name]" NAME="Sollano 1991" YEAR="1991">
<REFERENCE MODIFIED="2014-10-01 11:06:15 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sollano SD, Ang VN, Moreno JA</AU>
<TI>Endoscopic hemostasis of bleeding peptic ulcers :1:10000 adrenalin injection vs 1:10000 adrenalin injection vs heater probe</TI>
<SO>Gastroenterologia Japonica</SO>
<YR>1991</YR>
<VL>26</VL>
<NO>Suppl 3</NO>
<PG>83-5</PG>
<IDENTIFIERS MODIFIED="2014-10-01 11:06:15 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 11:06:15 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="1884968"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Villanueva-1993" MODIFIED="2014-10-01 11:06:53 -0400" MODIFIED_BY="[Empty name]" NAME="Villanueva 1993" YEAR="1993">
<REFERENCE MODIFIED="2014-10-01 11:06:53 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Villanueva C, Balanzo J, Espinos JC, Fabrega E, Sainz S, Gonzalez D et al</AU>
<TI>Endoscopic injection therapy of bleeding ulcer: a prospective and randomized comparison of adrenaline alone or with polidocanol</TI>
<SO>Journal of Clinical Gastroenterology</SO>
<YR>1993</YR>
<VL>17</VL>
<NO>3</NO>
<PG>195-200</PG>
<IDENTIFIERS MODIFIED="2014-10-01 11:06:50 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 11:06:50 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8228078"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Villanueva-1996" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NAME="Villanueva 1996" YEAR="1996">
<REFERENCE MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Villanueva C, Balanzo J, Sabat M, Gallego A, Ortiz J, Soriano G et al</AU>
<TI>Injection therapy alone or with endoscopic hemoclip for bleeding peptic ulcer. Preliminary results of a randomized trial</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1996</YR>
<VL>43</VL>
<PG>A281</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Buffoli-2001" MODIFIED="2014-07-11 09:58:04 -0400" MODIFIED_BY="[Empty name]" NAME="Buffoli 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-07-11 09:58:04 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Buffoli F, Graffeo M, Nicosia F, Gentile C, Cesar P, Rotti F et al</AU>
<TI>Peptic ulcer bleeding comparison of two hemostatic procedures</TI>
<SO>American Journal of Gastroenterology</SO>
<YR>2001</YR>
<VL>96</VL>
<PG>89-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chittmittrapap-2010" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NAME="Chittmittrapap 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - CCTR&lt;br&gt;S. Chittmittrapap&lt;/p&gt;" NOTES_MODIFIED="2014-10-01 10:53:19 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Chittmittrapap S, Limmathurotsakul D, Rerknimitr R, Ridtitid W, Kongkam P, Treeprasertsuk S et al</AU>
<TI>A retrospective study comparing the results of argon plasma coagulation versus bipolar probe coaptation as a treatment for high risk peptic ulcer bleeding</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2010</YR>
<VL>Conference</VL>
<NO>var.pagings</NO>
<PG>5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chua-2001" NAME="Chua 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="OTHER">
<AU>Chua TS, Fock KM, Ng TM, Khor JL, Theo EK</AU>
<TI>Treatment of bleeding peptic ulcers with combination of epinephrine injection and endoscopic hemoclip application</TI>
<SO>Gastroenterology</SO>
<YR>2001</YR>
<VL>120</VL>
<PG>A4370</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chung-1990" NAME="Chung 1990" YEAR="1990">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chung SC, Leung JW, Leung HT, Lo KK, Griffin SM, Li AK</AU>
<TI>Does adding a sclerosant improve the results of endoscopic epinephrine injection in actively bleeding ulcers? An interim report of a randomized trial</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1992</YR>
<VL>38</VL>
<PG>A21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chung-1992" NAME="Chung 1992" YEAR="1992">
<REFERENCE PRIMARY="YES" TYPE="OTHER">
<AU>Chung SC, Leong HT, Chan AC, Yung MY, Leung JW, Li AK</AU>
<TI>Epinephrine or epinephrine plus alcohol for injection of peptic ulcers?</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1992</YR>
<VL>38</VL>
<PG>A21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chung-1997a" MODIFIED="2009-12-12 07:09:29 -0500" MODIFIED_BY="[Empty name]" NAME="Chung 1997a" YEAR="1997">
<REFERENCE MODIFIED="2009-12-12 07:09:29 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chung IK, Kim HS, Park SH, Lee MH, Kim SJ</AU>
<TI>The comparison of hemostatic efficacy of endoscopic hemoclip, hypertonic saline epinephrine injection and combined method in treatment for bleeding peptic ulcer</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1997</YR>
<VL>45</VL>
<NO>4</NO>
<PG>AB88</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dedeu-2003" NAME="Dedeu 2003" YEAR="2003">
<REFERENCE PRIMARY="YES" TYPE="OTHER">
<AU>Dedeu JM, Villanueva C, Gomez C, Minana JM, Sola-Vera J, Gallego A et al</AU>
<TI>Endoscopic injection alone or combined with bipolar electrocoagulation for bleeding peptic ulcer. Preliminary results of a prospective and randomized trial</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2003</YR>
<VL>49</VL>
<PG>A439</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Goede-1998" NAME="De Goede 1998" YEAR="1998">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>De Goede E, Gevers AM, Simoens M, Hiele M, Rutgeerts P</AU>
<TI>Interim results of a randomized trial comparing injection therapy with epinephrine polidocanol 1% versus hemoclip vs injection combined with hemoclip for bleeding ulcers</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1998</YR>
<VL>53</VL>
<PG>A234</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ell-2002" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NAME="Ell 2002" YEAR="2002">
<REFERENCE MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Ell C</AU>
<TI>Endoclip versus injection therapy in bleeding gastroduodenal ulcers: results of a prospective randomized multicenter trial</TI>
<SO>Gastroenterology</SO>
<YR>2002</YR>
<VL>122</VL>
<PG>A1542</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gevers-2002" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NAME="Gevers 2002" YEAR="2002">
<REFERENCE MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gevers AM, De Goede E, Simoens M, Hiele M, Ruteerts P</AU>
<TI>A randomized trial comparing injection therapy with hemoclip and with injection combined with hemoclip for bleeding ulcers</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2002</YR>
<VL>55</VL>
<PG>466-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grgov-2013" MODIFIED="2014-07-14 14:16:39 -0400" MODIFIED_BY="[Empty name]" NAME="Grgov 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-07-14 14:16:39 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Grgov S, Radovanovi&#263;-Dini&#263; B, Tasi&#263; T</AU>
<TI>Could application of epinephrine improve hemostatic efficacy of hemoclips for bleeding peptic ulcers? A prospective randomized study</TI>
<SO>Vojnosanitetski Pregled: Military Medical &amp; Pharmaceutical Journal of Serbia &amp; Montenegro</SO>
<YR>2013</YR>
<VL>70</VL>
<NO>9</NO>
<PG>824-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="0042-8450"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karaman-2011" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NAME="Karaman 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Karaman A, Baskol M, Gursoy S, Torun E, Yurci A, Ozel BD et al</AU>
<TI>Epinephrine plus argon plasma or heater probe coagulation in ulcer bleeding</TI>
<SO>World Journal of Gastroenterology</SO>
<YR>2011</YR>
<VL>17</VL>
<NO>36</NO>
<PG>4109-12</PG>
<PB>Department of Gastroenterology, Erciyes University, 38030 Kayseri, Turkey. drkaraman@hotmail.com</PB>
<CY>China</CY>
<IDENTIFIERS MODIFIED="2014-05-30 06:32:56 -0400" MODIFIED_BY="Cathy Bennett">
<IDENTIFIER TYPE="OTHER" VALUE="1007-9327"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lecleire-2009" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NAME="Lecleire 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Lecleire S, Antonietti M, Iwanicki-Caron I, Duclos A, Ramirez S, Ben-Soussan E et al</AU>
<TI>Endoscopic band ligation could decrease recurrent bleeding in Mallory-Weiss syndrome as compared to haemostasis by hemoclips plus epinephrine</TI>
<SO>Alimentary Pharmacology &amp; Therapeutics</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>4</NO>
<PG>399-405</PG>
<PB>Gastroenterology Department, Digestive Endoscopy Unit, Rouen University Hospital, Rouen Cedex, France. stephane.lecleire@churouen.fr</PB>
<CY>England</CY>
<IDENTIFIERS MODIFIED="2014-05-30 06:32:56 -0400" MODIFIED_BY="Cathy Bennett">
<IDENTIFIER TYPE="OTHER" VALUE="1365-2036"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ljubicic-2012" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NAME="Ljubicic 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Ljubicic N, Budimir I, Biscanin A, Nikolic M, Supanc V, Hrabar D et al</AU>
<TI>Endoclips vs large or small-volume epinephrine in peptic ulcer recurrent bleeding</TI>
<SO>World Journal of Gastroenterology</SO>
<YR>2012</YR>
<VL>18</VL>
<NO>18</NO>
<PG>2219-24</PG>
<PB>Department of Internal Medicine, 'Sestre milosrdnice' University Hospital Center, 10000 Zagreb, Croatia. neven.ljubicic@kbcsm.hr</PB>
<CY>China</CY>
<IDENTIFIERS MODIFIED="2014-05-30 06:32:56 -0400" MODIFIED_BY="Cathy Bennett">
<IDENTIFIER TYPE="OTHER" VALUE="1007-9327"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Male-1999" NAME="Male 1999" YEAR="1999">
<REFERENCE PRIMARY="YES" TYPE="OTHER">
<AU>Male GY, Lin H, Pergn CH, Lee FY, Chang FY, Lee SD</AU>
<TI>A prospective randomized trial comparing injection of epinephrine alone, bipolar electrocoagulation for the arrest of peptic ulcer bleeding</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1999</YR>
<VL>49</VL>
<PG>A452</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pescatore-1999" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NAME="Pescatore 1999" YEAR="1999">
<REFERENCE MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Pescatore P, Jorned P, Borovicka J, Suter W, Delative J, Wissel P et al</AU>
<TI>Randomized study of epinephrine versus epinephrine + fibrin injection in peptic ulcer bleeding. interim analysis</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1999</YR>
<VL>49</VL>
<PG>A448</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sabat-1998" NAME="Sabat 1998" YEAR="1998">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sabat M, Villanueva C, Ortiz J, Sainz S, Torras X, Casso X et al</AU>
<TI>Final results of a prospective and randomized trial evaluating endoscopic hemoclip for bleeding peptic ulcer</TI>
<SO>Gastroenterology</SO>
<YR>1998</YR>
<VL>114</VL>
<PG>G1118</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taghavi-2009" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NAME="Taghavi 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Taghavi SA, Soleimani SM, Hosseini-Asl SMK, Eshraghian A, Eghbali H, Dehghani SM et al</AU>
<TI>Adrenaline injection plus argon plasma coagulation versus adrenaline injection plus hemoclips for treating high-risk bleeding peptic ulcers: a prospective, randomized trial</TI>
<SO>Canadian Journal of Gastroenterology and Hepatology</SO>
<YR>2009</YR>
<VL>23</VL>
<NO>10</NO>
<PG>699-704</PG>
<PB>Gastroenterohepatology Research Centre, Nemazee Hospital, Shiraz, Iran. ataghavi@sums.ac.ir</PB>
<CY>Canada</CY>
<IDENTIFIERS MODIFIED="2014-05-30 06:32:56 -0400" MODIFIED_BY="Cathy Bennett">
<IDENTIFIER TYPE="OTHER" VALUE="0835-7900"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tsoi-2009" MODIFIED="2014-06-13 06:28:43 -0400" MODIFIED_BY="Cathy Bennett" NAME="Tsoi 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-06-13 06:28:43 -0400" MODIFIED_BY="Cathy Bennett" NOTES="&lt;p&gt;NOT IN FILE&lt;br&gt;Nature Reviews Gastroenterology and Hepatology&lt;/p&gt;" NOTES_MODIFIED="2014-06-13 06:28:43 -0400" NOTES_MODIFIED_BY="Cathy Bennett" PRIMARY="NO" TYPE="OTHER">
<AU>Tsoi KKF, Chiu PWY, Sung JJY</AU>
<TI>Endoscopy for upper gastrointestinal bleeding: is routine second-look necessary?</TI>
<SO>Nature Reviews Gastroenterology and Hepatology</SO>
<YR>2009</YR>
<VL>6</VL>
<PG>717-22</PG>
<EN>12</EN>
<PB>Nature Publishing Group (Houndmills, Basingstoke, Hampshire RG21 6XS, United Kingdom)</PB>
<IDENTIFIERS MODIFIED="2014-05-30 06:32:56 -0400" MODIFIED_BY="Cathy Bennett">
<IDENTIFIER TYPE="OTHER" VALUE="1759-5045"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wehrmann-1994" NAME="Wehrmann 1994" YEAR="1994">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wehrmann T, Fremdling D, Leabcke B, Jong M</AU>
<TI>Epinephrine plus polidocanol versus epinephrine alone for endoscopic treatment of peptic ulcer haemorrhage. a prospective, randomized trial</TI>
<SO>European Journal of Gastroenterology and Hepatology</SO>
<YR>1994</YR>
<VL>6</VL>
<PG>1033-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-ASGE-2004" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NAME="ASGE 2004" TYPE="JOURNAL_ARTICLE">
<AU>American Society for Gastrointestinal Endoscopy</AU>
<TI>ASGE guideline: the role of endoscopy in acute non-variceal upper GI hemorrhage</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2004</YR>
<VL>60</VL>
<PG>497-504</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-British-Society-2002" NAME="British Society 2002" TYPE="JOURNAL_ARTICLE">
<AU>British Society of Gastroenterology Endoscopy Committee</AU>
<TI>Non variceal upper gastrointestinal hemorrhage guidelines</TI>
<SO>Gut</SO>
<YR>2002</YR>
<VL>51</VL>
<PG>1-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brullet-1996" NAME="Brullet 1996" TYPE="JOURNAL_ARTICLE">
<AU>Brullet E, Calvet X, Campo R, Rue M, Calot L, Donoso L</AU>
<TI>Factors predicting failure of endoscopic injection therapy in bleeding duodenal ulcer</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1996</YR>
<VL>43</VL>
<PG>111-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cook-1992" MODIFIED="2010-01-17 14:05:47 -0500" MODIFIED_BY="[Empty name]" NAME="Cook 1992" TYPE="JOURNAL_ARTICLE">
<AU>Cook DJ, Guyatt GH, Salena BJ, Laine LA</AU>
<TI>Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis</TI>
<SO>Gastroenterology</SO>
<YR>1992</YR>
<VL>102</VL>
<PG>139-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cooper-1999" MODIFIED="2014-07-14 14:15:35 -0400" MODIFIED_BY="[Empty name]" NAME="Cooper 1999" TYPE="JOURNAL_ARTICLE">
<AU>Cooper GS, Chak A, Way LE</AU>
<TI>Early endoscopy in upper gastrointestinal haemorrhage associations with recurrent bleeding, surgery, and length of hospital stay</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1999</YR>
<VL>49</VL>
<PG>145-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Feu-2003" NAME="Feu 2003" TYPE="JOURNAL_ARTICLE">
<AU>Feu F, Brullet E, Calvet X, Fernandez-Llamazares J, Guardiola J, Moreno P et al</AU>
<TI>Guidelines for the diagnosis and treatment of acute non-variceal upper gastrointestinal bleeding</TI>
<SO>Gastroenterologia y Hepatologia</SO>
<YR>2003</YR>
<VL>26</VL>
<PG>70-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Forrest-1974" NAME="Forrest 1974" TYPE="JOURNAL_ARTICLE">
<AU>Forrest JA, Finlayson ND, Shearman DJ</AU>
<TI>Endoscopy in gastrointestinal bleeding</TI>
<SO>Lancet</SO>
<YR>1974</YR>
<VL>2</VL>
<PG>394-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gisbert-2001" NAME="Gisbert 2001" TYPE="JOURNAL_ARTICLE">
<AU>Gisbert JP, Gonzalez L, Calvet X, Roque M, Gabriel R, Pajares JM</AU>
<TI>Proton pump inhibitors versus H2 antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer</TI>
<SO>Alimentary Pharmacology and Therapeutics</SO>
<YR>2001</YR>
<VL>15</VL>
<PG>917-28</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" MODIFIED="2014-05-30 11:46:23 -0400" MODIFIED_BY="Cathy Bennett" NAME="Higgins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>11</NO>
<PG>1539-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]</TI>
<SO>The Cochrane Collaboration, 2008. www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hwang-2012" MODIFIED="2014-06-13 06:03:36 -0400" MODIFIED_BY="Cathy Bennett" NAME="Hwang 2012" TYPE="OTHER">
<AU>Hwang JH, Fisher DA, Ben-Menachem T, Chandrasekhara V, Chathadi K, Decker GA</AU>
<TI>The role of endoscopy in the management of acute non-variceal upper GI bleeding</TI>
<SO>Gastrointestinal Endoscopy</SO>
<VL>75</VL>
<NO>6</NO>
<PG>1132-8</PG>
<IDENTIFIERS MODIFIED="2014-06-13 06:03:36 -0400" MODIFIED_BY="Cathy Bennett">
<IDENTIFIER MODIFIED="2014-06-13 06:03:36 -0400" MODIFIED_BY="Cathy Bennett" TYPE="DOI" VALUE="10.1016/j.gie.2012.02.033"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kovacs-2008" MODIFIED="2010-01-17 14:06:14 -0500" MODIFIED_BY="[Empty name]" NAME="Kovacs 2008" TYPE="JOURNAL_ARTICLE">
<AU>Kovacs TO</AU>
<TI>Management of gastroduodenal peptic bleeding</TI>
<SO>Current Gastroenterology Reports</SO>
<YR>2008</YR>
<VL>10</VL>
<PG>535-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Laine-2003" NAME="Laine 2003" TYPE="JOURNAL_ARTICLE">
<AU>Laine L</AU>
<TI>Endoscopic therapy for bleeding ulcers:room for improvement?</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2003</YR>
<VL>57</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Laine-2009" MODIFIED="2014-06-13 06:13:56 -0400" MODIFIED_BY="Cathy Bennett" NAME="Laine 2009" TYPE="JOURNAL_ARTICLE">
<AU>Laine L, McQuaid KR</AU>
<TI>Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials</TI>
<SO>Clinical Gastroenterology and Hepatology</SO>
<YR>2009</YR>
<VL>7</VL>
<PG>33-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Laine-2012" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NAME="Laine 2012" TYPE="JOURNAL_ARTICLE">
<AU>Laine L, Jensen DM</AU>
<TI>Management of patients with ulcer bleeding</TI>
<SO>American Journal of Gastroenterology</SO>
<YR>2012</YR>
<VL>107</VL>
<PG>345-60</PG>
<IDENTIFIERS MODIFIED="2014-06-13 05:09:56 -0400" MODIFIED_BY="Cathy Bennett">
<IDENTIFIER MODIFIED="2014-06-13 05:09:56 -0400" MODIFIED_BY="Cathy Bennett" TYPE="DOI" VALUE="10.1038/ajg.2011.480;"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lin-2002" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NAME="Lin 2002" TYPE="JOURNAL_ARTICLE">
<AU>Lin HJ, Hsleh YH, Tseng GY, Perng GL, Chang FY, Lee SD</AU>
<TI>A prospective, randomized trial of large- versus small-volume endoscopic injection of epinephrine for peptic ulcer bleeding</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2002</YR>
<VL>55</VL>
<PG>615-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Llach-1996" NAME="Llach 1996" TYPE="JOURNAL_ARTICLE">
<AU>Llach L, Bordas JM, Salmeron JM, Panes J, Garcia Pagan JC, Feu Fet al</AU>
<TI>A prospective randomized trial of heater probe thermocoagulation versus injection therapy in peptic ulcer hemorrhage</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1996</YR>
<VL>43</VL>
<PG>117-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marmo-2003" NAME="Marmo 2003" TYPE="JOURNAL_ARTICLE">
<AU>Marmo R, Rotondano G, Bianco MA, Piscopo R, Prisco A, Cipolletta L</AU>
<TI>Outcome of endoscopic treatment for peptic ulcer bleeding; is a second look necessary? A meta-analysis</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2003</YR>
<VL>57</VL>
<PG>62-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NICE-2012" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NAME="NICE 2012" TYPE="OTHER">
<AU>NICE</AU>
<TI>Acute upper gastrointestinal bleeding: management</TI>
<SO>NICE clinical guideline 141,</SO>
<YR>June 2012</YR>
<VL>guidance.nice.org.uk/cg141</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Peter-2008" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NAME="Peter 2008" TYPE="JOURNAL_ARTICLE">
<AU>Peter S, Wilcox CM</AU>
<TI>Modern endoscopic therapy of peptic ulcer bleeding</TI>
<SO>Digestive Diseases</SO>
<YR>2008</YR>
<VL>20</VL>
<PG>291-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Randall-1989" NAME="Randall 1989" TYPE="JOURNAL_ARTICLE">
<AU>Randall GM, Jensen DM, Hirabayashi K, Machicado GA</AU>
<TI>Controlled study of different sclerosing agents for coagulation of canine gut arteries</TI>
<SO>Gastroenterology</SO>
<YR>1989</YR>
<VL>96</VL>
<PG>1274-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2014-07-14 14:15:10 -0400" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan) Version 5.3</TI>
<YR>2014</YR>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ritgeers-1989" NAME="Ritgeers 1989" TYPE="JOURNAL_ARTICLE">
<AU>Rutgeerts P, Geobes K, Vantrapen G</AU>
<TI>Experimental studies of injection therapy for severe nonvariceal bleeding in dogs</TI>
<SO>Gastroenterology</SO>
<YR>1989</YR>
<VL>97</VL>
<PG>610-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rollhauser-2000" NAME="Rollhauser 2000" TYPE="JOURNAL_ARTICLE">
<AU>Rollhauser C, Fleischer DE</AU>
<TI>Current status of endoscopic therapy for ulcer bleeding</TI>
<SO>Best Practice and Research. Clinical Gastroenterology</SO>
<YR>2000</YR>
<VL>14</VL>
<PG>391-410</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Savides-2000" NAME="Savides 2000" TYPE="JOURNAL_ARTICLE">
<AU>Savides TJ, Jensen DM</AU>
<TI>Therapeutic endoscopy for nonvariceal gastrointestinal bleeding</TI>
<SO>Gastroenterology Clinics of North America</SO>
<YR>2000</YR>
<VL>29</VL>
<PG>465-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Simoens-2001" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NAME="Simoens 2001" TYPE="JOURNAL_ARTICLE">
<AU>Simoens M, Rutgeerts P</AU>
<TI>Non variceal upper gastrointestinal bleeding</TI>
<SO>Best Practice and Research. Clinical Gastroenterology</SO>
<YR>2001</YR>
<VL>15</VL>
<PG>121-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spiegel-2003" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NAME="Spiegel 2003" TYPE="JOURNAL_ARTICLE">
<AU>Spiegel BM, Ofman JJ, Woods K, Vakil NB</AU>
<TI>Minimizing recurrent peptic ulcer haemorrhage after endoscopic hemostasis::the cost effectiveness of competing strategies</TI>
<SO>The American Journal of Gastroenterology</SO>
<YR>2003</YR>
<VL>98</VL>
<PG>86-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yuan-2008" MODIFIED="2014-07-14 14:14:55 -0400" MODIFIED_BY="[Empty name]" NAME="Yuan 2008" TYPE="JOURNAL_ARTICLE">
<AU>Yuan Y, Wang C, Hunt RH</AU>
<TI>Endoscopic clipping for acute non variceal for upper GI bleeding: a meta-analysis and critical appraisal of randomized controlled trials</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2008</YR>
<VL>68</VL>
<NO>2</NO>
<PG>339-51</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2014-06-13 06:30:21 -0400" MODIFIED_BY="Cathy Bennett">
<REFERENCE ID="REF-Vergara-2007" MODIFIED="2014-06-13 06:30:21 -0400" MODIFIED_BY="Cathy Bennett" NAME="Vergara 2007" TYPE="COCHRANE_REVIEW">
<AU>Vergara M, Calvet X, Gisbert J</AU>
<TI>Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcer disease</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2014-06-13 06:29:21 -0400" MODIFIED_BY="Cathy Bennett">
<IDENTIFIER MODIFIED="2014-06-13 06:29:21 -0400" MODIFIED_BY="Cathy Bennett" TYPE="DOI" VALUE="10.1002/14651858.CD005584"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-10-01 13:27:42 -0400" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-10-01 13:27:39 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Balanzo-1990">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 64)&#8226; Age (years): 65 (mean)<BR/>&#8226; Sex (male/female): 38/26<BR/>&#8226; Duodenal/gastric ulcer: 20/41<BR/>&#8226; Forrest group: Ia/Ib = 24, IIa = 40</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection vs epinephrine injection plus thrombin injection. No specification about how many different endoscopists participated in the intervention process<BR/>&#8226; Medical treatment: not specified<BR/>&#8226; Second-look endoscopy: yes<BR/>&#8226; Epinephrine volume: not specified</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed</U>
</B>
</P>
<P>Rebleeding rates, surgery rate and mortality</P>
<UL>
<LI>Mortality criteria: not specified</LI>
<LI>Bleeding criteria: not specified</LI>
<LI>Emergency surgery rates</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-03-12 13:36:53 -0400" MODIFIED_BY="Cathy Bennett"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Choudari-1994">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 107)<BR/>&#8226; Age (years): 68.5 (median)<BR/>&#8226; Sex (male/female): 68/39<BR/>&#8226; Duodenal/gastric ulcer: 63/44<BR/>&#8226; Forrest group: Ia/Ib = 57, IIa = 50 (with high-risk stigmata (Forrest Ia-Ib-IIa))</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions </U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection (n = 55) vs epinephrine injection plus ethanolamine (n = 52). Only 1 endoscopist carried out the procedures<BR/>&#8226; Medical treatment: H2 antagonists<BR/>&#8226; Second-look endoscopy: yes<BR/>&#8226; Epinephrine volume: 7.5 mL in each group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed</U>
</B>
<BR/>Rebleeding rate, surgery rate, units of blood transfused, duration of hospital admission and mortality<BR/>&#8226; Mortality criteria: 30-day mortality<BR/>&#8226; Bleeding criteria: fresh hematemesis or melena plus shock or fall in haemoglobin &gt; 2 g/dL</P>
<UL>
<LI>Emergency surgery</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-03-12 13:43:12 -0400" MODIFIED_BY="Cathy Bennett"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chung-1993">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 200)<BR/>&#8226; Age (years): 54.5 (mean)<BR/>&#8226; Sex (male/female): 138/58<BR/>&#8226; Duodenal/gastric ulcer: 117/75<BR/>&#8226; Forrest group: Ia = 62, Ib = 134</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection (n = 99) vs epinephrine injection plus sodium tetradecyl sulphate (n = 101)<BR/>&#8226; Medical treatment: ranitidine 50 mg/6 h intravenously<BR/>&#8226; Second-look endoscopy: yes<BR/>&#8226; Epinephrine volume: not specified</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed<BR/>
</U>
</B>Rebleeding rate, surgery rate, hospital stay, transfusion requirements and mortality<BR/>&#8226; Mortality criteria: hospital mortality<BR/>&#8226; Bleeding criteria: fresh hematemesis or melena plus shock or fall in haemoglobin &gt; 2 g/dL</P>
<UL>
<LI>Emergency surgery</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-03-12 13:45:45 -0400" MODIFIED_BY="Cathy Bennett"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chung-1996">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 160)<BR/>&#8226; Age (years): 55.2 (mean)<BR/>&#8226; Sex (male/female): 118/42<BR/>&#8226; Duodenal/gastric ulcer: 108/51<BR/>&#8226; Forrest group: (Forrest Ia-Ib) Ia = 35, Ib = 125</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions </U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection (n = 81) vs epinephrine injection plus ethanol injection (n = 79)<BR/>&#8226; Medical treatment: H2 antagonists<BR/>&#8226; Second-look endoscopy: yes<BR/>&#8226; Epinephrine volume: not specified</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed<BR/>
</U>
</B>Rebleeding rate, surgery rate and mortality<B>
<U>
<BR/>
</U>
</B>&#8226; Mortality criteria: hospital mortality<BR/>&#8226; Bleeding criteria: not specified</P>
<P>Emergency surgery (for uncontrolled arterial bleeding)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-03-12 13:46:04 -0400" MODIFIED_BY="Cathy Bennett"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chung-1997">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 276)<BR/>&#8226; Age (years): 58.5 (mean)<BR/>&#8226; Sex (male/female): 187/89<BR/>&#8226; Duodenal/gastric ulcer: 176/87<BR/>&#8226; Forrest group: Ia = 58, Ib = 212</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection (n = 136) vs epinephrine injection and heat probe (n = 140)<BR/>&#8226; Medical treatment: ranitidine<BR/>&#8226; Second-look endoscopy: yes<BR/>&#8226; Epinephrine volume: 9.5 vs 10.1</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed</U>
</B>
</P>
<P>Rebleeding rate, length of hospital stay, requirement for blood transfusion, surgery rate and mortality</P>
<UL>
<LI>Mortality criteria: hospital mortality</LI>
<LI>Bleeding criteria: not specified</LI>
<LI>Emergency surgery</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed</U>
</B>
<BR/>Rebleeding rate, surgery rate and mortality<BR/>&#8226; Mortality criteria: hospital mortality<BR/>&#8226; Bleeding criteria: not specified</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chung-1999">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 124)<BR/>&#8226; Age (years): 55.5 (mean)<BR/>&#8226; Sex (male/female): 69/14<BR/>&#8226; Duodenal/gastric ulcer: 20/61<BR/>&#8226; Forrest group: Ia = 8, Ib = 27, IIa = 48</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection (n = 41) vs epinephrine injection plus haemoclip (n = 42) vs haemoclip only group (n = 41)<BR/>&#8226; Medical treatment: not specified<BR/>&#8226; Second-look endoscopy: yes<BR/>&#8226; Epinephrine volume: not specified</P>
<UL>
<LI>Emergency surgery</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed<BR/>
</U>
</B>Rebleeding rate, surgery rate and mortality<BR/>&#8226; Mortality criteria: hospital mortality<BR/>&#8226; Bleeding criteria: fresh hematemesis or melena plus shock or transfusion &gt; 8 U</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-03-12 13:46:39 -0400" MODIFIED_BY="Cathy Bennett"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Garrido-2002">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 85)<BR/>&#8226; Age (years): 63.1 (mean)<BR/>&#8226; Sex (male/female): 50/35<BR/>&#8226; Duodenal/gastric ulcer: 27/58<BR/>&#8226; Forrest group: Ia/Ib = 25, IIa = 52, IIb = 8</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection vs epinephrine injection and polidocanol injection<BR/>&#8226; Medical treatment: not specified<BR/>&#8226; Second-look endoscopy: no<BR/>&#8226; Epinephrine volume: not specified</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed<BR/>
</U>
</B>Rebleeding rate<BR/>&#8226; Mortality criteria: not specified<BR/>&#8226; Bleeding criteria: haematemesis or fresh melena</P>
<P>&#8226; Emergency surgery (assessed for whole group, but no separate data for the n = 85 cases randomly assigned)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Spanish language report</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Grgov-2012">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 58)<BR/>&#8226; Age (years): 62.2 (epinephrine); 65.0 (combination therapy) mean<BR/>&#8226; Sex (male/female): 43/15<BR/>&#8226; Duodenal/gastric ulcer: 30/28<BR/>&#8226; Forrest group: Ia = 5, Ib = 47, IIa = 6 (epinephrine Ia n = 1, Ib n = 27, IIa n = 2; combination therapy Ia n = 4, Ib n = 20, IIa n = 4)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>&#8226; Primary intervention: epinephrine injection (n = 30) vs epinephrine injection and haemoclip (n = 28)<BR/>&#8226; Medical treatment: proton pump inhibitors (PPIs) as an intravenous bolus of 80 mg<I>,</I> followed by infusion of 8 mg/h for 72 hours, and after that oral PPI<BR/>&#8226; Second-look endoscopy: no (only if rebleeding suspected)<BR/>&#8226; Epinephrine volume: epinephrine diluted in physiological saline solution (1:10,000), 0.5-2 mL fractions into 4 quadrants around the ulcer. Epinephrine group mean 11 mL (4-20 mL); epinephrine plus haemoclip 10.4 mL (4-20 mL) (no statistically significant difference in volume)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed</U>
</B>
<BR/>Rebleeding rate (initial and final), surgery rate, adequate clip placement and mortality<BR/>&#8226;Mortality criteria: mortality</P>
<P>&#8226;Bleeding criteria: new hematemesis or melena after the appearance of fresh blood aspiration from a nasogastric probe and an increase in pulse rate over 100 per minute, decrease in systolic blood pressure by more than 30 mm Hg and a decrease in haemoglobin of at least 2 g/dL</P>
<P>&#8226; Emergency surgery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-01 09:15:00 -0400" MODIFIED_BY="Cathy Bennett">
<P>Translated from Serbo-Croatian</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kubba-1996">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 140)<BR/>&#8226; Age (years): 70 (median)<BR/>&#8226; Sex (male/female): 93/47<BR/>&#8226; Duodenal/gastric ulcer: 78/52<BR/>&#8226; Forrest group: Ia/Ib = 51, IIa = 89</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection (n = 70) vs epinephrine injection and thrombin injection (n = 70)<BR/>&#8226; Medical treatment: not specified<BR/>&#8226; Second-look endoscopy: no<BR/>&#8226; Epinephrine volume: 10 mL median in epinephrine alone vs 7 mL median in combined therapy group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed<BR/>
</U>
</B>Rebleeding rate, surgery rate and mortality<BR/>&#8226; Mortality criteria: 30-day mortality</P>
<P>&#8226; Bleeding criteria: fresh hematemesis or melena plus shock or fall in haemoglobin &gt; 2 g/dL</P>
<P>&#8226; Emergency surgery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-03-12 13:47:14 -0400" MODIFIED_BY="Cathy Bennett"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee-1997">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 60)<BR/>&#8226; Age (years): not specified<BR/>&#8226; Sex (male/female): not specified<BR/>&#8226; Duodenal/gastric ulcer: not specified<BR/>&#8226; Forrest group: Ia/Ib = 37, IIa = 23</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection vs epinephrine injection and ethanol injection<BR/>&#8226; Medical treatment: not specified<BR/>&#8226; Second-look endoscopy: no<BR/>&#8226; Epinephrine volume: 17.6 mL in epinephrine group alone vs 14.7 mL in combined therapy group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed<BR/>
</U>
</B>Rebleeding rate, surgery rate and mortality<BR/>&#8226; Mortality criteria: not specified<BR/>&#8226; Bleeding criteria: not specified</P>
<P>&#8226; Emergency surgery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Abstract report only; bleeding ulcer participants were a subgroup of n = 60 with active bleeding or a non-bleeding visible vessel</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lin-1993">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 64)<BR/>&#8226; Age (years): 59.6 (mean)<BR/>&#8226; Sex (male/female): 57/7<BR/>&#8226; Duodenal/gastric ulcer: 34/29<BR/>&#8226; Forrest group: Ia = 21 Ib = 43</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection (n = 32) vs epinephrine injection and ethanol injection (n = 32)<BR/>&#8226; Medical treatment: ranitidine or cimetidine<BR/>&#8226; Second-look endoscopy: no<BR/>&#8226; Epinephrine volume: 6 mL in epinephrine group vs 5.5 mL in combined therapy group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed<BR/>
</U>
</B>Bleeding rate, surgery rate, hospital stay, blood transfusions and mortality<BR/>&#8226; Mortality criteria: hospital mortality<BR/>&#8226; Bleeding criteria: unstable vital signs or continued bloody stools or hematemesis</P>
<P>&#8226; Emergency surgery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-03-12 13:48:15 -0400" MODIFIED_BY="Cathy Bennett"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lin-1999">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 96)<BR/>&#8226; Age (years): 67.7 (mean)<BR/>&#8226; Sex (male/female): 57/7<BR/>&#8226; Duodenal/gastric ulcer: 25/37<BR/>&#8226; Forrest group: Ia = 6, Ib = 16, IIa = 42</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection (n = 32) vs epinephrine injection and bipolar electrocoagulation (n = 32) (vs bipolar electrocoagulation alone = 32)<BR/>&#8226; Medical treatment: omeprazole 40 mg/6 h intravenously<BR/>&#8226; Second-look endoscopy: yes<BR/>&#8226; Epinephrine volume: 7.1 mL vs 6.8 mL</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed<BR/>
</U>
</B>Bleeding rate, blood transfusions, surgery rate and mortality<BR/>&#8226; Mortality criteria: hospital mortality<BR/>&#8226; Bleeding criteria: unstable vital signs or continued bloody stools or hematemesis</P>
<P>&#8226; Emergency surgery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-03-12 13:48:31 -0400" MODIFIED_BY="Cathy Bennett"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lo-2006">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 108)<BR/>&#8226; Age (years): 63.5 (mean)<BR/>&#8226; Sex (male/female): 81/24<BR/>&#8226; Duodenal/gastric ulcer: 51/54<BR/>&#8226; Forrest group: Ia/Ib = 42, IIa = 34, IIb = 30</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection (n = 53) vs epinephrine injection plus haemoclip (n = 52). Study was performed by 4 different endoscopists<BR/>&#8226; Medical treatment: pantoprazole 40 mg intravenously<BR/>&#8226; Second-look endoscopy: no<BR/>&#8226; Epinephrine volume: maximum 20 mL</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed</U>
</B>
</P>
<P>Rebleeding rate, surgery, complications and 30-day mortality</P>
<UL>
<LI>Mortality criteria: 30-day mortality</LI>
</UL>
<UL>
<LI>Bleeding criteria: not specified</LI>
</UL>
<UL>
<LI>Emergency surgery</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-03-12 13:41:03 -0400" MODIFIED_BY="Cathy Bennett"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Loizou-1991">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 42)<BR/>&#8226; Age (years): 60.5 (mean)<BR/>&#8226; Sex (male/female): 31/11<BR/>&#8226; Duodenal/gastric ulcer: 22/20<BR/>&#8226; Forrest group: Ia/Ib = 8, IIa = 34</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection (n = 21) vs epinephrine injection and Nd:YAG laser photocoagulation (n = 21)<BR/>&#8226; Medical treatment: ranitidine 300 mg/12 h oral intake<BR/>&#8226; Second-look endoscopy: no<BR/>&#8226; Epinephrine volume: 10 mL in both groups</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed<BR/>
</U>
</B>Bleeding rate, surgery rate and mortality<BR/>&#8226; Mortality criteria: 30-day mortality<BR/>&#8226; Bleeding criteria: fresh hematemesis or melena plus shock or fall in haemoglobin despite transfusion</P>
<P>&#8226; Emergency surgery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-03-12 13:48:45 -0400" MODIFIED_BY="Cathy Bennett"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Park-2004">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, single blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 90)<BR/>&#8226; Age (years): 61.8 (mean)<BR/>&#8226; Sex (male/female): 76/14<BR/>&#8226; Duodenal/gastric ulcer: 18/72<BR/>&#8226; Forrest group: Ia = 18, Ib = 28, IIa = 44</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection (n = 45) vs epinephrine injection plus haemoclip application or band ligation (n = 45)<BR/>&#8226; Medical treatment: ranitidine 50 mg/6 h intravenously<BR/>&#8226; Second-look endoscopy: no<BR/>&#8226; Epinephrine volume: not specified</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed<BR/>
</U>
</B>Bleeding rate, surgery rate and mortality<BR/>&#8226; Mortality criteria: bleeding-related deaths<BR/>&#8226; Bleeding criteria: fresh hematemesis, instability of vital signs and/or decrease in haemoglobin level of more than 2 g/dL/24 h</P>
<P>&#8226; Emergency surgery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pescatore-2002">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 135)<BR/>&#8226; Age (years): 68.7 (median)<BR/>&#8226; Sex (male/female): 90/45<BR/>&#8226; Duodenal/gastric ulcer: 88/47<BR/>&#8226; Forrest group: Ia = 15, Ib = 47, IIa = 51, IIb = 22</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection (n = 70) vs epinephrine injection plus fibrin glue (n = 65)<BR/>&#8226; Medical treatment: not specified<BR/>&#8226; Second-look endoscopy: yes<BR/>&#8226; Epinephrine volume: 10.3 mL in epinephrine group vs 7.5 mL in combined therapy</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed<BR/>
</U>
</B>Bleeding rate, surgery rate, blood transfusion and mortality<BR/>&#8226; Mortality criteria: 30-day mortality<BR/>&#8226; Bleeding criteria: fresh hematemesis or melena plus shock or fall in haemoglobin despite transfusion</P>
<P>&#8226; Emergency surgery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sollano-1991">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 83)<BR/>&#8226; Age (years): not specified<BR/>&#8226; Sex (male/female): not specified<BR/>&#8226; Duodenal/gastric ulcer: 29/29<BR/>&#8226; Forrest group: Ia = 6, Ib = 35, IIa = 20</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection (n = 32) vs epinephrine injection and ethoxy sclerol (n = 29) (vs heater probe only n = 22)<BR/>&#8226; Medical treatment: not specified<BR/>&#8226; Second-look endoscopy: yes<BR/>&#8226; Epinephrine volume: 8.6 mL in epinephrine alone vs 11 mL in combined therapy</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed<BR/>
</U>
</B>Bleeding rate, surgery rate and mortality<BR/>&#8226; Mortality criteria: not specified<BR/>&#8226; Bleeding criteria: recurrence of hematemesis, melena or anaemia</P>
<P>&#8226; Emergency surgery (after rebleeding)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-03-12 13:49:40 -0400" MODIFIED_BY="Cathy Bennett"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 13:27:39 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Villanueva-1993">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 63)<BR/>&#8226; Age (years): 62 (mean)<BR/>&#8226; Sex (male/female): 43/20<BR/>&#8226; Duodenal/gastric ulcer: 31/30<BR/>&#8226; Forrest group: Ia = 1, Ib = 22, IIa = 40</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 13:27:39 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection (n = 30) vs epinephrine injection and polidocanol injection (n = 33)<BR/>&#8226; Medical treatment: ranitidine 50 mg/6 h intravenously<BR/>&#8226; Second-look endoscopy: yes<BR/>&#8226; Epinephrine volume: Both groups received epinephrine in equal amounts. Those in group B also received polidocanol; accordingly, the total volume injected was greater (12 mL in epinephrine alone vs 15.2 mL in combined therapy&#8212;group B-)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed<BR/>
</U>
</B>Bleeding rate, surgery rate, blood transfusions and mortality<BR/>&#8226; Mortality criteria: hospital mortality<BR/>&#8226; Bleeding criteria: fresh hematemesis or melena plus hypovolaemia or fall in haemoglobin requiring transfusion</P>
<P>&#8226; Emergency surgery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-03-12 13:49:51 -0400" MODIFIED_BY="Cathy Bennett"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Villanueva-1996">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised trial, not double blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Participant characteristics</U>
</B>
<BR/>&#8226; Number randomly assigned (n = 78)<BR/>&#8226; Age (years): not specified<BR/>&#8226; Sex (male/female): not specified<BR/>&#8226; Duodenal/gastric ulcer: not specified<BR/>&#8226; Forrest group: Ia/Ib = 25, IIa = 53</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Interventions</U>
</B>
<BR/>&#8226; Primary intervention: epinephrine injection vs epinephrine injection and polidocanol injection<BR/>&#8226; Medical treatment: ranitidine<BR/>&#8226; Second-look endoscopy: no<BR/>&#8226; Epinephrine volume: not specified</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Outcomes assessed<BR/>
</U>
</B>Bleeding rate, surgery rate and mortality<BR/>&#8226; Mortality criteria: hospital mortality<BR/>&#8226; Bleeding criteria: not specified</P>
<P>&#8226; Emergency surgery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Abstract report only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2014-10-01 13:27:42 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Buffoli-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chittmittrapap-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Non-randomised (retrospective) study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chua-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chung-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Preliminary results published later in another article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chung-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Preliminary results published later in another article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chung-1997a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Preliminary results published later in another article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-De-Goede-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Preliminary results published later in another article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dedeu-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Does not specify number of participants in each group<BR/>We contacted the author but did not receive an answer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ell-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Does not specify number of participants in each group<BR/>It was not possible to contact this study author to clarify the results. The study was published only as an abstract, and no contact address was provided</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gevers-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Combined epinephrine plus polidocanol in both groups</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Grgov-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised,(n = 70) but compared (n = 34) participants with endoscopic haemoclip therapy versus (n = 36) participants with epinephrine injection plus endoscopic haemoclip therapy Compared haemoclip with and without epinephrine, does not fit inclusion criteria. Serbo-Croatian</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Karaman-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Compares APC or heater probe. Epinephrine injection (5-6 mL, 1:10,000 dilution) was applied around the ulcer in all participants before both of these 2 methods were applied. Does not fit our inclusion criteria (epinephrine vs epinephrine plus second method)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lecleire-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Mallory Weiss not in our inclusion criteria, not a comparison of epinephrine vs epinephrine plus second method</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ljubicic-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Compares small volume epinephrine vs large volume epinephrine vs haemoclip alone</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Male-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Preliminary results published later in another article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pescatore-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Preliminary results published later in another article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sabat-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>No definition of further clinically significant bleeding was established, only endoscopic rebleeding. The aim of the study was directed to endoscopic signs, not to clinical rebleeding</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 13:27:42 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Taghavi-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 13:27:42 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised, but not epinephrine vs epinephrine plus second method (i.e. compared epinephrine injection plus argon plasma coagulation vs epinephrine injection plus haemoclips)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tsoi-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Review article, not trial report</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wehrmann-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>Study was excluded because primary endpoint was not achieved. Included studies must define clinically relevant rebleeding (confirmed by endoscopy), but in this study, investigators considered only endoscopic rebleeding. Results did not allow detection of which participants presented with clinical rebleeding</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-10-01 13:27:39 -0400" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Balanzo-1990">
<DESCRIPTION>
<P>Study authors did not explain the method used for sequence generation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Choudari-1994">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chung-1993">
<DESCRIPTION>
<P>Random number list generated by computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chung-1996">
<DESCRIPTION>
<P>Quote: "The treatment option had been determined by a computer generated random number list" (page 592)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chung-1997">
<DESCRIPTION>
<P>Quote: "Randomisations took place at the time of endoscopy when actively bleeding ulcers were seen. The endoscopy nurse then opened a sealed envelope containing the treatment option, which had previously been determined by a random number list generated by a computer. Treatment was concealed from the endoscopist when the patient was admitted into the trial" (page 1308)</P>
<P>Comment: adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-02 04:27:57 -0400" MODIFIED_BY="Cathy Bennett" RESULT="YES" STUDY_ID="STD-Chung-1999">
<DESCRIPTION>
<P>Quote: "The procedure performed was randomly chosen by means of drawing a single number (1 to 3) contained in sequentially numbered opaque envelopes" (page 14)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Garrido-2002">
<DESCRIPTION>
<P>Study authors did not explain sequence generation</P>
<P>Comment: unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Grgov-2012">
<DESCRIPTION>
<P>Study authors did not explain sequence generation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kubba-1996">
<DESCRIPTION>
<P>Study authors did not explain sequence generation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-1997">
<DESCRIPTION>
<P>Study authors did not explain sequence generation (abstract)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lin-1993">
<DESCRIPTION>
<P>Quote: "Two forms of injection were arranged by a statistician who was not involved in the study" (page 1182)</P>
<P>Comment: probably adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lin-1999">
<DESCRIPTION>
<P>Quote: "Randomisation was performed by a statistician who was not involved in the study" (page 716)</P>
<P>Comment: adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lo-2006">
<DESCRIPTION>
<P>Page 769: "Randomization was carried out during endoscopy by an individual not directly involved in the study who opened the sealed and numbered envelopes that contained the treatment assignments, which had been randomised with a computer program. NB re-bleeders in the epinephrine group were then randomised again, but the results of this second randomised study are not added to the data from the original groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Loizou-1991">
<DESCRIPTION>
<P>Study authors did not explain sequence generation</P>
<P>Comment: unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-2004">
<DESCRIPTION>
<P>Quote: "The allocation of patients to treatment was by drawing sequentially numbered envelopes, each containing a previously determined, randomly selected assignment based on a table of random numbers" (page 174)</P>
<P>Comment: adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pescatore-2002">
<DESCRIPTION>
<P>Quote: "Randomization was performed within each center by using a computer-generated randomization list and sealed envelopes" (page 349)</P>
<P>Comment: adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sollano-1991">
<DESCRIPTION>
<P>Comment: did not explain sequence generation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Villanueva-1993">
<DESCRIPTION>
<P>Table of random numbers</P>
<P>Comment: adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Villanueva-1996">
<DESCRIPTION>
<P>Study authors did not explain sequence generation (abstract)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2014-10-01 13:27:39 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Balanzo-1990">
<DESCRIPTION>
<P>Study authors did not explain the method used for allocation concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Choudari-1994">
<DESCRIPTION>
<P>Quote: "were then randomised by opening a sealed envelope to receive... " (pages 608-609)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chung-1993">
<DESCRIPTION>
<P>Sealed and numbered envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chung-1996">
<DESCRIPTION>
<P>Quote: "We randomised patients into two groups by opening a sealed envelope containing the treatment option for each" (page 592)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chung-1997">
<DESCRIPTION>
<P>Quote: "Randomisations took place at the time of endoscopy when actively bleeding ulcers were seen. The endoscopy nurse then opened a sealed envelope containing the treatment option, which had previously been determined by a random number list generated by a computer. Treatment was concealed from the endoscopist when the patient was admitted into the trial" (page 1308)</P>
<P>Comment: adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-02 04:27:57 -0400" MODIFIED_BY="Cathy Bennett" RESULT="YES" STUDY_ID="STD-Chung-1999">
<DESCRIPTION>
<P>Quote: "The procedure performed was randomly chosen by means of drawing a single number (1 to 3) contained in sequentially numbered opaque envelopes" (page 14)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Garrido-2002">
<DESCRIPTION>
<P>Study authors did not explain allocation concealment</P>
<P>Comment: unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Grgov-2012">
<DESCRIPTION>
<P>Study authors did not explain allocation concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 13:27:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kubba-1996">
<DESCRIPTION>
<P>Quote: "Patients were randomized by opening a sealed envelope to be administered either injection with dilute epinephrine (group 1) or epinephrine plus human thrombin (group 2). The randomization was performed during the endoscopy" (page 634)</P>
<P>Comment: probably adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-1997">
<DESCRIPTION>
<P>Study authors did not explain allocation concealment (abstract)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lin-1993">
<DESCRIPTION>
<P>Quote: "For every patient enrolled in the study, a sealed envelope was opened before performing an endoscopic injection to decide the injected solution. Two forms of injection were arranged by a statistician who was not involved in the study" (page 1182)</P>
<P>Comment: probably adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lin-1999">
<DESCRIPTION>
<P>Quote: "For every patient enrolled in the study, a sealed envelope was opened before performing endoscopic treatment" (page 716)</P>
<P>Comment: adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lo-2006">
<DESCRIPTION>
<P>Page 769: "Randomization was carried out during endoscopy by an individual not directly involved in the study who opened the sealed and numbered envelopes that contained the treatment assignments, which had been randomised with a computer program"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 13:27:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Loizou-1991">
<DESCRIPTION>
<P>Quote: "Patients were stratified into two groups according to whether the visible vessel was actively bleeding at the time of endoscopy or not and separately randomised, by opening sealed numbered envelopes, to receive either epinephrine injection treatment or epinephrine injection + Nd:YAG laser photocoagulation" (page 1101)</P>
<P>Comment: adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-2004">
<DESCRIPTION>
<P>Quote: "The allocation of patients to treatment was by drawing sequentially numbered envelopes, each containing a previously determined, randomly selected assignment based on a table of random numbers" (page 174)</P>
<P>Comment: adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pescatore-2002">
<DESCRIPTION>
<P>Quote: "Randomization was performed within each center by using a computer-generated randomization list and sealed envelopes" (page 349)</P>
<P>Comment: adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sollano-1991">
<DESCRIPTION>
<P>Comment: did not explain allocation concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Villanueva-1993">
<DESCRIPTION>
<P>An opaque sealed envelope</P>
<P>Comment: adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Villanueva-1996">
<DESCRIPTION>
<P>Study authors did not explain (abstract)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Balanzo-1990">
<DESCRIPTION>
<P>Not done. Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Choudari-1994">
<DESCRIPTION>
<P>Not done. Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chung-1993">
<DESCRIPTION>
<P>Quote: (abstract p 611): "After the procedure the patients were transferred to the surgical gastroenterology ward and were treated by surgeons who were unaware of the mode of treatment"<BR/>Criteria: blinding was incomplete, as it is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chung-1996">
<DESCRIPTION>
<P>Not done</P>
<P>Criteria: Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chung-1997">
<DESCRIPTION>
<P>Not done</P>
<P>Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chung-1999">
<DESCRIPTION>
<P>Not done</P>
<P>Criteria: Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Garrido-2002">
<DESCRIPTION>
<P>Not done</P>
<P>Criteria: Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Grgov-2012">
<DESCRIPTION>
<P>Not done</P>
<P>Criteria: Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kubba-1996">
<DESCRIPTION>
<P>Not done</P>
<P>Criteria: Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-1997">
<DESCRIPTION>
<P>Not done</P>
<P>Criteria: Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1993">
<DESCRIPTION>
<P>Not done</P>
<P>Criteria: Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1999">
<DESCRIPTION>
<P>Not done</P>
<P>Criteria: Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lo-2006">
<DESCRIPTION>
<P>Not done. Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Loizou-1991">
<DESCRIPTION>
<P>Not done</P>
<P>Criteria: Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Park-2004">
<DESCRIPTION>
<P>Single blind. Quote: "A prospective, randomized, single-blind comparative trial was conducted in a university-affiliated academic medical center" (page 173)</P>
<P>Comment: It is unclear what single blinded means. It might be true that managing clinicians did not know what the endoscopic treatment had been, but this is not clearly specified in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pescatore-2002">
<DESCRIPTION>
<P>Not done</P>
<P>Criteria: Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sollano-1991">
<DESCRIPTION>
<P>Not done</P>
<P>Criteria: Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Villanueva-1993">
<DESCRIPTION>
<P>Not done: Blinding is virtually impossible in studies on endoscopic treatment. Review authors believe that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Villanueva-1996">
<DESCRIPTION>
<P>Not done: Blinding is virtually impossible in studies on endoscopic treatment. Review authors that this did not introduce significant bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2014-03-12 08:14:28 -0400" MODIFIED_BY="Cathy Bennett" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2014-03-12 08:14:28 -0400" MODIFIED_BY="Cathy Bennett" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2014-10-01 13:27:37 -0400" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Balanzo-1990">
<DESCRIPTION>
<P>n = 64 participants entered the study. For the outcome of haemostasis, all participants were accounted for. It is unclear why only 25 (group A) and 24 participants (group B) received an elective endoscopy; the outcome of participants not receiving a second (elective) endoscopy is also unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 13:27:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Choudari-1994">
<DESCRIPTION>
<P>No missing outcome data: 107 participants were randomly assigned; however 5 patients who were actively bleeding from peptic ulcers were not included because the bleeding point was not identified, or initial haemostasis could not be achieved by epinephrine; a further 2 patients were excluded because<BR/>their ulcers were inaccessible to injection. It is unclear whether these participants were randomly assigned but were not included in the analyses, or whether they were not randomly assigned. Outcomes were presented for all randomly assigned participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chung-1993">
<DESCRIPTION>
<P>No missing outcome data: 200 participants were randomly assigned. Outcomes were presented for all those randomly assigned, including details of n = 4 who were excluded after randomisation and those lost to follow up (n = 13) or who did not return for follow-up to determine ulcer healing 4 weeks after discharge</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chung-1996">
<DESCRIPTION>
<P>No missing outcome data: 15 participants were excluded before randomisation (reasons given), 160 participants were randomly assigned. Outcomes were presented for all those randomly assigned, along with details of loss to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 13:27:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chung-1997">
<DESCRIPTION>
<P>No missing outcome data: Randomisation took place at the time of endoscopy when actively bleeding ulcers were seen. 276 randomly assigned, Six patients were excluded after randomisation (n = 2 in epinephrine; n = 4 in combined therapy), as their ulcers were subsequently found to be malignant</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chung-1999">
<DESCRIPTION>
<P>No missing outcome data: 143 participants were randomly assigned. Nineteen participants could not undergo follow-up endoscopic examinations because of personal objections or transfer to other hospitals</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Garrido-2002">
<DESCRIPTION>
<P>It is unclear whether n = 340 participants were randomly assigned or only the n = 85 reported in this publication who were treated endoscopically. Reporting of outcomes and numbers in each group at each time point is unclear, for example, 3 participants died as a result of haemorrhage, but it is not clear which therapy they received</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grgov-2012">
<DESCRIPTION>
<P>No missing outcome data: 58 participants were randomly assigned. All participants were accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kubba-1996">
<DESCRIPTION>
<P>No missing outcome data: 140 participants were randomly assigned (once participants/ulcers not meeting the inclusion criteria had been excluded at initial endoscopy). All participants were accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-1997">
<DESCRIPTION>
<P>Not possible to determine, short abstract report</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1993">
<DESCRIPTION>
<P>Peptic ulcers with bleeding (oozing or spurting) were found in 100 participants. A total of 36 cases were excluded from the study, and it is unclear whether they were excluded after randomisation: 20 participants refused to give informed consent, 8 had bleeding gastric <BR/>cancer and 8 had a bleeding tendency. 64 participants who had actively bleeding ulcer at initial endoscopy were randomly assigned, and all 64 participants were accounted for in each group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 13:27:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lin-1999">
<DESCRIPTION>
<P>No missing outcome data: 96 randomly assigned, n = 1 in the epinephrine group; n = 2 in the gold probe group and n = 2 in the injection and gold probe group were excluded because no haemostasis was achieved. All other participants were accounted for in the groups to which they were randomly assigned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lo-2006">
<DESCRIPTION>
<P>No missing outcome data: 108 participants randomly assigned, Three patients were excluded because of inability to obtain informed consent, gastric malignancy or multiple bleeding sites at endoscopy</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Loizou-1991">
<DESCRIPTION>
<P>No missing outcome data: 42 participants were randomly assigned at endoscopy provided they fit the inclusion criteria. All participants were accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-2004">
<DESCRIPTION>
<P>No missing outcome data: 90 participants were randomly assigned. All participants were accounted for in a flow diagram showing outcomes for all. "Peptic ulcer with either an actively bleeding vessel (spurting or oozing) or a non-bleeding visible vessel was found in 123 patients. Thirty-three were excluded (before randomisation) because of inability to obtain informed consent, bleeding diathesis, gastric malignancy" (study report, page 175)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pescatore-2002">
<DESCRIPTION>
<P>No missing outcome data: 135 participants were randomly assigned. Unclear whether the following participants were excluded after randomisation: "Patients were excluded because of endoscopically uncontrollable bleeding; these patients underwent immediate surgery. Three of the latter patients had large bleeding vessels on the posterior aspect of the duodenal bulb, whereas 1 patient bled from an aorto-duodenal fistula. Two further patients were excluded because of a suspicion that the bleeding gastric ulcer was neoplastic (later confirmed by histology)" (study report, page 350)</P>
<P>Unclear whether all randomly assigned participants were accounted for, as some outcomes are reported as percentages</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sollano-1991">
<DESCRIPTION>
<P>No missing outcome data: 83 were randomly assigned to epinephrine injection vs epinephrine injection and haemoclip application or band ligation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Villanueva-1993">
<DESCRIPTION>
<P>No missing outcome data: 63 participants were randomly assigned. 3 additional participants were excluded, as they were found not to fit with the inclusion criteria on endoscopy (reasons given). Outcomes were reported for all participants who remained in the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Villanueva-1996">
<DESCRIPTION>
<P>All participants were accounted for in the groups to which they were randomly assigned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Balanzo-1990">
<DESCRIPTION>
<P>All prespecified outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Choudari-1994">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chung-1993">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chung-1996">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chung-1997">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chung-1999">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Garrido-2002">
<DESCRIPTION>
<P>It is unclear whether all outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Grgov-2012">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kubba-1996">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-1997">
<DESCRIPTION>
<P>Study outcomes were efficacy and safety of endoscopic treatment. All outcomes were reported but not by the intervention group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lin-1993">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lin-1999">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lo-2006">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Loizou-1991">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-2004">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pescatore-2002">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sollano-1991">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Villanueva-1993">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Villanueva-1996">
<DESCRIPTION>
<P>All prespecified outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2010-01-06 13:04:47 -0500" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2014-10-01 13:56:25 -0400" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2014-10-01 13:56:25 -0400" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2014-10-01 13:54:09 -0400" MODIFIED_BY="[Empty name]">Epinephrine versus epinephrine and any second endoscopic method in high-risk bleeding ulcers</TITLE>
<TABLE COLS="7" ROWS="23">
<TR>
<TD COLSPAN="7">
<P>
<B>Epinephrine versus epinephrine and any second endoscopic method in high-risk bleeding ulcers</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with high-risk bleeding ulcers<BR/>
<B>Settings:</B> secondary care (hospital)<BR/>
<B>Intervention:</B> epinephrine versus epinephrine and any second endoscopic method<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Number of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Epinephrine versus epinephrine and any second endoscopic method</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Recurrent and persistent bleeding overall rates with or without second-look endoscopy</B>
<BR/>Rebleeding (persistent or recurrent bleeding)</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 0.57 </B>
<BR/>(0.43-0.76)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>1926<BR/>(19 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Favours combined therapy</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>223 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>127 per 1000</B>
<BR/>(96-170)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>222 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>127 per 1000</B>
<BR/>(95-169)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Surgery rate</B>
<BR/>Number requiring emergency surgery</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 0.68 </B>
<BR/>(0.5-0.93)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>1841<BR/>(18 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Favours combined therapy</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>106 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>72 per 1000</B>
<BR/>(53-99)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>102 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>69 per 1000</B>
<BR/>(51-95)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Mortality rate</B>
<BR/>Number of deaths (30-day mortality or in-hospital mortality)</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 0.64 </B>
<BR/>(0.39-1.06)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>1841<BR/>(18 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Favours combined therapy</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>47 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>30 per 1000</B>
<BR/>(18-49)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>32 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>20 per 1000</B>
<BR/>(12-34)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Adverse effects of endoscopy therapy</B>
<BR/>Adverse effects</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.25 </B>
<BR/>(0.4-3.96)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>1281<BR/>(12 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>No statistically significant difference between groups</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>8 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>10 per 1000</B>
<BR/>(3-31)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
<BR/>(0-0)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence.<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Moderate statistical heterogeneity was present.<BR/>
<SUP>b</SUP>Relatively few events.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">Procedure-related adverse effects</TITLE>
<TABLE COLS="3" ROWS="13">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Adverse effects in epinephrine plus second agent group (combined therapy)</P>
</TH>
<TH>
<P>Adverse effects in epinephrine group</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Lo-2006" TYPE="STUDY">Lo 2006</LINK>
</P>
</TD>
<TD>
<P>None</P>
</TD>
<TD>
<P>None</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chung-1993" TYPE="STUDY">Chung 1993</LINK>
</P>
</TD>
<TD>
<P>Quote, page 613: "A 75-year-old man in the epinephrine plus STD group had abdominal pain after injection therapy. An actively bleeding pre-pyloric ulcer had been injected with 8 ml of epinephrine followed by 1 ml of STD. Signs of upper abdominal peritonitis developed 36 hours later. At operation extensive infarction and necrosis were seen along the lesser curvature of the stomach. The right gastric artery was cord-like and thrombosed along its course. Extensive coagulative necrosis was observed in the arteries in the muscularis propria. It is likely that the STD was injected directly into the right gastric artery and travelled in the artery along the lesser curvature. It caused coagulative necrosis in the smaller arteries and necrosis along the lesser curvature of the stomach. Fortunately, the patient made an uneventful recovery after a subtotal gastrectomy"</P>
</TD>
<TD>
<P>No untoward cardiovascular events were observed during endoscopic injection therapy in either group.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chung-1997" TYPE="STUDY">Chung 1997</LINK>
</P>
</TD>
<TD>
<P>Two participants underwent surgery for perforations related to heat probe application</P>
</TD>
<TD>
<P>None</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chung-1999" TYPE="STUDY">Chung 1999</LINK>
</P>
</TD>
<TD>
<P>No 'notable' complications were reported in the haemoclip and combined therapy groups</P>
</TD>
<TD>
<P>Three participants.<BR/>In 1 case, bleeding was aggravated during<BR/>treatment of a non-bleeding visible vessel, and surgical intervention for control of bleeding ultimately was required. In the other 2 cases, submucosal haematoma developed</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Grgov-2012" TYPE="STUDY">Grgov 2012</LINK>
</P>
</TD>
<TD>
<P>None</P>
</TD>
<TD>
<P>None</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kubba-1996" TYPE="STUDY">Kubba 1996</LINK>
</P>
</TD>
<TD>
<P>None</P>
</TD>
<TD>
<P>None</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Lin-1993" TYPE="STUDY">Lin 1993</LINK>
</P>
</TD>
<TD>
<P>None</P>
</TD>
<TD>
<P>None</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>
</P>
</TD>
<TD>
<P>None</P>
</TD>
<TD>
<P>None</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Loizou-1991" TYPE="STUDY">Loizou 1991</LINK>
</P>
</TD>
<TD>
<P>None</P>
</TD>
<TD>
<P>Text states no procedure-related complications, but in 1 participant in the epinephrine group, injection provoked spurting haemorrhage</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Pescatore-2002" TYPE="STUDY">Pescatore 2002</LINK>
</P>
</TD>
<TD>
<P>Perforation (leading to surgical intervention) (n = 1)</P>
<P>Non&#8211;procedure-related complications: pneumonia (n = 1)</P>
</TD>
<TD>
<P>Ulcer haemorrhage (n = 1 patient in group E) induced by epinephrine injection that led to surgical intervention.</P>
<P>Non&#8211;procedure-related complications were reported: </P>
<P>pneumonia (n = 3); stroke (n = 1)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Sollano-1991" TYPE="STUDY">Sollano 1991</LINK>
</P>
</TD>
<TD>
<P>Mucosal injury or necrosis (n = 1)</P>
</TD>
<TD>
<P>Mucosal injury or necrosis (n = 1)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Villanueva-1993" TYPE="STUDY">Villanueva 1993</LINK>
</P>
</TD>
<TD>
<P>Size of ulcer increased 5-fold after infection, developed pneumoperitoneum, resolved spontaneously</P>
</TD>
<TD>
<P>None</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Epinephrine versus epinephrine and any second endoscopic method</NAME>
<DICH_OUTCOME CHI2="7.32374077040119" CI_END="1.3977594753551457" CI_START="0.4217212340651503" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7677661433490206" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="27" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.1454324450054776" LOG_CI_START="-0.37497453129446756" LOG_EFFECT_SIZE="-0.11477104314449504" METHOD="MH" MODIFIED="2014-07-14 04:48:57 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8354990944539529" P_Q="1.0" P_Z="0.3873107664150952" Q="0.0" RANDOM="YES" SCALE="286.42" SORT_BY="EFFECT_SIZE" STUDIES="14" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="689" TOTAL_2="691" WEIGHT="99.99999999999999" Z="0.8645045945796505">
<NAME>Initial failure of haemostasis (persistent bleeding)</NAME>
<GROUP_LABEL_1>Combined therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combined therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epinephrine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-11 04:12:58 -0400" MODIFIED_BY="[Empty name]" ORDER="111" O_E="0.0" SE="0.0" STUDY_ID="STD-Sollano-1991" TOTAL_1="29" TOTAL_2="32" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.930879612644028" CI_START="0.010175839491836992" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5944897432947772" LOG_CI_START="-1.9924297519668148" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2014-05-28 07:07:09 -0400" MODIFIED_BY="Cathy Bennett" ORDER="109" O_E="0.0" SE="1.5195693169746844" STUDY_ID="STD-Loizou-1991" TOTAL_1="21" TOTAL_2="21" VAR="2.309090909090909" WEIGHT="4.046880611205571"/>
<DICH_DATA CI_END="2.204294298968605" CI_START="0.029454760233037426" EFFECT_SIZE="0.2548076923076923" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3432695774236185" LOG_CI_START="-1.5308445081475637" LOG_EFFECT_SIZE="-0.5937874653619726" MODIFIED="2014-05-20 13:37:20 -0400" MODIFIED_BY="Cathy Bennett" ORDER="180" O_E="0.0" SE="1.1008638908788537" STUDY_ID="STD-Lo-2006" TOTAL_1="52" TOTAL_2="53" VAR="1.211901306240929" WEIGHT="7.710706458842048"/>
<DICH_DATA CI_END="3.117823319099362" CI_START="0.034596946470203525" EFFECT_SIZE="0.3284313725490196" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.49385150093804536" LOG_CI_START="-1.46096223038819" LOG_EFFECT_SIZE="-0.4835553647250723" ORDER="104" O_E="0.0" SE="1.1482672622650612" STUDY_ID="STD-Chung-1997" TOTAL_1="136" TOTAL_2="134" VAR="1.3185177055896986" WEIGHT="7.087212549285962"/>
<DICH_DATA CI_END="7.888578229356675" CI_START="0.014085061703212953" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8969987366967316" LOG_CI_START="-1.8512412461360563" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="107" O_E="0.0" SE="1.6143297699232972" STUDY_ID="STD-Lin-1993" TOTAL_1="32" TOTAL_2="32" VAR="2.606060606060606" WEIGHT="3.5857244485333086"/>
<DICH_DATA CI_END="5.17753496166036" CI_START="0.046013588167997235" EFFECT_SIZE="0.4880952380952381" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7141230401787028" LOG_CI_START="-1.3371138988629951" LOG_EFFECT_SIZE="-0.3114954293421462" ORDER="105" O_E="0.0" SE="1.2049067317796998" STUDY_ID="STD-Chung-1999" TOTAL_1="42" TOTAL_2="41" VAR="1.4518002322880372" WEIGHT="6.4365709700872085"/>
<DICH_DATA CI_END="1.942893269064466" CI_START="0.12867407797463776" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.2884489437137834" LOG_CI_START="-0.8905089350417459" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="102" O_E="0.0" SE="0.6925256939166184" STUDY_ID="STD-Chung-1993" TOTAL_1="98" TOTAL_2="98" VAR="0.47959183673469385" WEIGHT="19.48451686153367"/>
<DICH_DATA CI_END="5.586774324208722" CI_START="0.05136949861654112" EFFECT_SIZE="0.5357142857142857" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.747161128541056" LOG_CI_START="-1.2892946731141317" LOG_EFFECT_SIZE="-0.27106677228653797" MODIFIED="2014-05-20 10:18:05 -0400" MODIFIED_BY="Cathy Bennett" ORDER="184" O_E="0.0" SE="1.1962242185110534" STUDY_ID="STD-Grgov-2012" TOTAL_1="28" TOTAL_2="30" VAR="1.4309523809523808" WEIGHT="6.530346749408718"/>
<DICH_DATA CI_END="13.902157778612597" CI_START="0.05944733861840928" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.143082213104131" LOG_CI_START="-1.225867583420581" LOG_EFFECT_SIZE="-0.04139268515822506" ORDER="112" O_E="0.0" SE="1.391532836969231" STUDY_ID="STD-Villanueva-1993" TOTAL_1="33" TOTAL_2="30" VAR="1.9363636363636363" WEIGHT="4.82585763026392"/>
<DICH_DATA CI_END="15.499949390237672" CI_START="0.06451633968752372" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1903302801331048" LOG_CI_START="-1.1903302801331048" LOG_EFFECT_SIZE="0.0" ORDER="110" O_E="0.0" SE="1.3984117975602022" STUDY_ID="STD-Park-2004" TOTAL_1="45" TOTAL_2="45" VAR="1.9555555555555557" WEIGHT="4.778496424181784"/>
<DICH_DATA CI_END="8.383428283463806" CI_START="0.2683866222650336" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9234216534894845" LOG_CI_START="-0.5712391353781221" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2014-05-28 07:06:55 -0400" MODIFIED_BY="Cathy Bennett" ORDER="101" O_E="0.0" SE="0.8779711460710615" STUDY_ID="STD-Balanzo-1990" TOTAL_1="32" TOTAL_2="32" VAR="0.7708333333333333" WEIGHT="12.122744081527843"/>
<DICH_DATA CI_END="20.96934157435162" CI_START="0.19075467800536708" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.321584794074541" LOG_CI_START="-0.7195248027465787" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="108" O_E="0.0" SE="1.1989578808281798" STUDY_ID="STD-Lin-1999" TOTAL_1="32" TOTAL_2="32" VAR="1.4375" WEIGHT="6.5006018987902925"/>
<DICH_DATA CI_END="10.880728359958203" CI_START="0.38647186090599583" EFFECT_SIZE="2.050632911392405" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0366579681675905" LOG_CI_START="-0.4128821216632115" LOG_EFFECT_SIZE="0.3118879232521895" ORDER="103" O_E="0.0" SE="0.8514670241057801" STUDY_ID="STD-Chung-1996" TOTAL_1="79" TOTAL_2="81" VAR="0.7249960931395532" WEIGHT="12.889193911438523"/>
<DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="106" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Lee-1997" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="4.001147404901139"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="21.918012899423914" CI_END="0.8112911719437415" CI_START="0.349947654518315" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5328315331820437" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="121" I2="40.68805388675682" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-0.09082324976722128" LOG_CI_START="-0.4559969129468708" LOG_EFFECT_SIZE="-0.27341008135704603" METHOD="MH" MODIFIED="2014-07-14 04:49:08 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.05664523225420193" P_Q="1.0" P_Z="0.0033365625534556758" Q="0.0" RANDOM="YES" SCALE="4.83" SORT_BY="EFFECT_SIZE" STUDIES="14" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.23629843324525956" TOTALS="YES" TOTAL_1="669" TOTAL_2="664" WEIGHT="99.99999999999997" Z="2.934899016561059">
<NAME>Recurrent bleeding only (bleeding after initial haemostasis)</NAME>
<GROUP_LABEL_1>Combined therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Epineprhine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combined therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epinephrine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9679652923754977" CI_START="0.017359962191078576" EFFECT_SIZE="0.12962962962962962" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.014140214592468722" LOG_CI_START="-1.7604512250249544" LOG_EFFECT_SIZE="-0.8872957198087117" MODIFIED="2014-05-28 07:36:20 -0400" MODIFIED_BY="Cathy Bennett" ORDER="1128" O_E="0.0" SE="1.0257917319069585" STUDY_ID="STD-Grgov-2012" TOTAL_1="27" TOTAL_2="28" VAR="1.0522486772486772" WEIGHT="3.570868019415999"/>
<DICH_DATA CI_END="0.7482444247544093" CI_START="0.04078335402602572" EFFECT_SIZE="0.1746880570409982" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.1259565104482333" LOG_CI_START="-1.3895170606790999" LOG_EFFECT_SIZE="-0.7577367855636665" MODIFIED="2014-05-28 07:36:20 -0400" MODIFIED_BY="Cathy Bennett" ORDER="181" O_E="0.0" SE="0.7422217219312096" STUDY_ID="STD-Lo-2006" TOTAL_1="51" TOTAL_2="49" VAR="0.5508930845065299" WEIGHT="5.845123536791608"/>
<DICH_DATA CI_END="0.7777113586632587" CI_START="0.04538758312013601" EFFECT_SIZE="0.18787878787878787" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.10918155802217913" LOG_CI_START="-1.3430629427370882" LOG_EFFECT_SIZE="-0.7261222503796336" MODIFIED="2014-05-28 07:36:20 -0400" MODIFIED_BY="Cathy Bennett" ORDER="120" O_E="0.0" SE="0.7247880331928974" STUDY_ID="STD-Lin-1999" TOTAL_1="30" TOTAL_2="31" VAR="0.5253176930596286" WEIGHT="6.041405255817469"/>
<DICH_DATA CI_END="0.8937865512255189" CI_START="0.05137509317406669" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="-0.048766184440134856" LOG_CI_START="-1.2892473774770166" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2014-05-30 12:03:36 -0400" MODIFIED_BY="Cathy Bennett" ORDER="118" O_E="0.0" SE="0.7286647932708022" STUDY_ID="STD-Lee-1997" TOTAL_1="28" TOTAL_2="30" VAR="0.530952380952381" WEIGHT="5.997037192049738"/>
<DICH_DATA CI_END="4.400464763415707" CI_START="0.010998838214177905" EFFECT_SIZE="0.22" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6434985477424099" LOG_CI_START="-1.9586531860979972" LOG_EFFECT_SIZE="-0.6575773191777937" MODIFIED="2014-05-30 12:04:30 -0400" MODIFIED_BY="Cathy Bennett" ORDER="123" O_E="0.0" SE="1.5285168093166777" STUDY_ID="STD-Sollano-1991" TOTAL_1="29" TOTAL_2="32" VAR="2.3363636363636364" WEIGHT="1.7885099340206725"/>
<DICH_DATA CI_END="0.9704594350879858" CI_START="0.05088591471616273" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.013022613274728749" LOG_CI_START="-1.2934024142759586" LOG_EFFECT_SIZE="-0.6532125137753437" MODIFIED="2014-05-28 07:36:20 -0400" MODIFIED_BY="Cathy Bennett" ORDER="122" O_E="0.0" SE="0.752101433090355" STUDY_ID="STD-Park-2004" TOTAL_1="44" TOTAL_2="44" VAR="0.5656565656565657" WEIGHT="5.737518532429489"/>
<DICH_DATA CI_END="1.121238420566331" CI_START="0.17293388512415625" EFFECT_SIZE="0.4403409090909091" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" LOG_CI_END="0.04969797095951666" LOG_CI_START="-0.7621199015751957" LOG_EFFECT_SIZE="-0.3562109653078395" MODIFIED="2014-05-28 07:36:20 -0400" MODIFIED_BY="Cathy Bennett" ORDER="119" O_E="0.0" SE="0.47686583689016965" STUDY_ID="STD-Lin-1993" TOTAL_1="32" TOTAL_2="31" VAR="0.22740102639296186" WEIGHT="9.922874768850443"/>
<DICH_DATA CI_END="2.6105876755260597" CI_START="0.10248215257392428" EFFECT_SIZE="0.5172413793103449" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4167382833953298" LOG_CI_START="-0.9893517610818796" LOG_EFFECT_SIZE="-0.28630673884327484" MODIFIED="2014-05-28 07:36:20 -0400" MODIFIED_BY="Cathy Bennett" ORDER="113" O_E="0.0" SE="0.8259442523838865" STUDY_ID="STD-Balanzo-1990" TOTAL_1="29" TOTAL_2="30" VAR="0.6821839080459771" WEIGHT="5.009602756112992"/>
<DICH_DATA CI_END="0.998602278610105" CI_START="0.295704923521944" EFFECT_SIZE="0.5434074074074075" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="25" LOG_CI_END="-6.074473068794475E-4" LOG_CI_START="-0.5291414443592034" LOG_EFFECT_SIZE="-0.2648744458330414" MODIFIED="2014-07-11 06:55:57 -0400" MODIFIED_BY="[Empty name]" ORDER="116" O_E="0.0" SE="0.31046348615401537" STUDY_ID="STD-Chung-1997" TOTAL_1="135" TOTAL_2="131" VAR="0.09638757623490449" WEIGHT="13.83055354676114"/>
<DICH_DATA CI_END="2.07776125505033" CI_START="0.19354561618374794" EFFECT_SIZE="0.6341463414634146" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3175956435238591" LOG_CI_START="-0.7132166610216942" LOG_EFFECT_SIZE="-0.19781050874891754" MODIFIED="2014-05-28 07:36:20 -0400" MODIFIED_BY="Cathy Bennett" ORDER="117" O_E="0.0" SE="0.6055042502932593" STUDY_ID="STD-Chung-1999" TOTAL_1="41" TOTAL_2="39" VAR="0.3666353971232019" WEIGHT="7.631404039083052"/>
<DICH_DATA CI_END="3.9550669145102075" CI_START="0.20697351574638634" EFFECT_SIZE="0.9047619047619048" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.5971538355850753" LOG_CI_START="-0.6840852231472558" LOG_EFFECT_SIZE="-0.0434656937810903" MODIFIED="2014-05-28 07:36:20 -0400" MODIFIED_BY="Cathy Bennett" ORDER="121" O_E="0.0" SE="0.7526061653349982" STUDY_ID="STD-Loizou-1991" TOTAL_1="21" TOTAL_2="19" VAR="0.5664160401002507" WEIGHT="5.732090078302595"/>
<DICH_DATA CI_END="2.443968320647025" CI_START="0.5402729266989034" EFFECT_SIZE="1.1490909090909092" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.38809557216898" LOG_CI_START="-0.26738679459269765" LOG_EFFECT_SIZE="0.06035438878814119" MODIFIED="2014-07-11 06:55:43 -0400" MODIFIED_BY="[Empty name]" ORDER="115" O_E="0.0" SE="0.3850335869258546" STUDY_ID="STD-Chung-1996" TOTAL_1="75" TOTAL_2="79" VAR="0.14825086306098964" WEIGHT="11.965258323368095"/>
<DICH_DATA CI_END="3.2041075651042084" CI_START="0.48384949889690027" EFFECT_SIZE="1.2451127819548873" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.505707087358224" LOG_CI_START="-0.3152897043946729" LOG_EFFECT_SIZE="0.09520869148177558" MODIFIED="2014-05-28 07:36:20 -0400" MODIFIED_BY="Cathy Bennett" ORDER="114" O_E="0.0" SE="0.48225757947531417" STUDY_ID="STD-Chung-1993" TOTAL_1="95" TOTAL_2="92" VAR="0.23257237296138897" WEIGHT="9.813431775800861"/>
<DICH_DATA CI_END="7.422733657177491" CI_START="0.6024010667939543" EFFECT_SIZE="2.1145833333333335" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.8705638774604924" LOG_CI_START="-0.22011426771320333" LOG_EFFECT_SIZE="0.3252248048736445" MODIFIED="2014-05-28 07:36:20 -0400" MODIFIED_BY="Cathy Bennett" ORDER="124" O_E="0.0" SE="0.6406697414189205" STUDY_ID="STD-Villanueva-1993" TOTAL_1="32" TOTAL_2="29" VAR="0.4104577175697865" WEIGHT="7.114322241195839"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="29.110875379720014" CI_END="0.7615132700926801" CI_START="0.432628702830495" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5739795277084406" ESTIMABLE="YES" EVENTS_1="125" EVENTS_2="216" I2="38.167438233274034" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.11832252426777969" LOG_CI_START="-0.36388467059415913" LOG_EFFECT_SIZE="-0.2411035974309694" METHOD="MH" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.047040758013028316" P_Q="1.0" P_Z="1.1871928330195515E-4" Q="0.0" RANDOM="YES" SCALE="44.59" SORT_BY="EFFECT_SIZE" STUDIES="19" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.13746881605173442" TOTALS="YES" TOTAL_1="958" TOTAL_2="968" WEIGHT="99.99999999999997" Z="3.8487558003314293">
<NAME>Recurrent and persistent bleeding overall rates with or without second-look endoscopy</NAME>
<GROUP_LABEL_1>Combined therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combined therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epinephrine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.662781433274203" CI_START="0.06269526023472448" EFFECT_SIZE="0.20384615384615384" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="15" LOG_CI_END="-0.1786296661240065" LOG_CI_START="-1.2027652906160513" LOG_EFFECT_SIZE="-0.6906974783700289" MODIFIED="2014-07-11 07:06:45 -0400" MODIFIED_BY="[Empty name]" ORDER="174" O_E="0.0" SE="0.601582335379729" STUDY_ID="STD-Lo-2006" TOTAL_1="52" TOTAL_2="53" VAR="0.36190130624092887" WEIGHT="4.166539378329536"/>
<DICH_DATA CI_END="0.8937865512255189" CI_START="0.05137509317406669" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="-0.048766184440134856" LOG_CI_START="-1.2892473774770166" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2014-05-28 07:26:30 -0400" MODIFIED_BY="Cathy Bennett" ORDER="190" O_E="0.0" SE="0.7286647932708022" STUDY_ID="STD-Grgov-2012" TOTAL_1="28" TOTAL_2="30" VAR="0.530952380952381" WEIGHT="3.1127757291646865"/>
<DICH_DATA CI_END="0.7129717306686718" CI_START="0.06440419075784884" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.14692768958431326" LOG_CI_START="-1.191085872332838" LOG_EFFECT_SIZE="-0.6690067809585756" ORDER="8" O_E="0.0" SE="0.6133436852128472" STUDY_ID="STD-Kubba-1996" TOTAL_1="70" TOTAL_2="70" VAR="0.3761904761904762" WEIGHT="4.050632998015563"/>
<DICH_DATA CI_END="1.1371645789185902" CI_START="0.05571157739514662" EFFECT_SIZE="0.25170068027210885" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.05582332356520451" LOG_CI_START="-1.2540545449275666" LOG_EFFECT_SIZE="-0.5991156106811811" ORDER="17" O_E="0.0" SE="0.7694287439526755" STUDY_ID="STD-Villanueva-1996" TOTAL_1="42" TOTAL_2="37" VAR="0.5920205920205919" WEIGHT="2.852193953565024"/>
<DICH_DATA CI_END="0.9256980681573206" CI_START="0.08545071575817187" EFFECT_SIZE="0.28125" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="12" LOG_CI_END="-0.033530642600510356" LOG_CI_START="-1.0682842951606517" LOG_EFFECT_SIZE="-0.5509074688805811" ORDER="7" O_E="0.0" SE="0.6078194176270156" STUDY_ID="STD-Garrido-2002" TOTAL_1="40" TOTAL_2="45" VAR="0.3694444444444444" WEIGHT="4.104539062278687"/>
<DICH_DATA CI_END="1.0184475748258677" CI_START="0.08836979165607813" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.007938678353536443" LOG_CI_START="-1.0536961689142117" LOG_EFFECT_SIZE="-0.5228787452803376" ORDER="13" O_E="0.0" SE="0.6236095644623236" STUDY_ID="STD-Park-2004" TOTAL_1="45" TOTAL_2="45" VAR="0.38888888888888895" WEIGHT="3.9529112224705214"/>
<DICH_DATA CI_END="0.9243960330499997" CI_START="0.12019860226412413" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.03414192691879562" LOG_CI_START="-0.9201005825205295" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="11" O_E="0.0" SE="0.5204164998665332" STUDY_ID="STD-Lin-1999" TOTAL_1="32" TOTAL_2="32" VAR="0.2708333333333333" WEIGHT="5.095846989851067"/>
<DICH_DATA CI_END="1.1353940444188015" CI_START="0.14092023891309263" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="10" LOG_CI_END="0.05514661185272456" LOG_CI_START="-0.8510266291967997" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="9" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Lee-1997" TOTAL_1="30" TOTAL_2="30" VAR="0.2833333333333333" WEIGHT="4.944473981262059"/>
<DICH_DATA CI_END="1.046629834173422" CI_START="0.16587632555708762" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.019793110140146116" LOG_CI_START="-0.780215593563358" LOG_EFFECT_SIZE="-0.38021124171160603" ORDER="10" O_E="0.0" SE="0.4699290726623895" STUDY_ID="STD-Lin-1993" TOTAL_1="32" TOTAL_2="32" VAR="0.22083333333333333" WEIGHT="5.806957291393599"/>
<DICH_DATA CI_END="0.9427182201385331" CI_START="0.29554004461075173" EFFECT_SIZE="0.5278361344537815" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="28" LOG_CI_END="-0.025618099125051117" LOG_CI_START="-0.5293836654588445" LOG_EFFECT_SIZE="-0.27750088229194786" MODIFIED="2014-07-02 15:46:53 -0400" MODIFIED_BY="[Empty name]" ORDER="5" O_E="0.0" SE="0.2959143873442412" STUDY_ID="STD-Chung-1997" TOTAL_1="136" TOTAL_2="134" VAR="0.08756532463731762" WEIGHT="9.245909409668707"/>
<DICH_DATA CI_END="2.195588890534318" CI_START="0.16396512186413478" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.34155102462740894" LOG_CI_START="-0.7852485238601217" LOG_EFFECT_SIZE="-0.2218487496163564" ORDER="12" O_E="0.0" SE="0.6618876325292973" STUDY_ID="STD-Loizou-1991" TOTAL_1="21" TOTAL_2="21" VAR="0.4380952380952381" WEIGHT="3.614967376615074"/>
<DICH_DATA CI_END="1.7109885522506887" CI_START="0.2175615095600205" EFFECT_SIZE="0.6101190476190477" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.23324710380703353" LOG_CI_START="-0.6624179364752129" LOG_EFFECT_SIZE="-0.2145854163340897" ORDER="6" O_E="0.0" SE="0.5261180782752454" STUDY_ID="STD-Chung-1999" TOTAL_1="42" TOTAL_2="41" VAR="0.2768002322880372" WEIGHT="5.022449268734969"/>
<DICH_DATA CI_END="2.4562215108132492" CI_START="0.2827287528373268" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.3902675304601213" LOG_CI_START="-0.5486300225553709" LOG_EFFECT_SIZE="-0.0791812460476248" ORDER="1" O_E="0.0" SE="0.5515130702591433" STUDY_ID="STD-Balanzo-1990" TOTAL_1="32" TOTAL_2="32" VAR="0.3041666666666667" WEIGHT="4.711227608086676"/>
<DICH_DATA CI_END="1.6512742619753693" CI_START="0.47633049215784506" EFFECT_SIZE="0.8868778280542986" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.2178192117063773" LOG_CI_START="-0.32209161636364664" LOG_EFFECT_SIZE="-0.05213620232863467" MODIFIED="2014-05-28 07:26:30 -0400" MODIFIED_BY="Cathy Bennett" ORDER="14" O_E="0.0" SE="0.31714629301003416" STUDY_ID="STD-Pescatore-2002" TOTAL_1="65" TOTAL_2="70" VAR="0.10058177117000644" WEIGHT="8.7403492811195"/>
<DICH_DATA CI_END="2.371284396738129" CI_START="0.3612028381724999" EFFECT_SIZE="0.9254807692307693" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.3749836436142605" LOG_CI_START="-0.4422488458507446" LOG_EFFECT_SIZE="-0.033632601118242046" ORDER="2" O_E="0.0" SE="0.48004640967780965" STUDY_ID="STD-Choudari-1994" TOTAL_1="52" TOTAL_2="55" VAR="0.23044455544455544" WEIGHT="5.655258656220379"/>
<DICH_DATA CI_END="1.6190154003917403" CI_START="0.5627846557685141" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.20925097986723515" LOG_CI_START="-0.249657752043809" LOG_EFFECT_SIZE="-0.02020338608828695" MODIFIED="2014-07-02 12:39:56 -0400" MODIFIED_BY="[Empty name]" ORDER="3" O_E="0.0" SE="0.26956526075940673" STUDY_ID="STD-Chung-1993" TOTAL_1="98" TOTAL_2="98" VAR="0.07266542980828695" WEIGHT="9.901504965923625"/>
<DICH_DATA CI_END="7.3367229039235555" CI_START="0.16595939542051152" EFFECT_SIZE="1.103448275862069" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8655021167891701" LOG_CI_START="-0.7799981559472703" LOG_EFFECT_SIZE="0.04275198042094988" MODIFIED="2014-05-28 07:26:30 -0400" MODIFIED_BY="Cathy Bennett" ORDER="15" O_E="0.0" SE="0.9665750055631018" STUDY_ID="STD-Sollano-1991" TOTAL_1="29" TOTAL_2="32" VAR="0.9342672413793104" WEIGHT="1.9413784433836552"/>
<DICH_DATA CI_END="2.2375780439330244" CI_START="0.6136511567742046" EFFECT_SIZE="1.1717902350813743" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="14" LOG_CI_END="0.3497781919023007" LOG_CI_START="-0.21207844277051058" LOG_EFFECT_SIZE="0.06884987456589504" MODIFIED="2014-07-02 15:46:45 -0400" MODIFIED_BY="[Empty name]" ORDER="4" O_E="0.0" SE="0.3300373684420061" STUDY_ID="STD-Chung-1996" TOTAL_1="79" TOTAL_2="81" VAR="0.10892466456812448" WEIGHT="8.444400694609616"/>
<DICH_DATA CI_END="5.427595756738439" CI_START="0.6090698851075563" EFFECT_SIZE="1.8181818181818181" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7346074942648749" LOG_CI_START="-0.2153328732533627" LOG_EFFECT_SIZE="0.2596373105057561" ORDER="16" O_E="0.0" SE="0.5579996741608694" STUDY_ID="STD-Villanueva-1993" TOTAL_1="33" TOTAL_2="30" VAR="0.3113636363636364" WEIGHT="4.635683689307051"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="28.579015612885225" CI_END="0.7800831486638192" CI_START="0.5089827692362241" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6301181486367646" ESTIMABLE="YES" EVENTS_1="124" EVENTS_2="212" I2="37.01672498515147" I2_Q="93.49357311525411" ID="CMP-001.04" LOG_CI_END="-0.10785910361557202" LOG_CI_START="-0.29329691973061156" LOG_EFFECT_SIZE="-0.2005780116730918" METHOD="MH" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.05377316003961108" P_Q="8.84093003916675E-5" P_Z="2.2354654243215135E-5" Q="15.369418848684354" RANDOM="YES" SCALE="40.0" SORT_BY="EFFECT_SIZE" STUDIES="19" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.13269520471927765" TOTALS="SUB" TOTAL_1="957" TOTAL_2="966" WEIGHT="199.99999999999994" Z="4.239973131758974">
<NAME>Recurrent and persistent bleeding and second-look endoscopy</NAME>
<GROUP_LABEL_1>Combined therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alonel</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combined therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epinephrine alone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="9.282350021590108" CI_END="1.0572836098943668" CI_START="0.6393163202286294" DF="9" EFFECT_SIZE="0.8221548922895906" ESTIMABLE="YES" EVENTS_1="97" EVENTS_2="121" I2="3.041794598710259" ID="CMP-001.04.01" LOG_CI_END="0.024191499786924284" LOG_CI_START="-0.19428420891703627" LOG_EFFECT_SIZE="-0.08504635456505596" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.41162992656404696" P_Z="0.12703078042850355" STUDIES="10" TAU2="0.005177532739689096" TOTAL_1="598" TOTAL_2="605" WEIGHT="99.99999999999997" Z="1.52591602016313">
<NAME>Confirmed by second-look endoscopy</NAME>
<DICH_DATA CI_END="0.9243960330499997" CI_START="0.12019860226412413" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.03414192691879562" LOG_CI_START="-0.9201005825205295" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="66" O_E="0.0" SE="0.5204164998665332" STUDY_ID="STD-Lin-1999" TOTAL_1="32" TOTAL_2="32" VAR="0.2708333333333333" WEIGHT="5.96699038206279"/>
<DICH_DATA CI_END="0.9427182201385331" CI_START="0.29554004461075173" EFFECT_SIZE="0.5278361344537815" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="28" LOG_CI_END="-0.025618099125051117" LOG_CI_START="-0.5293836654588445" LOG_EFFECT_SIZE="-0.27750088229194786" MODIFIED="2014-07-11 06:58:10 -0400" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="0.2959143873442412" STUDY_ID="STD-Chung-1997" TOTAL_1="136" TOTAL_2="134" VAR="0.08756532463731762" WEIGHT="17.75828597244478"/>
<DICH_DATA CI_END="1.7109885522506887" CI_START="0.2175615095600205" EFFECT_SIZE="0.6101190476190477" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.23324710380703353" LOG_CI_START="-0.6624179364752129" LOG_EFFECT_SIZE="-0.2145854163340897" MODIFIED="2009-11-04 09:59:27 -0500" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="0.5261180782752454" STUDY_ID="STD-Chung-1999" TOTAL_1="42" TOTAL_2="41" VAR="0.2768002322880372" WEIGHT="5.840723586984258"/>
<DICH_DATA CI_END="2.4562215108132492" CI_START="0.2827287528373268" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.3902675304601213" LOG_CI_START="-0.5486300225553709" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2014-07-11 06:57:26 -0400" MODIFIED_BY="[Empty name]" ORDER="60" O_E="0.0" SE="0.5515130702591433" STUDY_ID="STD-Balanzo-1990" TOTAL_1="32" TOTAL_2="32" VAR="0.3041666666666667" WEIGHT="5.324018314754627"/>
<DICH_DATA CI_END="1.6512742619753693" CI_START="0.47633049215784506" EFFECT_SIZE="0.8868778280542986" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.2178192117063773" LOG_CI_START="-0.32209161636364664" LOG_EFFECT_SIZE="-0.05213620232863467" MODIFIED="2014-07-11 06:58:19 -0400" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="0.31714629301003416" STUDY_ID="STD-Pescatore-2002" TOTAL_1="65" TOTAL_2="70" VAR="0.10058177117000644" WEIGHT="15.572664742657787"/>
<DICH_DATA CI_END="2.371284396738129" CI_START="0.3612028381724999" EFFECT_SIZE="0.9254807692307693" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.3749836436142605" LOG_CI_START="-0.4422488458507446" LOG_EFFECT_SIZE="-0.033632601118242046" ORDER="61" O_E="0.0" SE="0.48004640967780965" STUDY_ID="STD-Choudari-1994" TOTAL_1="52" TOTAL_2="55" VAR="0.23044455544455544" WEIGHT="6.9898123554304075"/>
<DICH_DATA CI_END="1.6190154003917403" CI_START="0.5627846557685141" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.20925097986723515" LOG_CI_START="-0.249657752043809" LOG_EFFECT_SIZE="-0.02020338608828695" MODIFIED="2014-07-11 06:57:39 -0400" MODIFIED_BY="[Empty name]" ORDER="62" O_E="0.0" SE="0.26956526075940673" STUDY_ID="STD-Chung-1993" TOTAL_1="98" TOTAL_2="98" VAR="0.07266542980828695" WEIGHT="21.157393414818937"/>
<DICH_DATA CI_END="7.3367229039235555" CI_START="0.16595939542051152" EFFECT_SIZE="1.103448275862069" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8655021167891701" LOG_CI_START="-0.7799981559472703" LOG_EFFECT_SIZE="0.04275198042094988" MODIFIED="2014-05-28 07:28:19 -0400" MODIFIED_BY="Cathy Bennett" ORDER="68" O_E="0.0" SE="0.9665750055631018" STUDY_ID="STD-Sollano-1991" TOTAL_1="29" TOTAL_2="32" VAR="0.9342672413793104" WEIGHT="1.7531144230878715"/>
<DICH_DATA CI_END="2.2375780439330244" CI_START="0.6136511567742046" EFFECT_SIZE="1.1717902350813743" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="14" LOG_CI_END="0.3497781919023007" LOG_CI_START="-0.21207844277051058" LOG_EFFECT_SIZE="0.06884987456589504" MODIFIED="2014-07-11 06:57:54 -0400" MODIFIED_BY="[Empty name]" ORDER="63" O_E="0.0" SE="0.3300373684420061" STUDY_ID="STD-Chung-1996" TOTAL_1="79" TOTAL_2="81" VAR="0.10892466456812448" WEIGHT="14.43402688170462"/>
<DICH_DATA CI_END="5.427595756738439" CI_START="0.6090698851075563" EFFECT_SIZE="1.8181818181818181" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7346074942648749" LOG_CI_START="-0.2153328732533627" LOG_EFFECT_SIZE="0.2596373105057561" MODIFIED="2009-11-04 09:59:48 -0500" MODIFIED_BY="[Empty name]" ORDER="69" O_E="0.0" SE="0.5579996741608694" STUDY_ID="STD-Villanueva-1993" TOTAL_1="33" TOTAL_2="30" VAR="0.3113636363636364" WEIGHT="5.202969926053904"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.3554857654135852" CI_END="0.4754072591048205" CI_START="0.21200857666064832" DF="8" EFFECT_SIZE="0.3174750641183541" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="91" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="-0.322934191213017" LOG_CI_START="-0.673646569632335" LOG_EFFECT_SIZE="-0.498290380422676" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9101115211443406" P_Z="2.5559764041077514E-8" STUDIES="9" TAU2="0.0" TOTAL_1="359" TOTAL_2="361" WEIGHT="99.99999999999997" Z="5.569413910469564">
<NAME>Without second-look endoscopy</NAME>
<DICH_DATA CI_END="0.9679652923754977" CI_START="0.017359962191078576" EFFECT_SIZE="0.12962962962962962" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.014140214592468722" LOG_CI_START="-1.7604512250249544" LOG_EFFECT_SIZE="-0.8872957198087117" MODIFIED="2014-05-20 13:21:12 -0400" MODIFIED_BY="Cathy Bennett" ORDER="190" O_E="0.0" SE="1.0257917319069585" STUDY_ID="STD-Grgov-2012" TOTAL_1="27" TOTAL_2="28" VAR="1.0522486772486772" WEIGHT="4.033285868841532"/>
<DICH_DATA CI_END="0.662781433274203" CI_START="0.06269526023472448" EFFECT_SIZE="0.20384615384615384" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="15" LOG_CI_END="-0.1786296661240065" LOG_CI_START="-1.2027652906160513" LOG_EFFECT_SIZE="-0.6906974783700289" MODIFIED="2014-07-11 06:59:38 -0400" MODIFIED_BY="[Empty name]" ORDER="183" O_E="0.0" SE="0.601582335379729" STUDY_ID="STD-Lo-2006" TOTAL_1="52" TOTAL_2="53" VAR="0.36190130624092887" WEIGHT="11.727008571858839"/>
<DICH_DATA CI_END="0.7129717306686718" CI_START="0.06440419075784884" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.14692768958431326" LOG_CI_START="-1.191085872332838" LOG_EFFECT_SIZE="-0.6690067809585756" ORDER="71" O_E="0.0" SE="0.6133436852128472" STUDY_ID="STD-Kubba-1996" TOTAL_1="70" TOTAL_2="70" VAR="0.3761904761904762" WEIGHT="11.281571408802526"/>
<DICH_DATA CI_END="1.1371645789185902" CI_START="0.05571157739514662" EFFECT_SIZE="0.25170068027210885" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.05582332356520451" LOG_CI_START="-1.2540545449275666" LOG_EFFECT_SIZE="-0.5991156106811811" ORDER="76" O_E="0.0" SE="0.7694287439526755" STUDY_ID="STD-Villanueva-1996" TOTAL_1="42" TOTAL_2="37" VAR="0.5920205920205919" WEIGHT="7.168702875636911"/>
<DICH_DATA CI_END="1.0184475748258677" CI_START="0.08836979165607813" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.007938678353536443" LOG_CI_START="-1.0536961689142117" LOG_EFFECT_SIZE="-0.5228787452803376" ORDER="75" O_E="0.0" SE="0.6236095644623236" STUDY_ID="STD-Park-2004" TOTAL_1="45" TOTAL_2="45" VAR="0.38888888888888895" WEIGHT="10.913193566882443"/>
<DICH_DATA CI_END="1.1407540697322185" CI_START="0.09985171477559443" EFFECT_SIZE="0.3375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.057192026828080035" LOG_CI_START="-1.0006444724939925" LOG_EFFECT_SIZE="-0.47172622283295623" ORDER="70" O_E="0.0" SE="0.6213783960769083" STUDY_ID="STD-Garrido-2002" TOTAL_1="40" TOTAL_2="45" VAR="0.3861111111111111" WEIGHT="10.991705750816848"/>
<DICH_DATA CI_END="1.1353940444188015" CI_START="0.14092023891309263" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="10" LOG_CI_END="0.05514661185272456" LOG_CI_START="-0.8510266291967997" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="72" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Lee-1997" TOTAL_1="30" TOTAL_2="30" VAR="0.2833333333333333" WEIGHT="14.978893131015118"/>
<DICH_DATA CI_END="1.046629834173422" CI_START="0.16587632555708762" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.019793110140146116" LOG_CI_START="-0.780215593563358" LOG_EFFECT_SIZE="-0.38021124171160603" ORDER="73" O_E="0.0" SE="0.4699290726623895" STUDY_ID="STD-Lin-1993" TOTAL_1="32" TOTAL_2="32" VAR="0.22083333333333333" WEIGHT="19.21820250771751"/>
<DICH_DATA CI_END="2.195588890534318" CI_START="0.16396512186413478" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.34155102462740894" LOG_CI_START="-0.7852485238601217" LOG_EFFECT_SIZE="-0.2218487496163564" ORDER="74" O_E="0.0" SE="0.6618876325292973" STUDY_ID="STD-Loizou-1991" TOTAL_1="21" TOTAL_2="21" VAR="0.4380952380952381" WEIGHT="9.687436318428256"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.819721313670083" CI_END="0.9320530264561986" CI_START="0.5003634558284944" CI_STUDY="95" CI_TOTAL="95" DF="17" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6829094181024528" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="98" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-0.030559379017024404" LOG_CI_START="-0.30071441662766896" LOG_EFFECT_SIZE="-0.16563689782234667" METHOD="MH" MODIFIED="2014-07-14 04:49:34 -0400" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.8109287331359796" P_Q="1.0" P_Z="0.016244380659329642" Q="0.0" RANDOM="YES" SCALE="466.84" SORT_BY="EFFECT_SIZE" STUDIES="18" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="918" TOTAL_2="923" WEIGHT="100.00000000000006" Z="2.403378127715128">
<NAME>Surgery rate</NAME>
<GROUP_LABEL_1>Combined therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combined therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epinephrine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.6338583134691316" CI_START="0.005250927450264603" EFFECT_SIZE="0.09262435677530018" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2132143922536133" LOG_CI_START="-2.2797639821257047" LOG_EFFECT_SIZE="-1.0332747949360455" MODIFIED="2008-06-17 05:19:08 -0400" MODIFIED_BY="[Empty name]" ORDER="175" O_E="0.0" SE="1.4643878375523887" STUDY_ID="STD-Lo-2006" TOTAL_1="52" TOTAL_2="53" VAR="2.144431738771361" WEIGHT="1.1743271945766245"/>
<DICH_DATA CI_END="2.605831928792184" CI_START="0.007831726612838538" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.41594640111102243" LOG_CI_START="-2.106142481139536" LOG_EFFECT_SIZE="-0.8450980400142568" ORDER="28" O_E="0.0" SE="1.4814874939752933" STUDY_ID="STD-Loizou-1991" TOTAL_1="21" TOTAL_2="21" VAR="2.1948051948051948" WEIGHT="1.147374953236321"/>
<DICH_DATA CI_END="1.2929853382383403" CI_START="0.020472601437730747" EFFECT_SIZE="0.1626984126984127" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.11159360024134855" LOG_CI_START="-1.6888269683649657" LOG_EFFECT_SIZE="-0.7886166840618086" ORDER="23" O_E="0.0" SE="1.0575759542248981" STUDY_ID="STD-Chung-1999" TOTAL_1="42" TOTAL_2="41" VAR="1.118466898954704" WEIGHT="2.251532441510753"/>
<DICH_DATA CI_END="1.6175863301015445" CI_START="0.0247282010583565" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.20886746812665352" LOG_CI_START="-1.6068074767986908" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="27" O_E="0.0" SE="1.0665364503850772" STUDY_ID="STD-Lin-1999" TOTAL_1="32" TOTAL_2="32" VAR="1.1375" WEIGHT="2.2138589079142377"/>
<DICH_DATA CI_END="4.2678079134480145" CI_START="0.010709828560469942" EFFECT_SIZE="0.21379310344827587" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6302048643590656" LOG_CI_START="-1.97021748116047" LOG_EFFECT_SIZE="-0.6700063084007022" MODIFIED="2014-05-20 12:28:07 -0400" MODIFIED_BY="Cathy Bennett" ORDER="192" O_E="0.0" SE="1.5275009580563874" STUDY_ID="STD-Grgov-2012" TOTAL_1="28" TOTAL_2="30" VAR="2.3332591768631814" WEIGHT="1.079290518911827"/>
<DICH_DATA CI_END="2.702679690507939" CI_START="0.03190566344750045" EFFECT_SIZE="0.29365079365079366" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.43179457811165756" LOG_CI_START="-1.4961322202127934" LOG_EFFECT_SIZE="-0.5321688210505678" ORDER="33" O_E="0.0" SE="1.132473744727348" STUDY_ID="STD-Villanueva-1996" TOTAL_1="42" TOTAL_2="37" VAR="1.2824967824967826" WEIGHT="1.9635639965114398"/>
<DICH_DATA CI_END="7.970891595095491" CI_START="0.013939608861256886" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.901506902722716" LOG_CI_START="-1.8557494121620408" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="29" O_E="0.0" SE="1.6196260080021871" STUDY_ID="STD-Park-2004" TOTAL_1="45" TOTAL_2="45" VAR="2.623188405797101" WEIGHT="0.9600013869332527"/>
<DICH_DATA CI_END="8.661483502210615" CI_START="0.015522103622333418" EFFECT_SIZE="0.36666666666666664" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9375922825076825" LOG_CI_START="-1.809049421630557" LOG_EFFECT_SIZE="-0.4357285695614374" ORDER="31" O_E="0.0" SE="1.6133909331065124" STUDY_ID="STD-Sollano-1991" TOTAL_1="29" TOTAL_2="32" VAR="2.603030303030303" WEIGHT="0.967435724747738"/>
<DICH_DATA CI_END="2.5395048073116095" CI_START="0.09844438934717235" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.40474903928980993" LOG_CI_START="-1.0068090306177724" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="26" O_E="0.0" SE="0.82915619758885" STUDY_ID="STD-Lin-1993" TOTAL_1="32" TOTAL_2="32" VAR="0.6875" WEIGHT="3.662930193094466"/>
<DICH_DATA CI_END="1.298005367218124" CI_START="0.24421885702179857" EFFECT_SIZE="0.5630252100840336" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" LOG_CI_END="0.11327648826434672" LOG_CI_START="-0.6122208056477554" LOG_EFFECT_SIZE="-0.24947215869170433" ORDER="22" O_E="0.0" SE="0.4261607017134929" STUDY_ID="STD-Chung-1997" TOTAL_1="136" TOTAL_2="134" VAR="0.18161294368493666" WEIGHT="13.866106989164534"/>
<DICH_DATA CI_END="2.41491020396828" CI_START="0.1490738659385484" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.3829009865798236" LOG_CI_START="-0.8265984858125364" LOG_EFFECT_SIZE="-0.2218487496163564" ORDER="24" O_E="0.0" SE="0.7104659772022196" STUDY_ID="STD-Kubba-1996" TOTAL_1="70" TOTAL_2="70" VAR="0.5047619047619049" WEIGHT="4.989014590830315"/>
<DICH_DATA CI_END="2.0050402575443287" CI_START="0.1888731278223218" EFFECT_SIZE="0.6153846153846154" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.3021230968833014" LOG_CI_START="-0.7238298275130878" LOG_EFFECT_SIZE="-0.21085336531489315" ORDER="30" O_E="0.0" SE="0.6026498263393205" STUDY_ID="STD-Pescatore-2002" TOTAL_1="65" TOTAL_2="70" VAR="0.3631868131868132" WEIGHT="6.9337994010732995"/>
<DICH_DATA CI_END="1.7230608163012406" CI_START="0.3431924899059493" EFFECT_SIZE="0.7689873417721519" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.2363006063615035" LOG_CI_START="-0.4644622244016868" LOG_EFFECT_SIZE="-0.11408080902009164" ORDER="21" O_E="0.0" SE="0.41163155562225484" STUDY_ID="STD-Chung-1996" TOTAL_1="79" TOTAL_2="81" VAR="0.16944053758399746" WEIGHT="14.862231574920822"/>
<DICH_DATA CI_END="1.6935639456174325" CI_START="0.4520791801108352" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.2288015993889709" LOG_CI_START="-0.34478549334434444" LOG_EFFECT_SIZE="-0.057991946977686754" ORDER="20" O_E="0.0" SE="0.33692789757345015" STUDY_ID="STD-Chung-1993" TOTAL_1="98" TOTAL_2="98" VAR="0.11352040816326531" WEIGHT="22.18336375368446"/>
<DICH_DATA CI_END="4.011378863407949" CI_START="0.27888490612453737" EFFECT_SIZE="1.0576923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.6032936818064123" LOG_CI_START="-0.5545749900875229" LOG_EFFECT_SIZE="0.024359345859444693" ORDER="19" O_E="0.0" SE="0.6801377894128605" STUDY_ID="STD-Choudari-1994" TOTAL_1="52" TOTAL_2="55" VAR="0.4625874125874126" WEIGHT="5.443867341021915"/>
<DICH_DATA CI_END="3.8424525343874083" CI_START="0.3360672129305714" EFFECT_SIZE="1.1363636363636365" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5846085113881913" LOG_CI_START="-0.47357385568852844" LOG_EFFECT_SIZE="0.05551732784983141" ORDER="32" O_E="0.0" SE="0.621581560508061" STUDY_ID="STD-Villanueva-1993" TOTAL_1="33" TOTAL_2="30" VAR="0.38636363636363635" WEIGHT="6.517861078888682"/>
<DICH_DATA CI_END="4.2342714917737405" CI_START="0.3690127104593066" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6267787005419575" LOG_CI_START="-0.43295867452584486" LOG_EFFECT_SIZE="0.09691001300805642" ORDER="18" O_E="0.0" SE="0.6224949798994366" STUDY_ID="STD-Balanzo-1990" TOTAL_1="32" TOTAL_2="32" VAR="0.3875" WEIGHT="6.498747116780503"/>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" ORDER="25" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Lee-1997" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="3.284692836198842"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.05535789744399" CI_END="1.061998438361684" CI_START="0.38561727449748606" CI_STUDY="95" CI_TOTAL="95" DF="15" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6399413592835042" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="43" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.026123878128310914" LOG_CI_START="-0.41384351924302715" LOG_EFFECT_SIZE="-0.19385982055735818" METHOD="MH" MODIFIED="2014-07-14 04:49:40 -0400" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.8162434149777272" P_Q="1.0" P_Z="0.08412977426724581" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="EFFECT_SIZE" STUDIES="18" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="918" TOTAL_2="923" WEIGHT="99.99999999999999" Z="1.727211009779118">
<NAME>Mortality rate</NAME>
<GROUP_LABEL_1>Combined therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combined therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epinephrine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="34" O_E="0.0" SE="0.0" STUDY_ID="STD-Balanzo-1990" TOTAL_1="32" TOTAL_2="32" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="44" O_E="0.0" SE="0.0" STUDY_ID="STD-Loizou-1991" TOTAL_1="21" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.1453355898227802" CI_START="0.0038804735345141415" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.058932756068136444" LOG_CI_START="-2.4111152741794992" LOG_EFFECT_SIZE="-1.1760912590556813" ORDER="40" O_E="0.0" SE="1.4509184399024042" STUDY_ID="STD-Kubba-1996" TOTAL_1="70" TOTAL_2="70" VAR="2.1051643192488263" WEIGHT="3.1727086628033527"/>
<DICH_DATA CI_END="2.6515870907376713" CI_START="0.007696584184088997" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4235058959862219" LOG_CI_START="-2.1137019760147355" LOG_EFFECT_SIZE="-0.8450980400142568" ORDER="41" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Lee-1997" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="3.0069685823449057"/>
<DICH_DATA CI_END="3.5672317467714656" CI_START="0.008757072575819168" EFFECT_SIZE="0.17674418604651163" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5523313243859315" LOG_CI_START="-2.057641050983522" LOG_EFFECT_SIZE="-0.7526548632987952" ORDER="49" O_E="0.0" SE="1.533110692863639" STUDY_ID="STD-Villanueva-1996" TOTAL_1="42" TOTAL_2="37" VAR="2.3504283965728274" WEIGHT="2.841640733256996"/>
<DICH_DATA CI_END="3.037028254786625" CI_START="0.03658547164847419" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4824488323663514" LOG_CI_START="-1.4366913418056761" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="43" O_E="0.0" SE="1.1273124382057236" STUDY_ID="STD-Lin-1999" TOTAL_1="32" TOTAL_2="32" VAR="1.2708333333333333" WEIGHT="5.255664056895954"/>
<DICH_DATA CI_END="7.970891595095491" CI_START="0.013939608861256886" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.901506902722716" LOG_CI_START="-1.8557494121620408" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="45" O_E="0.0" SE="1.6196260080021871" STUDY_ID="STD-Park-2004" TOTAL_1="45" TOTAL_2="45" VAR="2.623188405797101" WEIGHT="2.546165977840132"/>
<DICH_DATA CI_END="8.456536051503893" CI_START="0.014668621440720757" EFFECT_SIZE="0.3522012578616352" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9271925046720503" LOG_CI_START="-1.8336106993005525" LOG_EFFECT_SIZE="-0.4532090973142511" ORDER="35" O_E="0.0" SE="1.6217094682097721" STUDY_ID="STD-Choudari-1994" TOTAL_1="52" TOTAL_2="55" VAR="2.6299415992812216" WEIGHT="2.539627904334721"/>
<DICH_DATA CI_END="8.661483502210615" CI_START="0.015522103622333418" EFFECT_SIZE="0.36666666666666664" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9375922825076825" LOG_CI_START="-1.809049421630557" LOG_EFFECT_SIZE="-0.4357285695614374" ORDER="47" O_E="0.0" SE="1.6133909331065124" STUDY_ID="STD-Sollano-1991" TOTAL_1="29" TOTAL_2="32" VAR="2.603030303030303" WEIGHT="2.5658837181149483"/>
<DICH_DATA CI_END="1.3952814590891605" CI_START="0.14157062212127364" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.1446618232365778" LOG_CI_START="-0.8490268594593028" LOG_EFFECT_SIZE="-0.35218251811136253" ORDER="36" O_E="0.0" SE="0.5836976510538696" STUDY_ID="STD-Chung-1993" TOTAL_1="98" TOTAL_2="98" VAR="0.34070294784580496" WEIGHT="19.603801829528294"/>
<DICH_DATA CI_END="4.761334097402456" CI_START="0.04339363002496523" EFFECT_SIZE="0.45454545454545453" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6777286564939502" LOG_CI_START="-1.3625740181383625" LOG_EFFECT_SIZE="-0.3424226808222062" ORDER="48" O_E="0.0" SE="1.1984838907401452" STUDY_ID="STD-Villanueva-1993" TOTAL_1="33" TOTAL_2="30" VAR="1.4363636363636363" WEIGHT="4.649987581984685"/>
<DICH_DATA CI_END="3.9816002278089737" CI_START="0.11734799792069489" EFFECT_SIZE="0.6835443037974683" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6000576525843134" LOG_CI_START="-0.9305243155192593" LOG_EFFECT_SIZE="-0.16523333146747293" ORDER="37" O_E="0.0" SE="0.8990714245669731" STUDY_ID="STD-Chung-1996" TOTAL_1="79" TOTAL_2="81" VAR="0.8083294264728864" WEIGHT="8.262810747159294"/>
<DICH_DATA CI_END="15.091116797276316" CI_START="0.06314627728393032" EFFECT_SIZE="0.9761904761904762" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.17872138032877" LOG_CI_START="-1.1996522476851" LOG_EFFECT_SIZE="-0.01046543367816498" ORDER="39" O_E="0.0" SE="1.3970684422346806" STUDY_ID="STD-Chung-1999" TOTAL_1="42" TOTAL_2="41" VAR="1.9518002322880372" WEIGHT="3.422006495242393"/>
<DICH_DATA CI_END="16.322321561693393" CI_START="0.07033063154248821" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2127819295236744" LOG_CI_START="-1.1528554827687882" LOG_EFFECT_SIZE="0.029963223377443202" MODIFIED="2014-05-20 12:48:26 -0400" MODIFIED_BY="Cathy Bennett" ORDER="193" O_E="0.0" SE="1.3895871260746413" STUDY_ID="STD-Grgov-2012" TOTAL_1="28" TOTAL_2="30" VAR="1.9309523809523808" WEIGHT="3.4589527624762213"/>
<DICH_DATA CI_END="7.424435324406626" CI_START="0.15620895905671559" EFFECT_SIZE="1.0769230769230769" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8706634283838773" LOG_CI_START="-0.8062940616410748" LOG_EFFECT_SIZE="0.032184683371401235" ORDER="46" O_E="0.0" SE="0.9850531307141105" STUDY_ID="STD-Pescatore-2002" TOTAL_1="65" TOTAL_2="70" VAR="0.9703296703296704" WEIGHT="6.883302939748358"/>
<DICH_DATA CI_END="3.018142383675822" CI_START="0.4201225083411688" EFFECT_SIZE="1.1260504201680672" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.47973972416922767" LOG_CI_START="-0.37662405022467393" LOG_EFFECT_SIZE="0.051557836972276866" ORDER="38" O_E="0.0" SE="0.5030323201480279" STUDY_ID="STD-Chung-1997" TOTAL_1="136" TOTAL_2="134" VAR="0.2530415151135081" WEIGHT="26.395167090701342"/>
<DICH_DATA CI_END="73.36132469680044" CI_START="0.12735357039021622" EFFECT_SIZE="3.056603773584906" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8654671648554813" LOG_CI_START="-0.8949888749717976" LOG_EFFECT_SIZE="0.48523914494184195" MODIFIED="2008-06-17 05:21:33 -0400" MODIFIED_BY="[Empty name]" ORDER="176" O_E="0.0" SE="1.6215055422723186" STUDY_ID="STD-Lo-2006" TOTAL_1="52" TOTAL_2="53" VAR="2.629280223619846" WEIGHT="2.5402667286295944"/>
<DICH_DATA CI_END="100.2049917255156" CI_START="0.2494885690772842" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0008893565097607" LOG_CI_START="-0.6029493478377235" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="42" O_E="0.0" SE="1.5295077441431735" STUDY_ID="STD-Lin-1993" TOTAL_1="32" TOTAL_2="32" VAR="2.3393939393939394" WEIGHT="2.855044188938783"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.546892846517042" CI_END="3.960647900746669" CI_START="0.3975475936416305" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2548091656517393" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.5977662355980272" LOG_CI_START="-0.4006108709858292" LOG_EFFECT_SIZE="0.09857768230609906" METHOD="MH" MODIFIED="2014-07-14 04:49:48 -0400" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.6030924564987667" P_Q="1.0" P_Z="0.6987224893845577" Q="0.0" RANDOM="YES" SCALE="493.64" SORT_BY="EFFECT_SIZE" STUDIES="12" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="640" TOTAL_2="641" WEIGHT="100.0" Z="0.387045547669832">
<NAME>Adverse effects of endoscopy therapy</NAME>
<GROUP_LABEL_1>Combined treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combined therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epineprhine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="55" O_E="0.0" SE="0.0" STUDY_ID="STD-Lin-1999" TOTAL_1="32" TOTAL_2="32" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="53" O_E="0.0" SE="0.0" STUDY_ID="STD-Kubba-1996" TOTAL_1="70" TOTAL_2="70" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-02 08:15:44 -0400" MODIFIED_BY="[Empty name]" ORDER="193" O_E="0.0" SE="0.0" STUDY_ID="STD-Grgov-2012" TOTAL_1="30" TOTAL_2="28" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-10-12 10:43:26 -0400" MODIFIED_BY="[Empty name]" ORDER="185" O_E="0.0" SE="0.0" STUDY_ID="STD-Lo-2006" TOTAL_1="52" TOTAL_2="53" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="54" O_E="0.0" SE="0.0" STUDY_ID="STD-Lin-1993" TOTAL_1="32" TOTAL_2="32" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.6197530802576594" CI_START="0.007431991939140536" EFFECT_SIZE="0.13953488372093023" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.41826035966513947" LOG_CI_START="-2.1288947700570255" LOG_EFFECT_SIZE="-0.8553172051959429" ORDER="52" O_E="0.0" SE="1.4962115318200409" STUDY_ID="STD-Chung-1999" TOTAL_1="42" TOTAL_2="41" VAR="2.2386489479512734" WEIGHT="15.363085102122664"/>
<DICH_DATA CI_END="7.7443737981982546" CI_START="0.014347333174563614" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8889863069264973" LOG_CI_START="-1.8432288163658224" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="56" O_E="0.0" SE="1.6049166881048922" STUDY_ID="STD-Loizou-1991" TOTAL_1="21" TOTAL_2="21" VAR="2.5757575757575757" WEIGHT="13.352403434565199"/>
<DICH_DATA CI_END="16.865644535014425" CI_START="0.06876483796404613" EFFECT_SIZE="1.0769230769230769" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2270029427770102" LOG_CI_START="-1.162633576034208" LOG_EFFECT_SIZE="0.032184683371401235" ORDER="57" O_E="0.0" SE="1.4036843200412514" STUDY_ID="STD-Pescatore-2002" TOTAL_1="65" TOTAL_2="70" VAR="1.9703296703296704" WEIGHT="17.45522834023928"/>
<DICH_DATA CI_END="64.69095211475431" CI_START="0.11565502849243409" EFFECT_SIZE="2.735294117647059" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.810843543088873" LOG_CI_START="-0.9368354800655133" LOG_EFFECT_SIZE="0.43700403151168" ORDER="59" O_E="0.0" SE="1.614000259431409" STUDY_ID="STD-Villanueva-1993" TOTAL_1="33" TOTAL_2="30" VAR="2.6049968374446553" WEIGHT="13.202532074814266"/>
<DICH_DATA CI_END="72.75324500824112" CI_START="0.1237058223173485" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8618523688984008" LOG_CI_START="-0.907609859459076" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2014-05-28 07:47:04 -0400" MODIFIED_BY="Cathy Bennett" ORDER="50" O_E="0.0" SE="1.626795821996309" STUDY_ID="STD-Chung-1993" TOTAL_1="98" TOTAL_2="98" VAR="2.6464646464646466" WEIGHT="12.995659831351624"/>
<DICH_DATA CI_END="77.95335151989555" CI_START="0.1396989326010007" EFFECT_SIZE="3.3" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8918347919470073" LOG_CI_START="-0.8548069121912323" LOG_EFFECT_SIZE="0.5185139398778874" MODIFIED="2014-05-28 07:47:04 -0400" MODIFIED_BY="Cathy Bennett" ORDER="58" O_E="0.0" SE="1.6133909331065124" STUDY_ID="STD-Sollano-1991" TOTAL_1="29" TOTAL_2="32" VAR="2.603030303030303" WEIGHT="13.212506308941117"/>
<DICH_DATA CI_END="101.67460143047147" CI_START="0.23875580120823905" EFFECT_SIZE="4.927007299270073" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0072124786238477" LOG_CI_START="-0.6220460672746111" LOG_EFFECT_SIZE="0.6925832056746182" ORDER="51" O_E="0.0" SE="1.5444394849004606" STUDY_ID="STD-Chung-1997" TOTAL_1="136" TOTAL_2="134" VAR="2.3852933225196" WEIGHT="14.418584907965835"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="27.18324346343202" CI_END="0.9057492358531204" CI_START="0.5347546183181839" CI_STUDY="95" CI_TOTAL="95" DF="22" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6959551615661903" ESTIMABLE="YES" EVENTS_1="110" EVENTS_2="158" I2="19.067788839859105" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="-0.04299202369134239" LOG_CI_START="-0.2718454560291002" LOG_EFFECT_SIZE="-0.15741873986022137" METHOD="MH" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.20434931599163786" P_Q="0.6191927765943734" P_Z="0.007010288832819504" Q="0.9586773909396903" RANDOM="YES" SCALE="1000.0" SORT_BY="EFFECT_SIZE" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.07837010868854995" TOTALS="SUB" TOTAL_1="744" TOTAL_2="753" WEIGHT="300.0" Z="2.6963551078609655">
<NAME>Recurrent and persistent bleeding according to type of haemorrhage</NAME>
<GROUP_LABEL_1>Combined therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combined therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epinephrine alone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="14.105348898085044" CI_END="0.878837302463056" CI_START="0.4914436151549388" DF="12" EFFECT_SIZE="0.6571902167983472" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="128" I2="14.925890265435887" ID="CMP-001.08.01" LOG_CI_END="-0.05609151762538949" LOG_CI_START="-0.30852630292195726" LOG_EFFECT_SIZE="-0.1823089102736734" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2940316771194357" P_Z="0.004640564111699969" STUDIES="13" TAU2="0.041047575635351996" TOTAL_1="513" TOTAL_2="506" WEIGHT="100.0" Z="2.830979872899493">
<NAME>Forrest Ia-Ib (spurting or oozing haemorrhage)</NAME>
<DICH_DATA CI_END="0.82551474561183" CI_START="0.04726559097585214" EFFECT_SIZE="0.19753086419753085" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.08327516482316803" LOG_CI_START="-1.325454907622282" LOG_EFFECT_SIZE="-0.704365036222725" ORDER="84" O_E="0.0" SE="0.7296625298090944" STUDY_ID="STD-Kubba-1996" TOTAL_1="27" TOTAL_2="24" VAR="0.5324074074074076" WEIGHT="3.8341956782782565"/>
<DICH_DATA CI_END="1.0900607635467905" CI_START="0.08256420468448203" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="0.0374507076080972" LOG_CI_START="-1.0832081981687725" LOG_EFFECT_SIZE="-0.5228787452803376" ORDER="83" O_E="0.0" SE="0.6582805886043833" STUDY_ID="STD-Garrido-2002" TOTAL_1="10" TOTAL_2="15" VAR="0.43333333333333335" WEIGHT="4.634964384316785"/>
<DICH_DATA CI_END="1.3463104417893765" CI_START="0.06880107022028689" EFFECT_SIZE="0.30434782608695654" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.12914521413063618" LOG_CI_START="-1.1624048061373082" LOG_EFFECT_SIZE="-0.516629796003336" ORDER="87" O_E="0.0" SE="0.7586628751811003" STUDY_ID="STD-Park-2004" TOTAL_1="23" TOTAL_2="21" VAR="0.5755693581780539" WEIGHT="3.5658096576618483"/>
<DICH_DATA CI_END="1.4123298029386824" CI_START="0.11328798674862106" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.14993612367866105" LOG_CI_START="-0.9458161410227361" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2014-07-11 07:00:11 -0400" MODIFIED_BY="[Empty name]" ORDER="82" O_E="0.0" SE="0.6436503043467892" STUDY_ID="STD-Chung-1999" TOTAL_1="21" TOTAL_2="14" VAR="0.41428571428571426" WEIGHT="4.828855404029078"/>
<DICH_DATA CI_END="1.046629834173422" CI_START="0.16587632555708762" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.019793110140146116" LOG_CI_START="-0.780215593563358" LOG_EFFECT_SIZE="-0.38021124171160603" ORDER="85" O_E="0.0" SE="0.4699290726623895" STUDY_ID="STD-Lin-1993" TOTAL_1="32" TOTAL_2="32" VAR="0.22083333333333333" WEIGHT="8.395948472641798"/>
<DICH_DATA CI_END="0.9427182201385331" CI_START="0.29554004461075173" EFFECT_SIZE="0.5278361344537815" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="28" LOG_CI_END="-0.025618099125051117" LOG_CI_START="-0.5293836654588445" LOG_EFFECT_SIZE="-0.27750088229194786" MODIFIED="2014-07-02 15:48:19 -0400" MODIFIED_BY="[Empty name]" ORDER="81" O_E="0.0" SE="0.2959143873442412" STUDY_ID="STD-Chung-1997" TOTAL_1="136" TOTAL_2="134" VAR="0.08756532463731762" WEIGHT="17.09578598265165"/>
<DICH_DATA CI_END="1.3803831041262953" CI_START="0.20606195743353561" EFFECT_SIZE="0.5333333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="0.13999963489239628" LOG_CI_START="-0.6860021790198716" LOG_EFFECT_SIZE="-0.27300127206373764" ORDER="88" O_E="0.0" SE="0.48519755426698796" STUDY_ID="STD-Pescatore-2002" TOTAL_1="30" TOTAL_2="32" VAR="0.23541666666666672" WEIGHT="7.953066911516551"/>
<DICH_DATA CI_END="2.315846557152092" CI_START="0.3403114592223571" EFFECT_SIZE="0.8877551020408163" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.36470978062112663" LOG_CI_START="-0.46812342676887925" LOG_EFFECT_SIZE="-0.05170682307387634" ORDER="78" O_E="0.0" SE="0.4892103486117543" STUDY_ID="STD-Choudari-1994" TOTAL_1="28" TOTAL_2="29" VAR="0.23932676518883417" WEIGHT="7.842153498092175"/>
<DICH_DATA CI_END="1.6190154003917403" CI_START="0.5627846557685141" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.20925097986723515" LOG_CI_START="-0.249657752043809" LOG_EFFECT_SIZE="-0.02020338608828695" MODIFIED="2014-07-02 12:43:03 -0400" MODIFIED_BY="[Empty name]" ORDER="79" O_E="0.0" SE="0.26956526075940673" STUDY_ID="STD-Chung-1993" TOTAL_1="98" TOTAL_2="98" VAR="0.07266542980828695" WEIGHT="19.33585880604896"/>
<DICH_DATA CI_END="5.646562719564109" CI_START="0.23578254822755915" EFFECT_SIZE="1.1538461538461537" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.7517841564576873" LOG_CI_START="-0.6274883429599983" LOG_EFFECT_SIZE="0.062147906748844434" ORDER="89" O_E="0.0" SE="0.8101914936669333" STUDY_ID="STD-Villanueva-1993" TOTAL_1="13" TOTAL_2="10" VAR="0.6564102564102564" WEIGHT="3.152504017656366"/>
<DICH_DATA CI_END="2.2375780439330244" CI_START="0.6136511567742046" EFFECT_SIZE="1.1717902350813743" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="14" LOG_CI_END="0.3497781919023007" LOG_CI_START="-0.21207844277051058" LOG_EFFECT_SIZE="0.06884987456589504" MODIFIED="2014-07-02 15:48:10 -0400" MODIFIED_BY="[Empty name]" ORDER="80" O_E="0.0" SE="0.3300373684420061" STUDY_ID="STD-Chung-1996" TOTAL_1="79" TOTAL_2="81" VAR="0.10892466456812448" WEIGHT="14.66097068821881"/>
<DICH_DATA CI_END="7.0638950479606075" CI_START="0.19772295672474183" EFFECT_SIZE="1.1818181818181819" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8490442380737343" LOG_CI_START="-0.7039429037765108" LOG_EFFECT_SIZE="0.07255066714861175" ORDER="77" O_E="0.0" SE="0.9122323345331671" STUDY_ID="STD-Balanzo-1990" TOTAL_1="11" TOTAL_2="13" VAR="0.8321678321678321" WEIGHT="2.517979639412476"/>
<DICH_DATA CI_END="8.242820870331236" CI_START="0.1746974758584234" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.9160758620331982" LOG_CI_START="-0.7577133699379487" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="86" O_E="0.0" SE="0.9831920802501751" STUDY_ID="STD-Loizou-1991" TOTAL_1="5" TOTAL_2="3" VAR="0.9666666666666668" WEIGHT="2.18190685947525"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.292749596972103" CI_END="1.9904321207588263" CI_START="0.46951566871441514" DF="8" EFFECT_SIZE="0.9667156087540595" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="26" I2="29.15808562562106" ID="CMP-001.08.02" LOG_CI_END="0.2989473715294916" LOG_CI_START="-0.3283499098458746" LOG_EFFECT_SIZE="-0.014701269158191504" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.18565704142604322" P_Z="0.9268037147912822" STUDIES="9" TAU2="0.3440863179851766" TOTAL_1="216" TOTAL_2="232" WEIGHT="100.00000000000001" Z="0.09186699490840915">
<NAME>Forrest IIa (visible vessel)</NAME>
<DICH_DATA CI_END="2.849854399654223" CI_START="0.008522330443872626" EFFECT_SIZE="0.15584415584415584" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.45482267227446854" LOG_CI_START="-2.0694416305241825" LOG_EFFECT_SIZE="-0.8073094791248571" ORDER="96" O_E="0.0" SE="1.4827653467737483" STUDY_ID="STD-Park-2004" TOTAL_1="21" TOTAL_2="23" VAR="2.1985930735930737" WEIGHT="5.339866649175447"/>
<DICH_DATA CI_END="1.7583914243738303" CI_START="0.026032938145662522" EFFECT_SIZE="0.21395348837209302" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.24511555704244645" LOG_CI_START="-1.584476813510509" LOG_EFFECT_SIZE="-0.6696806282340313" ORDER="94" O_E="0.0" SE="1.0747116150911038" STUDY_ID="STD-Kubba-1996" TOTAL_1="43" TOTAL_2="46" VAR="1.1550050556117288" WEIGHT="9.05719899518635"/>
<DICH_DATA CI_END="1.9988287327900418" CI_START="0.0312683117741459" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.30077558371755564" LOG_CI_START="-1.5048955663734804" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="95" O_E="0.0" SE="1.0606601717798212" STUDY_ID="STD-Loizou-1991" TOTAL_1="16" TOTAL_2="16" VAR="1.125" WEIGHT="9.242185919514785"/>
<DICH_DATA CI_END="5.180743077657695" CI_START="0.04825562593098698" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7143920553787599" LOG_CI_START="-1.3164520467067224" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="93" O_E="0.0" SE="1.1929278784054478" STUDY_ID="STD-Garrido-2002" TOTAL_1="26" TOTAL_2="26" VAR="1.423076923076923" WEIGHT="7.683256740036103"/>
<DICH_DATA CI_END="2.6498175935704897" CI_START="0.17377014357166556" EFFECT_SIZE="0.6785714285714286" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4232159792831023" LOG_CI_START="-0.7600248400618829" LOG_EFFECT_SIZE="-0.16840443038939024" ORDER="90" O_E="0.0" SE="0.6950415144197627" STUDY_ID="STD-Balanzo-1990" TOTAL_1="21" TOTAL_2="19" VAR="0.48308270676691717" WEIGHT="16.414503537174493"/>
<DICH_DATA CI_END="17.668936688703905" CI_START="0.07703412690257114" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2472104145818428" LOG_CI_START="-1.1133168353206162" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="91" O_E="0.0" SE="1.3865853913910413" STUDY_ID="STD-Choudari-1994" TOTAL_1="24" TOTAL_2="28" VAR="1.9226190476190474" WEIGHT="5.990001651147596"/>
<DICH_DATA CI_END="8.029246839932956" CI_START="0.6305074561691107" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.9046748094627853" LOG_CI_START="-0.2003097732400604" LOG_EFFECT_SIZE="0.3521825181113625" ORDER="97" O_E="0.0" SE="0.6490734136415512" STUDY_ID="STD-Pescatore-2002" TOTAL_1="24" TOTAL_2="27" VAR="0.4212962962962963" WEIGHT="17.739583613851476"/>
<DICH_DATA CI_END="11.409796244984946" CI_START="0.5477749002526773" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.0572778888994756" LOG_CI_START="-0.2613978715554003" LOG_EFFECT_SIZE="0.3979400086720376" ORDER="98" O_E="0.0" SE="0.7745966692414833" STUDY_ID="STD-Villanueva-1993" TOTAL_1="20" TOTAL_2="20" VAR="0.5999999999999999" WEIGHT="14.381702842183978"/>
<DICH_DATA CI_END="14.955461666105391" CI_START="0.6908267283033147" EFFECT_SIZE="3.2142857142857144" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.1747998239836779" LOG_CI_START="-0.16063086778946647" LOG_EFFECT_SIZE="0.5070844780971057" MODIFIED="2014-07-11 06:14:10 -0400" MODIFIED_BY="[Empty name]" ORDER="92" O_E="0.0" SE="0.7844385988360818" STUDY_ID="STD-Chung-1999" TOTAL_1="21" TOTAL_2="27" VAR="0.6153439153439153" WEIGHT="14.151700051729774"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.596731351452756" CI_START="0.21661848064695113" DF="0" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-001.08.03" LOG_CI_END="0.4144270213979991" LOG_CI_START="-0.664304494614599" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2014-10-01 10:53:18 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.6498243312892176" STUDIES="2" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="100.0" Z="0.4540062478777974">
<NAME>Forrrest IIb (adherent clot)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="99" O_E="0.0" SE="0.0" STUDY_ID="STD-Garrido-2002" TOTAL_1="4" TOTAL_2="4" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.596731351452756" CI_START="0.21661848064695113" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4144270213979991" LOG_CI_START="-0.664304494614599" LOG_EFFECT_SIZE="-0.12493873660829995" ORDER="100" O_E="0.0" SE="0.6336522323129237" STUDY_ID="STD-Pescatore-2002" TOTAL_1="11" TOTAL_2="11" VAR="0.4015151515151514" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2014-07-14 04:50:24 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Epinephrine plus epinephrine and a second injected agent</NAME>
<DICH_OUTCOME CHI2="15.596142267205952" CI_END="1.0385951982937818" CI_START="0.5251009409012432" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.738489888786284" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="121" I2="35.88158001721345" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.016446310402947698" LOG_CI_START="-0.2797572035224044" LOG_EFFECT_SIZE="-0.13165544655972836" METHOD="MH" MODIFIED="2014-07-14 04:50:07 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.11179175633381644" P_Q="1.0" P_Z="0.08145331538658569" Q="0.0" RANDOM="YES" SCALE="2.92" SORT_BY="EFFECT_SIZE" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.11125941632182934" TOTALS="YES" TOTAL_1="560" TOTAL_2="575" WEIGHT="99.99999999999999" Z="1.7423151414107494">
<NAME>Recurrent and persistent bleeding</NAME>
<GROUP_LABEL_1>Combined epinephrine</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combination therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>epinephrine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7129717306686718" CI_START="0.06440419075784884" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.14692768958431326" LOG_CI_START="-1.191085872332838" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2014-05-30 12:10:27 -0400" MODIFIED_BY="Cathy Bennett" ORDER="130" O_E="0.0" SE="0.6133436852128472" STUDY_ID="STD-Kubba-1996" TOTAL_1="70" TOTAL_2="70" VAR="0.3761904761904762" WEIGHT="6.2104867242686765"/>
<DICH_DATA CI_END="0.9256980681573206" CI_START="0.08545071575817187" EFFECT_SIZE="0.28125" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="12" LOG_CI_END="-0.033530642600510356" LOG_CI_START="-1.0682842951606517" LOG_EFFECT_SIZE="-0.5509074688805811" MODIFIED="2014-05-30 12:10:27 -0400" MODIFIED_BY="Cathy Bennett" ORDER="129" O_E="0.0" SE="0.6078194176270156" STUDY_ID="STD-Garrido-2002" TOTAL_1="40" TOTAL_2="45" VAR="0.3694444444444444" WEIGHT="6.297642547260072"/>
<DICH_DATA CI_END="1.1353940444188015" CI_START="0.14092023891309263" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="10" LOG_CI_END="0.05514661185272456" LOG_CI_START="-0.8510266291967997" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2014-05-30 12:10:27 -0400" MODIFIED_BY="Cathy Bennett" ORDER="131" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Lee-1997" TOTAL_1="30" TOTAL_2="30" VAR="0.2833333333333333" WEIGHT="7.671963280722837"/>
<DICH_DATA CI_END="1.046629834173422" CI_START="0.16587632555708762" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.019793110140146116" LOG_CI_START="-0.780215593563358" LOG_EFFECT_SIZE="-0.38021124171160603" MODIFIED="2014-05-30 12:10:27 -0400" MODIFIED_BY="Cathy Bennett" ORDER="132" O_E="0.0" SE="0.4699290726623895" STUDY_ID="STD-Lin-1993" TOTAL_1="32" TOTAL_2="32" VAR="0.22083333333333333" WEIGHT="9.115830108719162"/>
<DICH_DATA CI_END="2.4562215108132492" CI_START="0.2827287528373268" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.3902675304601213" LOG_CI_START="-0.5486300225553709" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2014-05-30 12:10:27 -0400" MODIFIED_BY="Cathy Bennett" ORDER="125" O_E="0.0" SE="0.5515130702591433" STUDY_ID="STD-Balanzo-1990" TOTAL_1="32" TOTAL_2="32" VAR="0.3041666666666667" WEIGHT="7.287219580475159"/>
<DICH_DATA CI_END="1.6512742619753693" CI_START="0.47633049215784506" EFFECT_SIZE="0.8868778280542986" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.2178192117063773" LOG_CI_START="-0.32209161636364664" LOG_EFFECT_SIZE="-0.05213620232863467" MODIFIED="2014-05-30 12:10:27 -0400" MODIFIED_BY="Cathy Bennett" ORDER="133" O_E="0.0" SE="0.31714629301003416" STUDY_ID="STD-Pescatore-2002" TOTAL_1="65" TOTAL_2="70" VAR="0.10058177117000644" WEIGHT="14.290427286764228"/>
<DICH_DATA CI_END="2.371284396738129" CI_START="0.3612028381724999" EFFECT_SIZE="0.9254807692307693" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.3749836436142605" LOG_CI_START="-0.4422488458507446" LOG_EFFECT_SIZE="-0.033632601118242046" MODIFIED="2014-05-30 12:10:27 -0400" MODIFIED_BY="Cathy Bennett" ORDER="126" O_E="0.0" SE="0.48004640967780965" STUDY_ID="STD-Choudari-1994" TOTAL_1="52" TOTAL_2="55" VAR="0.23044455544455544" WEIGHT="8.859426100740682"/>
<DICH_DATA CI_END="1.6190154003917403" CI_START="0.5627846557685141" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.20925097986723515" LOG_CI_START="-0.249657752043809" LOG_EFFECT_SIZE="-0.02020338608828695" MODIFIED="2014-07-02 15:51:07 -0400" MODIFIED_BY="[Empty name]" ORDER="127" O_E="0.0" SE="0.26956526075940673" STUDY_ID="STD-Chung-1993" TOTAL_1="98" TOTAL_2="98" VAR="0.07266542980828695" WEIGHT="16.459446072077856"/>
<DICH_DATA CI_END="7.3367229039235555" CI_START="0.16595939542051152" EFFECT_SIZE="1.103448275862069" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8655021167891701" LOG_CI_START="-0.7799981559472703" LOG_EFFECT_SIZE="0.04275198042094988" MODIFIED="2014-07-11 07:38:47 -0400" MODIFIED_BY="[Empty name]" ORDER="134" O_E="0.0" SE="0.9665750055631018" STUDY_ID="STD-Sollano-1991" TOTAL_1="29" TOTAL_2="32" VAR="0.9342672413793104" WEIGHT="2.8954795785409906"/>
<DICH_DATA CI_END="2.2375780439330244" CI_START="0.6136511567742046" EFFECT_SIZE="1.1717902350813743" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="14" LOG_CI_END="0.3497781919023007" LOG_CI_START="-0.21207844277051058" LOG_EFFECT_SIZE="0.06884987456589504" MODIFIED="2014-07-11 07:38:13 -0400" MODIFIED_BY="[Empty name]" ORDER="128" O_E="0.0" SE="0.3300373684420061" STUDY_ID="STD-Chung-1996" TOTAL_1="79" TOTAL_2="81" VAR="0.10892466456812448" WEIGHT="13.748955301209474"/>
<DICH_DATA CI_END="5.427595756738439" CI_START="0.6090698851075563" EFFECT_SIZE="1.8181818181818181" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7346074942648749" LOG_CI_START="-0.2153328732533627" LOG_EFFECT_SIZE="0.2596373105057561" MODIFIED="2014-05-30 12:10:27 -0400" MODIFIED_BY="Cathy Bennett" ORDER="135" O_E="0.0" SE="0.5579996741608694" STUDY_ID="STD-Villanueva-1993" TOTAL_1="33" TOTAL_2="30" VAR="0.3113636363636364" WEIGHT="7.16312341922085"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.4042687835584635" CI_END="1.2142663667634817" CI_START="0.5930326869546902" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8485868524555733" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="59" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.08431396592078975" LOG_CI_START="-0.22692136840163654" LOG_EFFECT_SIZE="-0.07130370124042339" METHOD="MH" MODIFIED="2014-07-14 04:50:16 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9833481199883493" P_Q="1.0" P_Z="0.3691580800735482" Q="0.0" RANDOM="YES" SCALE="276.78" SORT_BY="EFFECT_SIZE" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="520" TOTAL_2="530" WEIGHT="99.99999999999999" Z="0.898051544821425">
<NAME>Surgery rate</NAME>
<GROUP_LABEL_1>Combined epinephrine</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combination therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epineprhrine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.661483502210615" CI_START="0.015522103622333418" EFFECT_SIZE="0.36666666666666664" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9375922825076825" LOG_CI_START="-1.809049421630557" LOG_EFFECT_SIZE="-0.4357285695614374" ORDER="144" O_E="0.0" SE="1.6133909331065124" STUDY_ID="STD-Sollano-1991" TOTAL_1="29" TOTAL_2="32" VAR="2.603030303030303" WEIGHT="1.2840258664180144"/>
<DICH_DATA CI_END="2.5395048073116095" CI_START="0.09844438934717235" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.40474903928980993" LOG_CI_START="-1.0068090306177724" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="142" O_E="0.0" SE="0.82915619758885" STUDY_ID="STD-Lin-1993" TOTAL_1="32" TOTAL_2="32" VAR="0.6875" WEIGHT="4.861611985688482"/>
<DICH_DATA CI_END="2.41491020396828" CI_START="0.1490738659385484" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.3829009865798236" LOG_CI_START="-0.8265984858125364" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2014-05-28 07:51:26 -0400" MODIFIED_BY="Cathy Bennett" ORDER="140" O_E="0.0" SE="0.7104659772022196" STUDY_ID="STD-Kubba-1996" TOTAL_1="70" TOTAL_2="70" VAR="0.5047619047619049" WEIGHT="6.621653117299759"/>
<DICH_DATA CI_END="2.0050402575443287" CI_START="0.1888731278223218" EFFECT_SIZE="0.6153846153846154" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.3021230968833014" LOG_CI_START="-0.7238298275130878" LOG_EFFECT_SIZE="-0.21085336531489315" ORDER="143" O_E="0.0" SE="0.6026498263393205" STUDY_ID="STD-Pescatore-2002" TOTAL_1="65" TOTAL_2="70" VAR="0.3631868131868132" WEIGHT="9.202862325405013"/>
<DICH_DATA CI_END="1.7230608163012406" CI_START="0.3431924899059493" EFFECT_SIZE="0.7689873417721519" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.2363006063615035" LOG_CI_START="-0.4644622244016868" LOG_EFFECT_SIZE="-0.11408080902009164" ORDER="139" O_E="0.0" SE="0.41163155562225484" STUDY_ID="STD-Chung-1996" TOTAL_1="79" TOTAL_2="81" VAR="0.16944053758399746" WEIGHT="19.725847709282142"/>
<DICH_DATA CI_END="1.6935639456174325" CI_START="0.4520791801108352" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.2288015993889709" LOG_CI_START="-0.34478549334434444" LOG_EFFECT_SIZE="-0.057991946977686754" ORDER="138" O_E="0.0" SE="0.33692789757345015" STUDY_ID="STD-Chung-1993" TOTAL_1="98" TOTAL_2="98" VAR="0.11352040816326531" WEIGHT="29.442796182989795"/>
<DICH_DATA CI_END="4.011378863407949" CI_START="0.27888490612453737" EFFECT_SIZE="1.0576923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.6032936818064123" LOG_CI_START="-0.5545749900875229" LOG_EFFECT_SIZE="0.024359345859444693" ORDER="137" O_E="0.0" SE="0.6801377894128605" STUDY_ID="STD-Choudari-1994" TOTAL_1="52" TOTAL_2="55" VAR="0.4625874125874126" WEIGHT="7.2253549258200875"/>
<DICH_DATA CI_END="3.8424525343874083" CI_START="0.3360672129305714" EFFECT_SIZE="1.1363636363636365" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5846085113881913" LOG_CI_START="-0.47357385568852844" LOG_EFFECT_SIZE="0.05551732784983141" ORDER="145" O_E="0.0" SE="0.621581560508061" STUDY_ID="STD-Villanueva-1993" TOTAL_1="33" TOTAL_2="30" VAR="0.38636363636363635" WEIGHT="8.65080956276921"/>
<DICH_DATA CI_END="4.2342714917737405" CI_START="0.3690127104593066" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6267787005419575" LOG_CI_START="-0.43295867452584486" LOG_EFFECT_SIZE="0.09691001300805642" ORDER="136" O_E="0.0" SE="0.6224949798994366" STUDY_ID="STD-Balanzo-1990" TOTAL_1="32" TOTAL_2="32" VAR="0.3875" WEIGHT="8.625440619769886"/>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" ORDER="141" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Lee-1997" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="4.359597704557606"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.8533726792257506" CI_END="0.9961507262218121" CI_START="0.24948217178260965" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.49851965517985497" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="28" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-0.0016749440925040678" LOG_CI_START="-0.6029604840008245" LOG_EFFECT_SIZE="-0.3023177140466643" METHOD="MH" MODIFIED="2014-07-14 04:50:24 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6636523390409381" P_Q="1.0" P_Z="0.04873721931581339" Q="0.0" RANDOM="YES" SCALE="12.53" SORT_BY="EFFECT_SIZE" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="520" TOTAL_2="530" WEIGHT="100.00000000000001" Z="1.9708833560517212">
<NAME>Mortality rate</NAME>
<GROUP_LABEL_1>Combined therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combination therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epinephrine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="146" O_E="0.0" SE="0.0" STUDY_ID="STD-Balanzo-1990" TOTAL_1="32" TOTAL_2="32" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.1453355898227802" CI_START="0.0038804735345141415" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.058932756068136444" LOG_CI_START="-2.4111152741794992" LOG_EFFECT_SIZE="-1.1760912590556813" ORDER="150" O_E="0.0" SE="1.4509184399024042" STUDY_ID="STD-Kubba-1996" TOTAL_1="70" TOTAL_2="70" VAR="2.1051643192488263" WEIGHT="5.925850942218024"/>
<DICH_DATA CI_END="2.6515870907376713" CI_START="0.007696584184088997" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4235058959862219" LOG_CI_START="-2.1137019760147355" LOG_EFFECT_SIZE="-0.8450980400142568" ORDER="151" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Lee-1997" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="5.616288635579958"/>
<DICH_DATA CI_END="8.456536051503893" CI_START="0.014668621440720757" EFFECT_SIZE="0.3522012578616352" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9271925046720503" LOG_CI_START="-1.8336106993005525" LOG_EFFECT_SIZE="-0.4532090973142511" ORDER="147" O_E="0.0" SE="1.6217094682097721" STUDY_ID="STD-Choudari-1994" TOTAL_1="52" TOTAL_2="55" VAR="2.6299415992812216" WEIGHT="4.74340949934169"/>
<DICH_DATA CI_END="8.661483502210615" CI_START="0.015522103622333418" EFFECT_SIZE="0.36666666666666664" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9375922825076825" LOG_CI_START="-1.809049421630557" LOG_EFFECT_SIZE="-0.4357285695614374" ORDER="154" O_E="0.0" SE="1.6133909331065124" STUDY_ID="STD-Sollano-1991" TOTAL_1="29" TOTAL_2="32" VAR="2.603030303030303" WEIGHT="4.792448996933248"/>
<DICH_DATA CI_END="1.3952814590891605" CI_START="0.14157062212127364" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.1446618232365778" LOG_CI_START="-0.8490268594593028" LOG_EFFECT_SIZE="-0.35218251811136253" ORDER="148" O_E="0.0" SE="0.5836976510538696" STUDY_ID="STD-Chung-1993" TOTAL_1="98" TOTAL_2="98" VAR="0.34070294784580496" WEIGHT="36.61515124427481"/>
<DICH_DATA CI_END="4.761334097402456" CI_START="0.04339363002496523" EFFECT_SIZE="0.45454545454545453" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6777286564939502" LOG_CI_START="-1.3625740181383625" LOG_EFFECT_SIZE="-0.3424226808222062" ORDER="155" O_E="0.0" SE="1.1984838907401452" STUDY_ID="STD-Villanueva-1993" TOTAL_1="33" TOTAL_2="30" VAR="1.4363636363636363" WEIGHT="8.68504997545498"/>
<DICH_DATA CI_END="3.9816002278089737" CI_START="0.11734799792069489" EFFECT_SIZE="0.6835443037974683" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6000576525843134" LOG_CI_START="-0.9305243155192593" LOG_EFFECT_SIZE="-0.16523333146747293" ORDER="149" O_E="0.0" SE="0.8990714245669731" STUDY_ID="STD-Chung-1996" TOTAL_1="79" TOTAL_2="81" VAR="0.8083294264728864" WEIGHT="15.43292815551466"/>
<DICH_DATA CI_END="7.424435324406626" CI_START="0.15620895905671559" EFFECT_SIZE="1.0769230769230769" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8706634283838773" LOG_CI_START="-0.8062940616410748" LOG_EFFECT_SIZE="0.032184683371401235" ORDER="153" O_E="0.0" SE="0.9850531307141105" STUDY_ID="STD-Pescatore-2002" TOTAL_1="65" TOTAL_2="70" VAR="0.9703296703296704" WEIGHT="12.85634186627115"/>
<DICH_DATA CI_END="100.2049917255156" CI_START="0.2494885690772842" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0008893565097607" LOG_CI_START="-0.6029493478377235" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="152" O_E="0.0" SE="1.5295077441431735" STUDY_ID="STD-Lin-1993" TOTAL_1="32" TOTAL_2="32" VAR="2.3393939393939394" WEIGHT="5.332530684411477"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2014-07-14 04:50:47 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Epinephrine versus epinephrine and mechanical endoscopic methods</NAME>
<DICH_OUTCOME CHI2="2.506933129642692" CI_END="0.5461860371153573" CI_START="0.18038916270644811" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3138885820115034" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="50" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-0.2626594065054437" LOG_CI_START="-0.7437895572495357" LOG_EFFECT_SIZE="-0.5032244818774897" METHOD="MH" MODIFIED="2014-07-14 04:50:32 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6433948362405941" P_Q="1.0" P_Z="4.1326108449400045E-5" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="EFFECT_SIZE" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="209" TOTAL_2="206" WEIGHT="100.0" Z="4.0999378612765955">
<NAME>Recurrrent and persistent bleeding</NAME>
<GROUP_LABEL_1>Combined therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combination therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epineprhine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.662781433274203" CI_START="0.06269526023472448" EFFECT_SIZE="0.20384615384615384" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="15" LOG_CI_END="-0.1786296661240065" LOG_CI_START="-1.2027652906160513" LOG_EFFECT_SIZE="-0.6906974783700289" MODIFIED="2014-07-11 07:41:21 -0400" MODIFIED_BY="[Empty name]" ORDER="182" O_E="0.0" SE="0.601582335379729" STUDY_ID="STD-Lo-2006" TOTAL_1="52" TOTAL_2="53" VAR="0.36190130624092887" WEIGHT="22.07039979768001"/>
<DICH_DATA CI_END="0.8937865512255189" CI_START="0.05137509317406669" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="-0.048766184440134856" LOG_CI_START="-1.2892473774770166" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2014-05-28 07:52:57 -0400" MODIFIED_BY="Cathy Bennett" ORDER="194" O_E="0.0" SE="0.7286647932708022" STUDY_ID="STD-Grgov-2012" TOTAL_1="28" TOTAL_2="30" VAR="0.530952380952381" WEIGHT="15.043357563842017"/>
<DICH_DATA CI_END="1.1371645789185902" CI_START="0.05571157739514662" EFFECT_SIZE="0.25170068027210885" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.05582332356520451" LOG_CI_START="-1.2540545449275666" LOG_EFFECT_SIZE="-0.5991156106811811" ORDER="158" O_E="0.0" SE="0.7694287439526755" STUDY_ID="STD-Villanueva-1996" TOTAL_1="42" TOTAL_2="37" VAR="0.5920205920205919" WEIGHT="13.49160252818049"/>
<DICH_DATA CI_END="1.0184475748258677" CI_START="0.08836979165607813" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.007938678353536443" LOG_CI_START="-1.0536961689142117" LOG_EFFECT_SIZE="-0.5228787452803376" ORDER="157" O_E="0.0" SE="0.6236095644623236" STUDY_ID="STD-Park-2004" TOTAL_1="45" TOTAL_2="45" VAR="0.38888888888888895" WEIGHT="20.53878818410267"/>
<DICH_DATA CI_END="1.7109885522506887" CI_START="0.2175615095600205" EFFECT_SIZE="0.6101190476190477" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.23324710380703353" LOG_CI_START="-0.6624179364752129" LOG_EFFECT_SIZE="-0.2145854163340897" ORDER="156" O_E="0.0" SE="0.5261180782752454" STUDY_ID="STD-Chung-1999" TOTAL_1="42" TOTAL_2="41" VAR="0.2768002322880372" WEIGHT="28.85585192619481"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.5455196464739379" CI_END="0.6216889222717165" CI_START="0.06344315028066067" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.19859985831693455" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="-0.20642687115384567" LOG_CI_START="-1.1976152601870012" LOG_EFFECT_SIZE="-0.7020210656704234" METHOD="MH" MODIFIED="2014-07-14 04:50:39 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9689210237788958" P_Q="1.0" P_Z="0.005497536168964942" Q="0.0" RANDOM="YES" SCALE="860.51" SORT_BY="EFFECT_SIZE" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="209" TOTAL_2="206" WEIGHT="100.00000000000001" Z="2.776336002976388">
<NAME>Surgery rate</NAME>
<GROUP_LABEL_1>Combined therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combination therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epineprhine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.6338583134691316" CI_START="0.005250927450264603" EFFECT_SIZE="0.09262435677530018" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2132143922536133" LOG_CI_START="-2.2797639821257047" LOG_EFFECT_SIZE="-1.0332747949360455" MODIFIED="2008-06-17 09:46:53 -0400" MODIFIED_BY="[Empty name]" ORDER="183" O_E="0.0" SE="1.4643878375523887" STUDY_ID="STD-Lo-2006" TOTAL_1="52" TOTAL_2="53" VAR="2.144431738771361" WEIGHT="15.807944031500936"/>
<DICH_DATA CI_END="1.2929853382383403" CI_START="0.020472601437730747" EFFECT_SIZE="0.1626984126984127" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.11159360024134855" LOG_CI_START="-1.6888269683649657" LOG_EFFECT_SIZE="-0.7886166840618086" ORDER="159" O_E="0.0" SE="1.0575759542248981" STUDY_ID="STD-Chung-1999" TOTAL_1="42" TOTAL_2="41" VAR="1.118466898954704" WEIGHT="30.30850259185432"/>
<DICH_DATA CI_END="4.2678079134480145" CI_START="0.010709828560469942" EFFECT_SIZE="0.21379310344827587" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6302048643590656" LOG_CI_START="-1.97021748116047" LOG_EFFECT_SIZE="-0.6700063084007022" MODIFIED="2014-05-20 10:02:42 -0400" MODIFIED_BY="Cathy Bennett" ORDER="185" O_E="0.0" SE="1.5275009580563874" STUDY_ID="STD-Grgov-2012" TOTAL_1="28" TOTAL_2="30" VAR="2.3332591768631814" WEIGHT="14.528628984734384"/>
<DICH_DATA CI_END="2.702679690507939" CI_START="0.03190566344750045" EFFECT_SIZE="0.29365079365079366" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.43179457811165756" LOG_CI_START="-1.4961322202127934" LOG_EFFECT_SIZE="-0.5321688210505678" ORDER="161" O_E="0.0" SE="1.132473744727348" STUDY_ID="STD-Villanueva-1996" TOTAL_1="42" TOTAL_2="37" VAR="1.2824967824967826" WEIGHT="26.43207949409179"/>
<DICH_DATA CI_END="7.970891595095491" CI_START="0.013939608861256886" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.901506902722716" LOG_CI_START="-1.8557494121620408" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="160" O_E="0.0" SE="1.6196260080021871" STUDY_ID="STD-Park-2004" TOTAL_1="45" TOTAL_2="45" VAR="2.623188405797101" WEIGHT="12.922844897818575"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9993918443748742" CI_END="2.7102226784538566" CI_START="0.19485565536307672" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7267064167805315" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.4330049750259767" LOG_CI_START="-0.7102869850094227" LOG_EFFECT_SIZE="-0.13864100499172294" METHOD="MH" MODIFIED="2014-07-14 04:50:47 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7358708574345046" P_Q="1.0" P_Z="0.6345382012104078" Q="0.0" RANDOM="YES" SCALE="509.24" SORT_BY="EFFECT_SIZE" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="209" TOTAL_2="206" WEIGHT="100.00000000000001" Z="0.47534905529432986">
<NAME>Mortality rate</NAME>
<GROUP_LABEL_1>Combined therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combination therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epineprhine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.5672317467714656" CI_START="0.008757072575819168" EFFECT_SIZE="0.17674418604651163" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5523313243859315" LOG_CI_START="-2.057641050983522" LOG_EFFECT_SIZE="-0.7526548632987952" ORDER="164" O_E="0.0" SE="1.533110692863639" STUDY_ID="STD-Villanueva-1996" TOTAL_1="42" TOTAL_2="37" VAR="2.3504283965728274" WEIGHT="19.188564110248738"/>
<DICH_DATA CI_END="7.970891595095491" CI_START="0.013939608861256886" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.901506902722716" LOG_CI_START="-1.8557494121620408" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="163" O_E="0.0" SE="1.6196260080021871" STUDY_ID="STD-Park-2004" TOTAL_1="45" TOTAL_2="45" VAR="2.623188405797101" WEIGHT="17.193330785739736"/>
<DICH_DATA CI_END="15.091116797276316" CI_START="0.06314627728393032" EFFECT_SIZE="0.9761904761904762" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.17872138032877" LOG_CI_START="-1.1996522476851" LOG_EFFECT_SIZE="-0.01046543367816498" ORDER="162" O_E="0.0" SE="1.3970684422346806" STUDY_ID="STD-Chung-1999" TOTAL_1="42" TOTAL_2="41" VAR="1.9518002322880372" WEIGHT="23.10756256100855"/>
<DICH_DATA CI_END="16.322321561693393" CI_START="0.07033063154248821" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2127819295236744" LOG_CI_START="-1.1528554827687882" LOG_EFFECT_SIZE="0.029963223377443202" MODIFIED="2014-05-20 10:02:08 -0400" MODIFIED_BY="Cathy Bennett" ORDER="186" O_E="0.0" SE="1.3895871260746413" STUDY_ID="STD-Grgov-2012" TOTAL_1="28" TOTAL_2="30" VAR="1.9309523809523808" WEIGHT="23.357047236940165"/>
<DICH_DATA CI_END="73.36132469680044" CI_START="0.12735357039021622" EFFECT_SIZE="3.056603773584906" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8654671648554813" LOG_CI_START="-0.8949888749717976" LOG_EFFECT_SIZE="0.48523914494184195" MODIFIED="2008-06-17 09:47:18 -0400" MODIFIED_BY="[Empty name]" ORDER="184" O_E="0.0" SE="1.6215055422723186" STUDY_ID="STD-Lo-2006" TOTAL_1="52" TOTAL_2="53" VAR="2.629280223619846" WEIGHT="17.153495306062826"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2014-07-14 04:51:09 -0400" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Epinephrine plus epinephrine and thermal methods</NAME>
<DICH_OUTCOME CHI2="0.7046756991490092" CI_END="0.7789676003822804" CI_START="0.30432693754634926" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4868889239571669" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="45" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="-0.1084806055723836" LOG_CI_START="-0.5166596042965866" LOG_EFFECT_SIZE="-0.3125701049344851" METHOD="MH" MODIFIED="2014-07-14 04:50:57 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7030426575581303" P_Q="1.0" P_Z="0.0026843039230072187" Q="0.0" RANDOM="YES" SCALE="833.68" SORT_BY="EFFECT_SIZE" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="189" TOTAL_2="187" WEIGHT="100.0" Z="3.0017524185727815">
<NAME>Recurrent and persistent bleeding</NAME>
<GROUP_LABEL_1>Combined therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combination therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epinephrine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9243960330499997" CI_START="0.12019860226412413" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.03414192691879562" LOG_CI_START="-0.9201005825205295" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2014-07-02 16:24:00 -0400" MODIFIED_BY="[Empty name]" ORDER="166" O_E="0.0" SE="0.5204164998665332" STUDY_ID="STD-Lin-1999" TOTAL_1="32" TOTAL_2="32" VAR="0.2708333333333333" WEIGHT="21.226305039816715"/>
<DICH_DATA CI_END="0.9427182201385331" CI_START="0.29554004461075173" EFFECT_SIZE="0.5278361344537815" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="28" LOG_CI_END="-0.025618099125051117" LOG_CI_START="-0.5293836654588445" LOG_EFFECT_SIZE="-0.27750088229194786" MODIFIED="2014-07-02 16:24:24 -0400" MODIFIED_BY="[Empty name]" ORDER="165" O_E="0.0" SE="0.2959143873442412" STUDY_ID="STD-Chung-1997" TOTAL_1="136" TOTAL_2="134" VAR="0.08756532463731762" WEIGHT="65.65145475214442"/>
<DICH_DATA CI_END="2.195588890534318" CI_START="0.16396512186413478" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.34155102462740894" LOG_CI_START="-0.7852485238601217" LOG_EFFECT_SIZE="-0.2218487496163564" ORDER="167" O_E="0.0" SE="0.6618876325292973" STUDY_ID="STD-Loizou-1991" TOTAL_1="21" TOTAL_2="21" VAR="0.4380952380952381" WEIGHT="13.122240208038866"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.492189331837666" CI_END="0.951778677164811" CI_START="0.21264317331495214" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4498769145064378" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="22" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="-0.021464028990288486" LOG_CI_START="-0.6723485552929451" LOG_EFFECT_SIZE="-0.34690629214161683" METHOD="MH" MODIFIED="2014-07-14 04:51:03 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.474215009920388" P_Q="1.0" P_Z="0.03668699671769796" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="EFFECT_SIZE" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="189" TOTAL_2="187" WEIGHT="100.0" Z="2.0892303047061214">
<NAME>Surgery rate</NAME>
<GROUP_LABEL_1>Combined therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combination therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epineprhine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.605831928792184" CI_START="0.007831726612838538" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.41594640111102243" LOG_CI_START="-2.106142481139536" LOG_EFFECT_SIZE="-0.8450980400142568" ORDER="170" O_E="0.0" SE="1.4814874939752933" STUDY_ID="STD-Loizou-1991" TOTAL_1="21" TOTAL_2="21" VAR="2.1948051948051948" WEIGHT="6.660197666056717"/>
<DICH_DATA CI_END="1.6175863301015445" CI_START="0.0247282010583565" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.20886746812665352" LOG_CI_START="-1.6068074767986908" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="169" O_E="0.0" SE="1.0665364503850772" STUDY_ID="STD-Lin-1999" TOTAL_1="32" TOTAL_2="32" VAR="1.1375" WEIGHT="12.850845218365464"/>
<DICH_DATA CI_END="1.298005367218124" CI_START="0.24421885702179857" EFFECT_SIZE="0.5630252100840336" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" LOG_CI_END="0.11327648826434672" LOG_CI_START="-0.6122208056477554" LOG_EFFECT_SIZE="-0.24947215869170433" ORDER="168" O_E="0.0" SE="0.4261607017134929" STUDY_ID="STD-Chung-1997" TOTAL_1="136" TOTAL_2="134" VAR="0.18161294368493666" WEIGHT="80.48895711557782"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.977834725282592" CI_END="2.263544401815546" CI_START="0.3738960480453104" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9199621222713025" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.35478901806005136" LOG_CI_START="-0.4272491251672161" LOG_EFFECT_SIZE="-0.03623005355358235" METHOD="MH" MODIFIED="2014-07-14 04:51:09 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.32273417930134507" P_Q="1.0" P_Z="0.855895571658021" Q="0.0" RANDOM="YES" SCALE="657.09" SORT_BY="EFFECT_SIZE" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="189" TOTAL_2="187" WEIGHT="100.0" Z="0.1816013726132096">
<NAME>Mortality rate</NAME>
<GROUP_LABEL_1>Combined therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Epinephrine alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Combination therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Epineprhine alone</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="173" O_E="0.0" SE="0.0" STUDY_ID="STD-Loizou-1991" TOTAL_1="21" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.037028254786625" CI_START="0.03658547164847419" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4824488323663514" LOG_CI_START="-1.4366913418056761" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="172" O_E="0.0" SE="1.1273124382057236" STUDY_ID="STD-Lin-1999" TOTAL_1="32" TOTAL_2="32" VAR="1.2708333333333333" WEIGHT="16.605137578811817"/>
<DICH_DATA CI_END="3.018142383675822" CI_START="0.4201225083411688" EFFECT_SIZE="1.1260504201680672" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.47973972416922767" LOG_CI_START="-0.37662405022467393" LOG_EFFECT_SIZE="0.051557836972276866" ORDER="171" O_E="0.0" SE="0.5030323201480279" STUDY_ID="STD-Chung-1997" TOTAL_1="136" TOTAL_2="134" VAR="0.2530415151135081" WEIGHT="83.39486242118818"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2014-10-01 13:27:40 -0400" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-07-14 14:18:12 -0400" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAeIAAAIhCAYAAACSfbkkAABP6ElEQVR42u2dAYRW2fvHI2uttVYk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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2014-10-01 13:27:40 -0400" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADOCAMAAADbsfL2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2014-10-01 13:27:40 -0400" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAQYAAANUCAIAAADejhS+AAAjGUlEQVR42u3dv64dSdXG4SMhIQIH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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2014-07-14 14:19:50 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2009-12-10 13:27:44 -0500" MODIFIED_BY="[Empty name]">MEDLINE search</TITLE>
<APPENDIX_BODY MODIFIED="2014-07-14 14:19:50 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>Ovid MEDLINE(R) </B>1946 to May Week 2 2014<B>, Ovid MEDLINE(R) Daily Update </B>May 22, 2014<B>, Ovid MEDLINE(R) In-Process &amp; Other Non-Indexed Citations </B>May 22, 2014</P>
<OL>
<LI>randomized controlled trial.pt.</LI>
<LI>controlled clinical trial.pt.</LI>
<LI>randomized.ab.</LI>
<LI>placebo.ab.</LI>
<LI>drug therapy.fs.</LI>
<LI>randomly.ab.</LI>
<LI>trial.ab.</LI>
<LI>groups.ab.</LI>
<LI>or/1-8</LI>
<LI>exp animals/ not humans.sh.</LI>
<LI>9 not 10</LI>
<LI>exp peptic ulcer/</LI>
<LI>exp peptic ulcer hemorrhage/</LI>
<LI>exp peptic ulcer perforation/</LI>
<LI>exp duodenal ulcer/</LI>
<LI>exp stomach ulcer/</LI>
<LI>(pep$ adj5 ulcer$).tw.</LI>
<LI>(stomach adj5 ulcer$).tw.</LI>
<LI>(duoden$ adj5 ulcer$).tw.</LI>
<LI>(gastr$ adj5 ulcer$).tw.</LI>
<LI>(bleed$ adj5 ulcer$).tw.</LI>
<LI>(rebleed$ adj5 ulcer$).tw.</LI>
<LI>(recurrent adj5 bleed$ adj5 ulcer$).tw.</LI>
<LI>(acute adj5 bleed$ adj5 ulcer$).tw.</LI>
<LI>exp gastrointestinal hemorrhage/</LI>
<LI>(gastrointestinal adj5 bleed$).tw.</LI>
<LI>(gastrointestinal adj5 rebleed$).tw.</LI>
<LI>(gastrointestinal adj5 hemorrhag$).tw.</LI>
<LI>(gastrointestinal adj5 haemorrhag$).tw.</LI>
<LI>(ulcer adj5 hemorrhag$).tw.</LI>
<LI>(ulcer adj5 haemorrhag$).tw.</LI>
<LI>(mucos$ adj5 injur$).tw.</LI>
<LI>(mucos$ adj5 ero$).tw.</LI>
<LI>(gastr$ adj5 ero$).tw.</LI>
<LI>(stomach adj5 ero$).tw.</LI>
<LI>or/12-35</LI>
<LI>exp epinephrine/</LI>
<LI>epinephrine.tw.</LI>
<LI>exp vasoconstrictor agents/</LI>
<LI>or/37-39</LI>
<LI>(argon adj5 plasma adj5 coagulat$).tw.</LI>
<LI>exp sclerotherapy/</LI>
<LI>sclerotherap$.tw.</LI>
<LI>exp electrocoagulation/</LI>
<LI>exp hemostasis/</LI>
<LI>exp hemostasis, endoscopic/</LI>
<LI>exp lasers/</LI>
<LI>exp endoscopy gastrointestinal/</LI>
<LI>electrocoagulat$.tw.</LI>
<LI>(therm$ adj5 coagulat$).tw.</LI>
<LI>(heater adj5 probe).tw.</LI>
<LI>laser$.tw.</LI>
<LI>endoclip$.tw.</LI>
<LI>hemoclip$.tw.</LI>
<LI>(monopolar adj5 coagulat$).tw.</LI>
<LI>(multipolar adj5 coagulat$).tw.</LI>
<LI>(bipolar adj5 coagulat$).tw.</LI>
<LI>exp sclerosing solutions/</LI>
<LI>sclerosant$.tw.</LI>
<LI>polidocanol.tw.</LI>
<LI>exp polyethylene glycols/</LI>
<LI>(endoscopic adj3 inject$).tw.</LI>
<LI>thrombin.tw.</LI>
<LI>fibrin glue.tw.</LI>
<LI>exp fibrin tissue adhesive/</LI>
<LI>cyanoacrylate.tw.</LI>
<LI>exp enbucrilate/</LI>
<LI>or/41-67</LI>
<LI>36 and 40 and 68</LI>
<LI>11 and 69</LI>
<LI>limit 70 to ed=20090601-20140523</LI>
</OL>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2011-09-22 09:32:49 -0400" MODIFIED_BY="Karin Dearness">CENTRAL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>EBM Reviews</B>&#8212;<B>Cochrane Central Register of Controlled Trials </B>April 2014</P>
<OL>
<LI>exp peptic ulcer/</LI>
<LI>exp peptic ulcer hemorrhage/</LI>
<LI>exp peptic ulcer perforation/</LI>
<LI>exp duodenal ulcer/</LI>
<LI>exp stomach ulcer/</LI>
<LI>(pep$ adj5 ulcer$).tw.</LI>
<LI>(stomach adj5 ulcer$).tw.</LI>
<LI>(duoden$ adj5 ulcer$).tw.</LI>
<LI>(gastr$ adj5 ulcer$).tw.</LI>
<LI>(bleed$ adj5 ulcer$).tw.</LI>
<LI>(rebleed$ adj5 ulcer$).tw.</LI>
<LI>(recurrent adj5 bleed$ adj5 ulcer$).tw.</LI>
<LI>(acute adj5 bleed$ adj5 ulcer$).tw.</LI>
<LI>exp gastrointestinal hemorrhage/</LI>
<LI>(gastrointestinal adj5 bleed$).tw.</LI>
<LI>(gastrointestinal adj5 rebleed$).tw.</LI>
<LI>(gastrointestinal adj5 hemorrhag$).tw.</LI>
<LI>(gastrointestinal adj5 haemorrhag$).tw.</LI>
<LI>(ulcer adj5 hemorrhag$).tw.</LI>
<LI>(ulcer adj5 haemorrhag$).tw.</LI>
<LI>(mucos$ adj5 injur$).tw.</LI>
<LI>(mucos$ adj5 ero$).tw.</LI>
<LI>(gastr$ adj5 ero$).tw.</LI>
<LI>(stomach adj5 ero$).tw.</LI>
<LI>or/1-24</LI>
<LI>exp epinephrine/</LI>
<LI>epinephrine.tw.</LI>
<LI>exp vasoconstrictor agents/</LI>
<LI>or/26-28</LI>
<LI>(argon adj5 plasma adj5 coagulat$).tw.</LI>
<LI>exp sclerotherapy/</LI>
<LI>sclerotherap$.tw.</LI>
<LI>exp electrocoagulation/</LI>
<LI>exp hemostasis/</LI>
<LI>exp hemostasis, endoscopic/</LI>
<LI>exp lasers/</LI>
<LI>exp endoscopy gastrointestinal/</LI>
<LI>electrocoagulat$.tw.</LI>
<LI>(therm$ adj5 coagulat$).tw.</LI>
<LI>(heater adj5 probe).tw.</LI>
<LI>laser$.tw.</LI>
<LI>endoclip$.tw.</LI>
<LI>hemoclip$.tw.</LI>
<LI>(monopolar adj5 coagulat$).tw.</LI>
<LI>(multipolar adj5 coagulat$).tw.</LI>
<LI>(bipolar adj5 coagulat$).tw.</LI>
<LI>exp sclerosing solutions/</LI>
<LI>sclerosant$.tw.</LI>
<LI>polidocanol.tw.</LI>
<LI>exp polyethylene glycols/</LI>
<LI>(endoscopic adj3 inject$).tw.</LI>
<LI>thrombin.tw.</LI>
<LI>fibrin glue.tw.</LI>
<LI>exp fibrin tissue adhesive/</LI>
<LI>cyanoacrylate.tw.</LI>
<LI>exp enbucrilate/</LI>
<LI>or/30-56</LI>
<LI>25 and 29 and 57</LI>
<LI>limit 58 to yr=2009-2014</LI>
</OL>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2011-09-22 09:32:58 -0400" MODIFIED_BY="Karin Dearness">EMBASE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-01 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>EMBASE </B>1980 to Week 20 2014</P>
<OL>
<LI>random:.tw. or placebo:.mp. or double-blind:.tw.</LI>
<LI>exp peptic ulcer/</LI>
<LI>exp peptic ulcer hemorrhage/</LI>
<LI>exp peptic ulcer perforation/</LI>
<LI>exp duodenal ulcer/</LI>
<LI>exp stomach ulcer/</LI>
<LI>(pep$ adj5 ulcer$).tw.</LI>
<LI>(stomach adj5 ulcer$).tw.</LI>
<LI>(duoden$ adj5 ulcer$).tw.</LI>
<LI>(gastr$ adj5 ulcer$).tw.</LI>
<LI>(bleed$ adj5 ulcer$).tw.</LI>
<LI>(rebleed$ adj5 ulcer$).tw.</LI>
<LI>(recurrent adj5 bleed$ adj5 ulcer$).tw.</LI>
<LI>(acute adj5 bleed$ adj5 ulcer$).tw.</LI>
<LI>exp gastrointestinal hemorrhage/</LI>
<LI>(gastrointestinal adj5 bleed$).tw.</LI>
<LI>(gastrointestinal adj5 rebleed$).tw.</LI>
<LI>(gastrointestinal adj5 hemorrhag$).tw.</LI>
<LI>(gastrointestinal adj5 haemorrhag$).tw.</LI>
<LI>(ulcer adj5 hemorrhag$).tw.</LI>
<LI>(ulcer adj5 haemorrhag$).tw.</LI>
<LI>(mucos$ adj5 injur$).tw.</LI>
<LI>(mucos$ adj5 ero$).tw.</LI>
<LI>(gastr$ adj5 ero$).tw.</LI>
<LI>(stomach adj5 ero$).tw.</LI>
<LI>or/2-25</LI>
<LI>exp epinephrine/</LI>
<LI>epinephrine.tw.</LI>
<LI>exp vasoconstrictor agents/</LI>
<LI>or/27-29</LI>
<LI>(argon adj5 plasma adj5 coagulat$).tw.</LI>
<LI>exp sclerotherapy/</LI>
<LI>sclerotherap$.tw.</LI>
<LI>exp electrocoagulation/</LI>
<LI>exp hemostasis/</LI>
<LI>exp hemostasis, endoscopic/</LI>
<LI>exp lasers/</LI>
<LI>exp endoscopy gastrointestinal/</LI>
<LI>electrocoagulat$.tw.</LI>
<LI>(therm$ adj5 coagulat$).tw.</LI>
<LI>(heater adj5 probe).tw.</LI>
<LI>laser$.tw.</LI>
<LI>endoclip$.tw.</LI>
<LI>hemoclip$.tw.</LI>
<LI>(monopolar adj5 coagulat$).tw.</LI>
<LI>(multipolar adj5 coagulat$).tw.</LI>
<LI>(bipolar adj5 coagulat$).tw.</LI>
<LI>exp sclerosing solutions/</LI>
<LI>sclerosant$.tw.</LI>
<LI>polidocanol.tw.</LI>
<LI>exp polyethylene glycols/</LI>
<LI>(endoscopic adj3 inject$).tw.</LI>
<LI>thrombin.tw.</LI>
<LI>fibrin glue.tw.</LI>
<LI>exp fibrin tissue adhesive/</LI>
<LI>cyanoacrylate.tw.</LI>
<LI>exp enbucrilate/</LI>
<LI>or/31-57</LI>
<LI>26 and 30 and 58</LI>
<LI>1 and 59</LI>
<LI>limit 60 to em=200901-201420</LI>
</OL>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;18 included studies identified in 2006 and 2009, plus one new included study in May 2014. Total 19 included studies&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;8 full-text articles assessed for eligibility&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;10 abstracts screened&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;116 records screened&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;116 de-duplicated records obtained in updated searches May 2014&lt;/p&gt;&lt;p&gt;&lt;/p&gt;"/>
<OUT TEXT="&lt;p&gt;106 records rejected as irrelevant&lt;/p&gt;"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;2 records rejected (already included or excluded in previous review version)&lt;/p&gt;"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;13 studies excluded in total in 2006 and 2009, 7 further studies excluded in 2014. Total 20 studies excluded with reasons&lt;/p&gt;"/>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>